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With continuing advances in genome sequencing technology, the chicken genome 
assembly is now better annotated with improved accuracy to the level of single 
nucleotide polymorphisms. Additionally, the genomes of other birds such as the duck, 
turkey and zebra finch have now been sequenced. A great opportunity exists in avian 
biology to use genome editing technology to introduce small and defined sequence 
changes to create specific haplotypes in chicken to investigate gene regulatory 
function, and also perform rapid and seamless transfer of specific alleles between 
chicken breeds. The methods for performing such precise genome editing are well 
established for mammalian species but are not readily applicable in birds due to 
evolutionary differences in reproductive biology.  
A significant leap forward to address this challenge in avian biology was the 
development of long-term culture methods for chicken primordial germ cells (PGCs). 
PGCs present a cell line in which to perform targeted genetic manipulations that will 
be heritable. Chicken PGCs have been successfully targeted to generate genetically 
modified chickens. However, genome editing to introduce small and defined sequence 
changes has not been demonstrated in any avian species. To address this deficit, the 
application of CRISPR/Cas9 and short oligonucleotide donors in chicken PGCs for 
performing small and defined sequence changes was investigated in this thesis. 
Specifically, homology-directed DNA repair (HDR) using oligonucleotide donors 
along with wild-type CRISPR/Cas9 (SpCas9-WT) or high fidelity CRISPR/Cas9 
(SpCas9-HF1) was investigated in cultured chicken PGCs. The results obtained 
showed that small sequences changes ranging from a single to a few nucleotides could 
be precisely edited in many loci in chicken PGCs. In comparison to SpCas9-WT, 
SpCas9-HF1 increased the frequency of biallelic and single allele editing to generate 
specific homozygous and heterozygous genotypes. This finding demonstrates the 
utility of high fidelity CRISPR/Cas9 variants for performing sequence editing with 
high efficiency in PGCs.  
Since PGCs can be converted into pluripotent stem cells that can potentially 
differentiate into many cell types from the three germ layers, genome editing of PGCs 
can, therefore, be used to generate PGC-derived avian cell types with defined genetic 
alterations to investigate the host-pathogen interactions of infectious avian diseases. 
To investigate this possibility, the chicken ANP32A gene was investigated as a target 
for genetic resistance to avian influenza virus in PGC-derived chicken cell lines. 
Targeted modification of ANP32A was performed to generate clonal lines of genome-
edited PGCs. Avian influenza minigenome replication assays were subsequently 
performed in the ANP32A-mutant PGC-derived cell lines. The results verified that 
ANP32A function is crucial for the function of both avian virus polymerase and 
human-adapted virus polymerase in chicken cells. Importantly, an asparagine to 





avian influenza polymerase function. This genetic change can be introduced into 
chickens and validated in virological studies. Importantly, the results of my 
investigation demonstrate the potential to use genome editing of PGCs as an approach 
to generate many types of unique cell models for the study of avian biology. 
Genome editing of PGCs may also be applied to unravel the genes that control the 
development of the avian germ cell lineage. In the mouse, gene targeting has been 
extensively applied to generate loss-of-function mouse models to use the reverse 
genetics approach to identify key genes that regulate the migration of specified PGCs 
to the genital ridges. Avian PGCs express similar cytokine receptors as their 
mammalian counterparts. However, the factors guiding the migration of avian PGCs 
are largely unknown. To address this, CRISPR/Cas9 was used in this thesis to generate 
clonal lines of chicken PGCs with loss-of-function deletions in the CXCR4 and c-Kit 
genes which have been implicated in controlling mouse PGC migration. The results 
showed that CXCR4-deficient PGCs are absent from the gonads whereas c-Kit-
deficient PGCs colonise the developing gonads in reduced numbers and are 
significantly reduced or absent from older stages. This finding shows a conserved role 
for CXCR4 and c-Kit signalling in chicken PGC development. Importantly, other 
genes suspected to be involved in controlling the development of avian germ cells can 
be investigated using this approach to increase our understanding of avian reproductive 
biology. 
Finally, the methods developed in this thesis for editing of the chicken genome may 

















More than 70 billion chickens globally produce meat and eggs which are dietary 
sources of high-quality protein, minerals and vitamins. The chicken is, therefore, an 
essential global commodity and importantly, a source of income for small and rural 
families in developing countries. The chicken is also a useful model for biological 
research, and a valuable bioreactor to produce recombinant therapeutic proteins to treat 
some human diseases. Useful traits or characteristics such as disease resistance can be 
introduced into the chicken by making or reproducing small changes in the DNA 
through a process called genome editing.  These DNA changes can be performed using 
a genome editing tool called CRISPR/Cas9 which is simple to construct and easy to 
apply. In the chicken, genome editing will be useful to scientists studying the function 
of genes to increase our understanding of health and diseases in birds.  
However, genome editing is difficult to perform in birds. This is because the common 
genome editing techniques that have been developed for laboratory animals like mice 
and rats are difficult to apply in birds due to differences in their reproductive systems. 
In the chicken, scientists have been able to perform genome editing on reproductive 
cells in the chick embryo called primordial germ cells (PGCs). PGCs give rise to sperm 
and egg in adult animals. Chicken PGCs can be obtained from young chick embryos 
growing in fertile eggs. The PGCs are then grown in the laboratory under special 
conditions. Genome editing is performed on the laboratory-grown PGCs to introduce 
a desired change in the chicken DNA. The genome-edited PGCs are then injected into 
a surrogate chick embryo growing in another fertile egg which is then incubated until 
it hatches into a chick. The injected genome-edited PGCs will eventually form sperm 
or egg once the hatched chick grows into an adult chicken.  
Using this method, CRISPR/Cas9 has been used to produce genome-edited chickens. 
However, scientists have not been able to specify the type of changes made in the DNA 
during genome editing in chicken PGCs. In order to use genome editing to introduce 
a useful trait like disease resistance to avian influenza, it would be necessary to develop 
a genome editing method to accurately introduce small and defined DNA changes. In 
this thesis, I show a method for accurately making such defined DNA changes in 
chicken PGCs using an enhanced variant of CRISPR/Cas9.  
Furthermore, I used cells produced from genome-edited PGCs in avian influenza (bird 
flu) experiments and discovered that a chicken gene called ANP32A may potentially 
be genome-edited in chickens to prevent avian influenza infections. However, this 
preliminary result must be verified in future animal studies. Scientists investigating 
diseases of birds face a shortage of avian cells to experiment on in the laboratory. 
Experimenting on cells produced from genome-edited PGCs can address the shortage 
of available chicken cells and can be used to discover other genes in chickens that can 





Finally, genome editing was performed on chicken PGCs to study the function of genes 
that control the development of PGCs in the chick embryo. During chick embryo 
development in the fertile egg, PGCs must migrate from where they originate in the 
young embryo to the location of the future genital organs in older embryos. Incorrect 
migration of PGCs can lead to the development of cancers or infertility in adult 
animals. Unlike in the mouse, the genes that control this PGC migration are mostly 
unknown for birds. In this thesis, I show that two genes called CXCR4 and c-Kit, are 
essential for promoting the migration of chicken PGCs. This method can be used to 
investigate other genes suspected to be involved in regulating the development of 
chicken PGCs to increase our understanding of the avian reproductive biology.  
All the methods developed in this thesis for genome editing of the chicken may be 
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1.0 GENERAL INTRODUCTION 
Thousands of years ago, humans began domesticating wild animals to meet a variety 
of needs such as meat, egg and milk for nutrition, the hide or skin for clothing, and 
even companionship derived from partnerships with animals like dogs and cats. These 
animals, prior to human contact, had adapted to their wild environment through the 
process of natural selection and passed down more favourable/adaptive phenotypes to 
their offspring (Darwin, 1859). During the cumulative process of domestication which 
happened over multiple generations, the domesticated animals that survived were 
adapted to survive in their new artificial environment through integrated changes in 
their genetics, anatomy, physiology, psychology and behaviour (Andersson, 2001). In 
this artificial environment, humans have continuously selected certain animals with 
desirable and identifiable characteristics to breed for specific purposes, leading to a 
diversity in domesticated animals within the same species (Colino-Rabanal et al., 
2018). Indeed, artificial selection or selective breeding by humans, which acts rapidly 
and by human design with more visible results, is quite similar to natural selection in 
the wild, which acts slowly often over thousands of years, since both types of selection 
eventually result in changes to the genome and the modification of phenotype (Cheng, 
2010). 
1.1 THE CHICKEN  
The domestic chicken, Gallus gallus domesticus, was domesticated from the wild red 
junglefowl, Gallus gallus gallus, with possible genetic contribution from the grey 
junglefowl, Gallus sonneratii, and other closely related species (Fig. 1.1) (Eriksson et 
al., 2008; Fumihito et al., 1994, 1996; Liu et al., 2006; Nishibori et al., 2005). It is 
believed that domestic chickens appeared around 8000 Before Present (BP) in 
Southeast Asia, and were introduced around 4500 BP into India and Oceania, around 
3000 BP into Europe, around 2300 BP into Africa, and brought to South America via 
the Pacific by the Polynesians (FAO, 2015; Storey et al., 2012). Numerically, the 
domestic chicken is the most widely farmed animal species and constitutes over 90% 





consumed and are a source of high quality dietary nutrients. The production of chicken 
and chicken by-products represents an important economic sector in many countries, 
and is a mainstay of many small or rural communities globally (FAO, 2015). 
Depending on whether or not they have been specially bred for egg and meat 
production through intense and structured genetic selection, chickens can be broadly 
classified as local/indigenous or commercial (FAO, 2015).  
1.1.1 Local chickens 
Local chicken breeds have largely been developed through adaptation to the natural 
environment and traditional production system of villages in which they have been 
raised over centuries (Fig. 1. 1) (Bettridge et al., 2018; Cheng, 2010). Local breeds 
in many parts of the world are able to reproduce without any assistance, appear to have 
an inherent scavenging and nesting habit and  are resilient to various diseases prevalent 
in their environment due to years of natural selection (Besbes, 2009; Bettridge et al., 
2018; Muir et al., 2008). Local chicken populations have also been shown to have high 
levels of genetic diversity and contain rare alleles which could encode for traits such 
as disease resilience and/or resistance (Bettridge et al., 2018; Elferink et al., 2012; 
Muir et al., 2008). Most local breeds are poor egg producers laying about 40 to 60 eggs 
per year (Guèye, 1998). They also have lower feed conversion rates and small body 
size. For instance, mature body weights for various African chicken breeds are 
between 1.3 and 1.9 kg for males and between 1.0 and 1.4 kg for females (Besbes et 
al., 2007). Also, local chickens are usually coloured or a mixture of different colours 
which is believed to help them camouflage in their environment (Besbes, 2009; FAO, 
2010).  
1.1.2 Commercial chickens 
In contrast, commercial chicken breeds have been intensely selected in intensive 
breeding systems in which environmental stresses are removed to allow greater 
focus on maximizing quality traits, and less focus on adaptation to local 
environment and disease resistance (Cheng, 2010; Muir et al., 2008). There are two 
main types of commercial chickens based on their productivity (Fig, 1.1): meat-






Figure 1.1 Chicken. A) Male red junglefowl in India. B) Indigenous chickens foraging 
in Ethiopia. C) Six-week-old broilers in a commercial broiler farm D) Layers housed in 
battery cages in a commercial layer farm. 











 egg-producing chickens called layers which can produce more than 300 eggs per 
year (FAO, 2015). Commercial chickens are usually grown under controlled 
environmental conditions for efficient productivity, and introducing them into hot 
tropical climates has been found to be problematic as they often have lower 
productivity due to the heat  (Bell et al., 2002; Lara & Rostagno, 2013). 
1.1.3 Poultry breeding  
Poultry breeding and genetic selection for efficient productivity in commercial 
chickens was performed using phenotype, performance and pedigree information prior 
to availability of genomics information (Bell et al., 2002; Burt, 2002; Preisinger, 2012; 
Wolc, 2014). Within highly selected commercial pedigree lines, selection limit can be 
reached resulting in no further noticeable improvement in phenotype with further 
breeding (Hunton, 1984; Johansson et al., 2010).  For commercial chickens, broilers 
and layers are obtained from 4-way crosses in a pyramidal breeding structure starting 
with pedigree lines, and pedigree and performance data for these pedigree lines are not 
publicly available (Table 1.1; Fig. 1.2) (FAO, 2015; Laughlin & MIBiol, 2007; Wolc 
et al., 2016). For local chickens, improvements in productivity by selecting within 
indigenous populations was challenging due to the absence of pedigree and 
performance records (Besbes, 2009; FAO, 2010; Pym, 2008).  Crossbreeding of local 
chickens with commercial chickens has been practiced to increase productivity of local 
chickens but the morphological features of the local chickens (feather colour and 
comb) are lost or diluted and any beneficial traits are usually not fixed and are lost in 
future generations (Besbes et al., 2007). Crossbreeding of commercial chickens with 
local chickens to introduce rare alleles into commercial pedigree lines is problematic 
due to the low productivity of local breeds and linkage drag that results in co-
segregation of unwanted alleles with the desired allele (Dekkers & Hospital, 2002; 
Wall et al., 2005). If useful alleles are identified in local breeds, it is not known how 
to transfer these alleles into commercial pedigree lines without the co-introduction of 
detrimental alleles. 
1.1.4 Genomics in poultry breeding 
Genomics has now become a core component of poultry breeding, especially 











Figure 1.2 Representation of a modern poultry breeding programme. (Adapted 
from FAO, 2015 and Laughlin, 2007) 
Table 1.1 Four-way broiler cross-breeding scheme showing relative numbers of 





Chicken Genome Sequencing Consortium, 2004). Available information on 
naturally occurring genetic variations, including small-scale sequence variation (< 
1-kbp) such as single nucleotide polymorphisms (SNPs) as well as structural 
variations (> 1-kbp)  such as copy number variation, are being linked to phenotype 
to improve the accuracy of selective breeding, and refine selection for specific traits 
(Wolc et al., 2016; Wolc et al., 2014). Additionally, genome-wide association 
studies have revealed that commercial pedigree lines possess narrow genetic 
diversity compared to local chickens and may be missing important rare alleles 
which may include traits for disease resilience and heat tolerance (Muir et al., 2008). 
With the improving capability in genome sequencing technologies, more robust 
screening for small-scale sequence variations including SNPs, single nucleotide 
substitutions, small sequence insertions/deletions/substitutions (INDELs) and 
alternative RNA splicing sites can be performed to select for specific traits. 
However, allele introgression to transfer and fix any desired genetics, while 
excluding unwanted co-segregating genetic regions, and maximally conserve the 
genome of the recipient population would be slow and lengthy using traditional 
crossbreeding alone (Dekkers & Hospital, 2002; Wall et al., 2005). Alternatively, 
allele introgression of any desired genotype might be performed faster and more 
precisely through direct genetic modification of the chicken reproductive germline. 
1.1.5 The chicken as a biological model   
In developmental biology, the ease of accessing and manipulating the chick embryo in 
ovo or ex vivo during development while it continues to develop has made the chicken 
a choice embryological model with enormous contribution to the field (Davey & 
Tickle, 2007; Stern, 2005). For example, classical techniques such as grafting and 
lineage tracing in a chick/quail chimeric embryos revealed that the neural crest gives 
rise to a wide range of tissues, including the entire peripheral nervous system, the 
dorsal root and enteric ganglia, pigment cells of the skin, Schwann cells and, 
connective tissues in the head and most of the skull (Creuzet et al., 2005; Davey & 
Tickle, 2007). Furthermore, studies using spontaneously-occurring chicken mutant 
models have been used to advance the understanding of autoimmune diseases such as 





model for human autoimmune vitiligo, and the University of California at Davis 
(UCD) 200 chicken line for human systemic sclerosis (Wick et al., 2006).  However, 
the use of the chicken as a model for the genetic dissection of physiological and 
anatomical development has lagged behind the mouse for which knockout and 
transgenic models are easily established.  
Furthermore, the chicken can be afflicted by many diseases that affect welfare and 
productivity. Some of these diseases are zoonotic with pandemic potential. For 
example, the zoonotic avian influenza virus causes disease that diminishes chicken 
productivity and is sometimes characterized by massive flock mortalities, and has 
caused at least 800 human fatalities since 2013 in a currently ongoing pandemic 
(Alexander, 2007)(OIE, 2018; WHO, 2018). Interestingly, the genetic basis for 
resistance and susceptibility to disease was first demonstrated in the chicken using 
inbred chicken lines carrying an MHC allele that rendered them resistant to Marek’s 
disease (Longenecker et al., 1976). With the availability of sophisticated genome 
sequencing technologies, unique genetic variations that increase or reduce disease 
susceptibility in the chicken can now be discovered but would need to be to be 
validated experimentally in cells or animals. However, the study of host genetic factors 
that influence the pathobiology of avian diseases has been challenging due to the 
difficulty of generating specific chicken models.  
Consequently, the development of efficient approaches to precisely target specific 
genes and introduce defined genetic changes into the genome of the chicken and other 
avian species will therefore be essential in order to avail avian biologists of a powerful 
molecular tool for the study of gene function, elucidation of avian biological 
development and the study of health and disease. 
1.2 METHODS FOR GENETIC MODIFICATION OF THE CHICKEN  
Three reasons for developing methods to modify the genome of the chicken include 
(Lee et al., 2017; McGrew, 2013):  
i. To increase the understanding of disease resistance and resilience and to 
generate disease-resistant and/or disease-resilient flocks. 





iii. To generate transgenic flocks for the production of biopharmaceutical proteins 
in eggs. 
Over the last three decades, there has been considerable effort to develop efficient 
methods to introduce genetic changes into the chicken genome. The unique 
reproductive biology of avian species has made the application of genetic modification 
challenging and often, completely inefficient. In the following sections, methods for 
achieving avian genetic modifications will be discussed.  
1.2.1 Manipulation of the avian zygote 
Transgenesis in animals was first demonstrated in the mouse through pronuclear 
injection to introduce exogenous DNA into the germline (Costantini & Lacy, 1981; 
Gordon & Ruddle, 1981). Pronuclear injection involves the microinjection of the 
foreign DNA, referred to as the transgene, into the pronucleus of a zygote prior to the 
first cleavage (Ittner & Götz, 2007). In the chicken, pronuclear injection is not 
practised because of the difficulty accessing the single-cell zygote (Sang, 2004). After 
ovulation in the laying hen, embryonic development proceeds rapidly so that the 
chicken egg at the point of lay contains a blastoderm containing up to 60, 000 cells. 
Therefore, microinjection of the zygote requires surgical removal of the fertilised 
zygote from inside a sacrificed laying hen within two to three hours of the previous 
oviposition, and then subsequent surgical transfer of the manipulated zygote to a 
surrogate hen (Perry, 1988; Sang, 1994). Also, there is the difficulty of visualising the 
pronuclei located in a very small pool of cytoplasm within a large opaque yolky ovum 
(Sang, 2004; Waddington et al., 1998). Pronuclear injection of the zygote is therefore 
not performed.  
Exogenous DNA, however, can be injected into the cytoplasm of the chicken zygote 
followed by ex ovo culture in a host shell until hatching (Fig. 1.3B) (Perry, 1988; Sang, 
1994). Cytoplasmic injection of the zygote is an efficient method of genetic 
modification in mouse, rat, pig, sheep, goat and cattle (Geurts et al., 2009; Horii et al., 
2014; Tan et al., 2016).  This method has been used to produce transgenic chickens 
harbouring a β-galactosidase reporter (Sang & Perry, 1989). However, germline 





between generations. In addition to the research above, generation of genetically 
modified chickens using through intracytoplasmic injection is not commonly practised 
due to the cost and difficulties in accessing the early chicken oocyte (Sang, 1994, 
2004).  
Transfection of cultured somatic cells followed by transfer of the nucleus into an 
enucleated egg is another established method of genetic modification commonly 
practised in mammalian species except in the rat and primate species (Wilmut et al., 
2002). This approach, called somatic cell nuclear transfer (SCNT), is the most widely 
used method for generating genetically modified livestock (Tan et al., 2016). SCNT is 
not practised in avian species due to the technical difficulties associated with 
accessing, visualizing and enucleation of the early avian oocyte (Sang & Perry, 1989). 
1.2.2 Retroviral transduction of the blastoderm  
Retroviruses are single-stranded, positive-sense RNA viruses that reverse-transcribe 
their genome into a DNA intermediate, the provirus, which is integrated into the 
genome of the host cell as part of their life cycle (Coffin et al., 1997). Through this 
process, exogenous DNA can be transferred into the host genome when a retrovirus 
containing a recombinant genome is used. The experimental technique of viral-
mediated gene transfer in avian species involves injection of the modified retrovirus 
in the subgerminal space under the stage X EG&K blastoderm (Fig. 1.3A) (Salter et 
al., 1987). Germline transmission after mating of the chimaeric animals will only occur 
if the provirus is incorporated into the genome of germ cells which are located in the 
blastoderm at this developmental stage. Replication-competent retroviruses capable of 
generating more infective viral particles to infect additional cells and replication-
defective retroviruses incapable of replication due to the removal of portions of the 
viral genome that are essential for replication (Dudek & Knipe, 2006; Sang, 2004). 
These viral vectors have been used to produce transgenic chickens and quails (Ahn et 
al., 2015; Mizuarai et al., 2001; Sang, 2004; Woodfint et al., 2017). For example, the 
replication-competent avian leucosis virus was used to generate disease-resistant 
transgenic chickens containing a proviral insert that conferred resistance to pathogenic 
avian leukosis virus (Salter & Crittenden, 1989). Replication-defective 





neomycin reporter gene  (Bosselman et al., 1989). Transgenic quails were generated 
using a replication-defective pantropic retroviral vector based on Moloney murine 
leukaemia virus (MoMLV) pseudotyped with vesicular stomatitis virus G protein 
(VSV-G) (Mizuarai et al., 2001). A major drawback with the use of retroviruses is that 
the transgene was present in founder (G0) birds at low levels and germline 
transmission of transgenes from founder birds to their progenies was also very ranging 
from 0 to 8% (Harvey et al., 2002; Koo et al., 2010; Mozdziak & Petitte, 2004; Rapp 
et al., 2003; Thoraval et al., 1995). 
1.2.3 Lentiviral vectors 
Lentiviruses have become the preferred viral vector for avian transgenesis and have 
been used to generate transgenic chickens, quails and zebra finch through injection of 
the modified lentivirus into the subgerminal space under the stage X EG&K 
blastoderm (Fig. 1.3A) (Mcgrew et al., 2004; McGrew et al., 2008; Scott & Lois, 
2005). Importantly, lentiviruses have been used to produce biopharmaceutical proteins 
in eggs including human extracellular superoxide dismutase, human interferon β1a, 
human interleukin-1 receptor antagonist, human neutrophil defensin 4, human 
lysozyme and human erythropoietin (Byun et al., 2013; Cao et al., 2015; Kwon et al., 
2018; Lillico et al., 2007; Liu et al., 2015; Whenham et al., 2014). Notably, Kanuma 
(Sebelipase alfa), which is a recombinant protein generated from the egg white of 
transgenic chickens generated using a lentiviral vector, has been approved for the 
treatment of human lysosomal acid lipase deficiency (Sheridan, 2016). Compared to 
lentiviruses, a limitation in the application of retroviruses is that they can only 
transduce dividing cells since they only enter the nucleus when the nuclear membrane 
breaks down (Naldini et al., 1996).  Lentiviruses have the advantage of infecting 
dividing, non-dividing and differentiated cells with a high rate of proviral DNA 
integration which can reach up to 100% transmission in multiple species (Durand & 
Cimarelli, 2011; Whitelaw et al., 2008). Lentiviral vectors have become an important 
vehicle for the delivery of artificial site-specific nucleases for genome editing 
especially in hard-to-transfect cells (Cai et al., 2016; Cai et al., 2014; Sanjana et al., 
2014). There are public concerns and issues of consumer acceptance of the generation 





delivered using HIV-lentiviral constructs if one of these GM products would enter the 
food chain (Garas et al., 2015). 
1.2.4 Genetic modification of chicken embryonic stem cells 
In mammals, embryonic stem cells (ESCs) are pluripotent cells isolated from the inner 
cell mass of a blastocyst and cultured in vitro (Nichols & Smith, 2009). Mammalian 
ESCs are capable of self-renewing in vitro and can differentiate into any specialised 
cell of the body, including germ cells, but not extra-embryonic tissues (Medvedev et 
al., 2010). Rat and mouse ESCs can be cultured for long term in vitro without 
differentiating, can be genetically modified in vitro, and then transplanted into a 
surrogate blastocyst to generate chimaeras which show efficient germline transmission 
upon breeding (Bradley et al., 1984; Gossler et al., 1986; Kawamata & Ochiya, 2010; 
Li et al., 2008; Martin, 1981; Thomson et al., 1998; Ueda et al., 2008). The in vitro 
culture of ESCs offered the opportunity to perform precise, targeted genetic changes 
and carry out genetic screening to identify cells with the desired genotype before 
generating the genetically modified animal (Gossler et al., 1986; Kawamata & Ochiya, 
2010). This approach reduces the cost and tackles the ethical issues and associated 
with breeding many animals to identify a single animal with the desired genetic change 
(Russell & Burch, 1959; Tannenbaum & Bennett, 2015). Bona fide livestock ESCs 
remain difficult to isolate and propagate in vitro. 
In the chicken, blastodermal cells isolated from stage X EG&K embryos and cultured 
for five days were shown to contribute to somatic and germ cell lineages (Etches et al., 
1996; Petitte et al., 1990). These studies provided initial evidence for the existence 
pluripotent embryonic stem cells in the chicken. Chicken embryonic stem cells 
(cESCs) have been isolated, cultured for long-term and used to produce chimeras after 
implantation into the subgerminal cavity of stage X EG&K embryos (Macdonald et 
al., 2010; Pain et al., 1996). However, contribution to the formation of the germline 
has not been observed for cESC after in vitro genetic modification (van de Lavoir et 







1.2.5 Direct targeting of the germ cell lineage 
Most of the methods for generating genetically modified chickens discussed in the 
previous sections are characterised by poor germline transmission or are only suitable 
Figure 1.3. Workflow of various methods for germline genetic modifications in 
the chicken. (A) Injection of virus mixture into the subgerminal cavity of stage X 
EG&K chicken embryo. (B) Surgical removal and subsequent microinjection of 
fertilised ova (single-cell zygote). (C) Sperm-mediated transfection and artificial 
insemination. (D) In vivo transfection of primordial germ-cells in embryonic 





for the generation of transgenic chickens. Therefore, methods that permit the 
development of genetically modified non-transgenic chickens and increase germline 
transmission by directly incorporating genetic changes into the germ cell lineage have 
been developed.  
1.2.5.1 Direct targeting of the adult gametes 
A method to directly transfect sperm was demonstrated for generating genome-edited 
chickens (Fig. 1.3C) (Cooper et al., 2017). In this method, termed STAGE (sperm 
transfection assisted gene editing), Cas9 mRNA, gRNA and HDR short single stranded 
oligodeoxynucleotides were incubated with lipofection reagent and washed 
spermatozoa. The sperm mixtures were then inseminated into the cloaca of hens. In 
the authors’ attempt to introduce INDELs into a GFP reporter gene, an average of 14% 
of G1 embryos and chicks contained INDELs on the GFP allele and  did not express 
GFP when transfected semen from GFP+ rooster was inseminated in non-transgenic 
hens. However, the attempt to introduce mutations with and without the HDR template 
in the DMRT1 gene failed to yield any G0 chicks with a mutation. This method requires 
the production of many G1 offspring to identify an individual with a desired specific 
genotype. Also, the stability of the mRNA during the sperm incubation would likely 
affect the CRISPR/Cas9 efficiency. Additionally, mutagenesis of the cloacal tissue by 
the gene editing reagents is very possible which may affect the health and welfare of 
the hen. Nevertheless, STAGE may be applied for avian species in which PGC culture 
methods are yet to be established  (Cooper et al., 2017). 
1.2.5.2 Targeting of primordial germ cells  
Primordial germ cells (PGCs) are the embryonic progenitors of the gametes, sperm 
and ovum. Chicken PGCs can be cultured in vitro for long term and contribute to the 
formation of the germline once injected into surrogate embryos (van de Lavoir, 
Diamond, et al., 2006; Whyte et al., 2015). This makes chicken PGCs highly useful 
for the generation of genetically modified chickens (Fig. 1.3E). Targeting of chicken 
PGCs offers a time-saving and cost-saving in vitro platform to perform precise genetic 
modifications in defined loci and screen for successfully targeted cells that can be used 
to produce the modified chickens. In the next sections, the origin, migration, culture 





1.3 PRIMORDIAL GERM CELLS  
1.3.1 Identification of PGCs 
PGCs were initially identified using histological features prior to the discovery of 
antibody markers of the germ cell lineage (Fig. 1.4) (Risley, 1933; Swift, 1914). 
Histologically, PGCs can be identified by their large round nucleus and single large 
nucleolus. The PGC cytoplasm appears to be relatively clear of organelles and contains 
granular material. The granular cytoplasmic material, also referred to as the germ 
plasm, has been shown to contain electron-dense masses using transmission electron 
microscopy (Extavour & Akam, 2003). The germ plasm contains germ-cell specific 
transcripts and proteins that are expressed at different embryonic stages and are 
required for germ cell development. Germ-cell specific markers enable the 
identification of PGCs, making them distinguishable from the surrounding soma. The 
most widely used molecular markers used for PGC identification are Vasa, Dazl and 
SSEA-1 which are conserved across many phyla (Castrillon et al., 2000; Chen et al., 
2014; Extavour & Akam, 2003; Jung et al., 2005; Kerr et al., 2008; Tagami et al., 
2017). The extensive characterization of the timing and migration has only been 
possible using specific histological and molecular features to identify PGCs. 
Avian PGCs have widely conserved histological features (Tagami et al., 2017). In 
particular, chicken PGCs have been well characterised and are identified by their large 
spherical nucleus which is eccentrically positioned, a glycogen-rich cytoplasm 
containing numerous refractive lipids, and their large size with a diameter of 10 – 20 
µm (Nakamura et al., 2007; Nakamura et al., 2013). Chicken PGCs are also 
Figure 1.4.  Drawing of primordial germ cells (arrows) and nearby entodermal 






distinguishable using periodic acid Schiff (PAS) staining for glycogen which is present 
in their cytoplasm in large amounts (Meyer, 1964; Nakamura et al., 2007; Tagami et 
al., 2017).  
Chicken PGCs have been principally molecularly identified using the chicken vasa 
homologue (Cvh) in most reports (Tsunekawa et al., 2000; Glover & McGrew, 2012; 
Tagami et al., 2017). Cvh is the earliest molecular marker of chicken PGCs expressed 
at all stages of embryonic development (Tsunekawa et al., 2000). Cvh is also expressed 
in vitro in long-term cultures, and exhibiting a similar expression pattern in vivo 
(Macdonald et al., 2010; Whyte et al., 2015). Another germ-cell specific marker is 
deleted-in-azoospermia-like (Dazl), which is also an RNA-binding protein expressed 
in the cytoplasm and nucleus of chicken PGCs (Kito et al., 2010). Like in human, 
Xenopus, zebrafish and mouse, Dazl is expressed in chicken PGCs at all stages of 
development (Chen et al., 2014; Rengaraj et al., 2010). Dazl is also expressed by 
chicken PGCs in vitro (Whyte et al., 2015). Another chicken germ-cell specific gene 
is the dead-end gene (cDnd1), and is expressed in vivo and in vitro, and is localised in 
the nucleus (Aramaki et al., 2007; Aramaki et al, 2009; Macdonald et al., 2010). 
1.3.2 Specification of PGCs 
PGCs are specified through one of two distinct mechanisms in animals. These 
mechanisms are preformation and induction (Extavour & Akam, 2003; Strome & 
Updike, 2015).  
1.3.2.1 Preformation 
In some animal species, the specification of PGCs is determined by a maternally 
inherited germ plasm which is stored in the oocyte prior to fertilization. This mode of 
specification in which a preformed germ plasm is transmitted from the oocyte onward 
to precursor cells of the PGCs which are identifiable in very early embryonic tissues 
is referred to as preformation or inheritance. Preformation has been described in 
Drosophila melanogaster (Fig 1.5A) (Illmensee & Mahowald, 1974; Leitch & Smith, 
2013; Santos & Lehmann, 2004), Caenorhabditis elegans (Strome & Wood, 1982; 
Strome & Updike, 2015), as well as in some vertebrates such as Xenopus and  zebrafish 
(Houston & King, 2000; Olsen et al., 1997).  In zebrafish for instance, the vasa mRNA 





egg or 1-cell stage embryo (Yoon et al., 1997). After fertilization and following 
cleavage division, vasa mRNA first localises along the cleavage furrow and finally 
segregates into four cells by the 32-cell stage of the early embryo which are specified 
as PGCs (Olsen et al., 1997; Yoon et al., 1997). 
 
Figure 1.5. PGC specification in Drosophila and Mouse. (A) Preformation model 
of PGC specification in Drosophila;  The nurse cells synthesise germ plasm RNAs 
and proteins (pink) that are localised to the posterior pole of the oocyte. This germ 
plasm will be segregated into pole cells to become PGCs (From Leitch & Smith, 2013). 
B) Specification of mouse PGCs by induction. Between ED 5.5-5.75, epiblast (Epi) 
cells acquire competence to be specified due to NODAL and WNT3 signalling.  From 
ED 6.25, a few competent proximal epiblast cells located next to the extraembryonic 
ectoderm (Exe) receive high levels of BMP signals to be specified as PRDM1- and 
PRDM14-positive PGC precursors. Between ED 6.5 and 7.5, a subset of PGC 
precursors are specified as PGCs. VE-visceral endoderm; ExM- extraembryonic 









Specification by induction or epigenesis occurs in some animals in which PGCs or 
PGC precursor cells containing the germ plasm are not present at the early stages of 
embryogenesis. Instead, inductive signals produced by neighbouring somatic cells 
specify PGCs in the presumptive mesoderm much later in embryonic development. 
The epigenetic mechanism of PGC specification occurs in all mammals and urodele 
amphibians. For instance, a germ plasm is not present in the oocyte or immediately 
after fertilization in the mouse (Extavour & Akam, 2003). Instead, bone morphogenic 
protein (Bmp) signals from the extraembryonic ectoderm and endoderm reach the cells 
of the proximal epiblast to induce the formation of PGC precursors between embryonic 
day (ED) 5.5 and 6.25 (Fig. 1.5B) (Saitou & Yamaji, 2010). 
1.3.2.3 Specification of chicken PGCs 
Using histological techniques, chicken PGCs were first reported to originate from the 
hypoblast (Swift, 1914), and then later found to arise from the epiblast instead (Eyal-
Giladi et al., 1981). Initially, it was proposed that avian PGCs arose through a gradual 
epigenetic mechanism that begins at very early blastoderm stages (Karagenç et al., 
1996). Following the isolation of the chicken vasa homologue (Cvh), 
immunocytochemical staining of chicken oocytes showed that Cvh co-localized with 
the mitochondrial cloud thereby suggesting the presence of a germ plasm in chicken 
oocytes (Tsunekawa et al., 2000). Cvh was also detected along cleavage furrows in 
cleavage-stage embryos from stage I-III EG&K (Roman numerals refer to the chick 
embryo staging system of Eyal Giladi & Kochav, 1976) (Tsunekawa et al., 2000). 
Also, the Dazl germ cell marker was shown to be expressed in the oocyte and early-
cleavage-stage chick embryo (Lee et al., 2016). These findings therefore suggest that 
chicken PGCs are probably specified by preformation. Functional studies such as 
ectopic transplantations and inhibition of the germ plasm are yet to be done to confirm 
this mode of specification in avian species. Nevertheless, induction is assumed to be 
the ancestral mode of PGC specification since it is the prevalent mode of PGC 
specification across metazoans whereas preformation in various animal phyla is 
assumed to have arisen through convergent evolution (Extavour & Akam, 2003; 





1.3.3 MIGRATION OF PGCs 
Shortly after specification, PGCs must migrate from the location of their origin to 
reach the somatic gonadal precursors where they will undergo sex-specific 
differentiation and further differentiate to form the gametes. 
1.3.3.1 Migratory route of PGCs 
1.3.3.1.1 Zebrafish  
In zebrafish, four PGC clusters equidistant from each other and close to the margin of 
the blastoderm are present following specification and form a square-like arrangement 
(Fig. 1.6).  Zebrafish PGC migration subsequently constitutes six distinct steps that 
involves active migration between intermediate targets during which PGCs move as 
polarised cells. At intermediate targets, zebrafish PGCs lose their polarity and are 
temporarily carried along by the movement of somatic tissues before resuming active 
migration to continue to the next target (Weidinger et al., 1999).  
1.3.3.1.2 Mouse  
In mouse, specified PGCs actively migrate at ED 7.5 from the extraembryonic 
mesoderm region close to the posterior primitive streak into the subjacent endoderm 
which will give rise to the hindgut (Fig. 1.7) (Anderson et al., 2000; Clark & Eddy, 
1975). Between ED 8.5 and 9.5, the mouse PGCs actively migrate along the hindgut 
to the level of the genital ridges, and subsequently migrate actively through the dorsal 
midline of the hindgut into the dorsal mesentery (Anderson et al., 2000; Clark & Eddy, 
1975; Molyneaux et al., 2001; Molyneaux & Wylie, 2004). Mouse PGCs then move 
laterally in two separate clusters from the midline to colonise the left and right 
developing genital ridges by ED 12.5 (Molyneaux et al., 2001). 
1.3.3.1.3 Chicken 
The laid chicken egg contains a stage X  EG&K   embryo containing approximately 
30 to 130 chicken PGCs distributed in the central area of the area pellucida on the 
ventral surface of the epiblast (Fig. 1.8) (Ginsburg & Eyal-Giladi, 1987; Nakamura et 
al., 2007; Tagami et al., 2017). Between stages XI-XIV EG&K , chicken PGCs are 
translocated during morphogenetic movements onto the dorsal surface of the hypoblast 
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Between stages 1-4 HH, the hypoblast containing the chicken PGCs is displaced into 
the anterior extraembryonic region known as the germinal crescent (Nakamura et al., 
2007; Nieuwkoop & Sutasurya, 1979). By stages 10-11 HH, chicken PGCs become 
concentrated in the splanchnopleura anterior to the head, and then accumulate in the 
vicinity of the sinusoids of the sinus terminalis which converge into the forming 
anterior vitelline veins within the yolk sac (Fig. 1.8G) (De Melo Bernardo et al., 2012; 
Nakamura et al., 2007). By stages 12-13 HH, chicken PGCs enter into blood 
circulation, and between stages 15-17, chicken PGCs extend lamellipodia to exit the 
blood vessels to migrate through the dorsal mesentery (Fig. 1.8H) (Fujimoto et al., 
1976; Tagami et al., 2017). By stage 18 HH, PGCs accumulate in the right and left 
lateral plate mesoderm and then, colonise the left and right developing genital ridges 
by stage 20 HH (Fig. 1.8I) (Stebler et al., 2004).  
1.3.3.2 Molecular control of PGC migration 
The migratory path of PGCs is not widely conserved between fish, mammals and birds 
as detailed out in the preceding section (Richardson & Lehmann, 2010). However, 
some principal genes expressed by PGCs that govern migration have been investigated 
in model organisms. 
1.3.3.2.1 CXCR4/SDF-1 and CXCR7/SDF-1 signalling 
CXCR4 (C-X-C Motif Chemokine Receptor 4) is a 7-transmembrane G protein-
coupled receptor (GPCR) that is located on the cell surface. It selectively binds the 
CXC chemokine, CXCL12 also known as Stromal Cell-Derived Factor 1 (SDF-1) 
(Busillo & Benovic, 2007). Mouse, zebrafish, Xenopus and chicken PGCs express the 
CXCR4 receptor (Ara et al., 2003; Doitsidou et al., 2002; Molyneaux et al., 2003; 
Stebler et al., 2004; Takeuchi et al., 2010). CXCR4/SDF-1 signalling is critical for 
directional migration in mouse, Xenopus and zebrafish and is discussed in CHAPTER 
FIVE (Ara et al., 2003; Doitsidou et al., 2002; Molyneaux et al., 2003; Takeuchi et al., 
2010). Mouse and zebrafish PGCs also express the CXCR7 receptor which is also 
bound by the SDF-1 ligand (Balabanian et al., 2005; Burns et al., 2006). Loss of 
CXCR7 function in zebrafish and mouse PGCs produces no phenotype (Boldajipour 





However, expression of CXCR7 receptor by somatic cells along the migration route 
of the zebrafish PGCs is essential to control the levels and gradient of SDF-1A by 
functioning as a decoy receptor that binds SDF-1A (Boldajipour et al., 2008; 
Mahabaleshwar et al., 2008).The CXCR7 transcript has been detected in in vitro 
cultured chicken PGCs but it is not known if CXCR7 signalling is critical for migration 
and or survival (Jean et al., 2015).  
1.3.3.2.2 c-Kit/SCF signalling 
Proto-oncogene c-Kit (also known as mast/stem cell growth factor, tyrosine-protein 
kinase  or CD117) is a member of the type III receptor tyrosine kinase (RTK) family  
(Yarden et al., 1987). c-Kit and other members of type III RTK  possess a 23-amino 
acid signal peptide followed by an extracellular ligand-binding domain containing five 
immunoglobulin-like domains, which is followed by a single hydrophobic 
transmembrane domain and a relatively large cytoplasmic domain (Opatowsky et al., 
2014; Yarden et al., 1987). The binding of the kit ligand (also known as stem cell 
factor, SCF) to c-Kit causes dimerization that results in autophosphorylation of the c-
Kit receptor which subsequently results in phosphorylation of different substrates and 
activating a cascade of several signalling pathways (Blume-Jensen et al., 1991; 
Lemmon et al., 1997; Roskoski, 2005). Chicken PGCs express the c-Kit receptor 
similar to migrating mouse PGCs (Miyahara et al., 2016; Srihawong et al., 2015; Tang 
& Zhang, 2007).  Using targeted loss-of-function mouse models, c-Kit/SCF signalling 
plays a critical role in promoting the motility of migrating PGCs and also essentially 
controls survival and proliferation as PGCs migrate from the primitive streak to the 
genital ridges (Farini et al., 2007; Gu et al, 2009; Runyan et al., 2006). C-kit/SCF 
signalling has been shown to activate polarization and directional migration of chicken 
PGCs in vitro, and also together with FGF2 promote in vitro proliferation of chicken 
PGCs (Miyahara et al., 2016; Srihawong et al., 2015)  The role of c-Kit and its ligand 
SCF in promoting the migration of chicken PGCs in vivo is unknown. 
1.3.3.2.3 Ror2/Wnt5a signalling 
Mouse PGCs express the Receptor Tyrosine Kinase Like Orphan Receptor 2 (Ror2) 





Member 5A (Wnt5a). Ror2 is a tyrosine-protein kinase transmembrane receptor and 
Ror2 signalling is required for heart, bone and cartilage development in mice and 
humans (Afzal et al., 2000; DeChiara et al., 2000; Oldridge et al., 2000; Person et al., 
2010; S. Takeuchi et al., 2000; Van Bokhoven et al., 2000). As illustrated using 
targeted loss-of-function mouse models, Ror2 and Wnt5a play an important role in 
regulating late migration and proliferation as PGCs exit the hindgut to the genital 
ridges (Cantú et al., 2016; Chawengsaksophak et al., 2012; Laird et al., 2011). Through 
RNA labelling and array hybridization, the expression of Ror2 was not detected in in 
vitro cultured chicken PGCs, and is not known if expression is activated in vivo for a 
role in late migration (Jean et al., 2015). 
1.3.3.2.4 Adhesion molecules 
Mouse PGCs were shown to turn the expression of the calcium-dependent cell 
adhesion molecules, E-cadherin and P-cadherin, between ED 10 and 12.5 as they leave 
the hindgut (Bendel-Stenzel et al., 2000). The role of P-cadherin is unclear while 
disruption of E-cadherin resulted in ectopic mouse PGCs and a failure of mouse 
PGCs to condense inside the genital ridges (Bendel-Stenzel et al., 2000). E-cadherin 
and N-cadherin is expressed by in vitro cultured chicken PGCs but it is unclear if these 
molecules play a role in chicken PGC migration (Whyte et al., 2015). Using loss-of-
function mouse models, integrin beta 1 has also been shown to be required for proper 
migration of mouse PGCs but the role of integrins in chicken PGC migration is yet 
to be investigated (Anderson et al., 1999). 
As highlighted in the preceding subsections, the molecular factors that support that 
govern the migration of chicken PGCs are largely unknown compared to other model 
organisms, especially the mouse for which gene targeting technology is well 
established. However, exogenous chicken PGCs injected into the vascular system of a 
stage 12-16 HH surrogate embryo survive and sense molecular cues that direct them 
to colonise the genital ridges. This biological behaviour is exploited to directly 
introduce heritable genetic modifications into the chicken germline. The ability to 
create of targeted loss-of-function mutations specifically in chicken PGCs can be used 
to investigate and unravel the genes that govern survival, migration and proliferation 





1.3.4 In vivo genetic modification of migrating PGCs 
A method to target PGCs in vivo was demonstrated by injecting transfection mixture 
containing eGFP-Tol2 transposon plasmid, Tol2 transposase and Lipofectamine 2000 
(Invitrogen) into the blood circulation of stage 14 HH chick embryo to transfect 
circulatory PGCs (Tyack et al., 2013). At this stage, PGCs are circulating in the 
vascular system and migrating towards the lateral plate en route to the genital ridges. 
Of three roosters selected as founders (G0) to breed for G1 germline transgenic 
offspring, only two transmitted the eGFP transgene at a rate of 1.5 % (Tyack et al., 
2013). The disadvantage of this method is that it is impossible to perform screening 
for a specific genotype ahead and would require the production of many birds to 
identify an individual with the desired mutation. Additionally, mutagenesis of other 
cells and tissues by the DNA transfection reagents is very possible which may impact 
the health and welfare of injected G0 birds. 
1.3.5 In vitro culture of PGCs 
PGCs isolated from mammalian species can only be cultured for short periods of 
approximately five days (De Felici & McLaren, 1983; Dolci et al., 1991; Durcova-
Hills et al., 1998; Farini et al., 2005; Matsui et al., 1991). In contrast, chicken PGCs 
(chicken PGCs) can be cultured in vitro for long term and contribute to the formation 
of the germline once injected into surrogate embryos (van de Lavoir, Diamond, et al., 
2006; Whyte et al., 2015).  
1.3.5.1 Short term culture of chicken PGCs 
In earlier studies, the isolation of chicken PGCs from the germinal crescent and 
embryonic blood and then subsequent introduction into surrogate embryos to form 
functional gametes and offspring was demonstrated (Naito et al., 1994; Petitte et al., 
1991; Tajima et al., 1993; Vick et al., 1993). Subsequently, short-term cultures of 
chicken gonadal PGCs for a few days to two months was demonstrated during which 
the slow proliferation and gradual differentiation of PGCs into adherent colonies was 
observed (Chang et al., 1997; Chang et al., 1995; Chang et al., 1995; Han et al., 2002; 
Park et al., 2003). Notably, it was observed that germline transmission increased from 





al. 2003). This observation demonstrated the utility of cultured germ cells for genetic 
modification and also the need to establish an efficient culture system for chicken 
PGCs to increase germline transmission and perform genetic modification of cultured 
germ cells. 
1.3.5.2 Long term culture of chicken PGCs: high serum medium 
The breakthrough in avian germ cell biology came when van de Lavoir and colleagues 
demonstrated for the first time in any species the long-term culture (more than 200 
days) and the genetic modification of chicken PGCs that were subsequently used to 
produce transgenic chickens (van de Lavoir et al., 2006). The van de Lavoir PGC 
medium was prepared using knockout (KO)-DMEM medium conditioned on buffalo 
rat liver (BRL) cells (which are known to produce leukaemia inhibitory factor), human 
recombinant fibroblast growth factor, foetal bovine serum (FBS), chicken serum and 
SCF. PGCs were grown on a feeder layer of either Sandoz inbred mouse-derived 
thioguanine-resistant and ouabain-resistant (STO) fibroblasts or BRL cells. After more 
than 200 days in culture, the chicken PGCs maintained expression of Cvh as well as 
telomerase which is a marker of immortalised cells (Avilion et al., 1996). Notably, 
germline transmission of male PGCs injected into female embryos, or female PGCs 
injected into male embryos did not occur.  
1.3.5.3 Long term culture of chicken PGCs: serum-free, feeder-free medium 
While the van de Lavoir medium revolutionised genetic modification technology in 
the chicken, this culture medium was complex, needing specific quality animal sera, 
and required feeder cells as the specific growth factors driving PGC proliferation and 
survival in culture had not been defined. Also, single cell cultures for the generation 
of clonal populations has not been demonstrated in this medium. Against this 
background, Whyte et al., (2015), in an elegant study, defined the growth factors and 
physiochemical conditions required for in vitro PGC culture leading to the 
development of a feeder-free and serum-free culture (Fig 1.9) (Whyte et al., 2015).  
Specifically, FGF2, insulin, and Activin signalling through their cognate receptors 
were sufficient to replace feeder cells for the derivation, expansion, and clonal growth 
of chicken PGCs. BMP4 signalling could replace Activin A in non-clonal growth 





requirement for chicken serum which is a potential source of viral contamination 
(Whyte et al., 2015). The serum-free Whyte medium (FAOT) permits clonal 
enrichment of genetically modified PGCs with a defined genotype, as has been 
demonstrated for mouse ES cells (Capecchi, 1989b; Oji et al., 2016). 
1.3.6 In vitro genetic modification of PGCs 
In early studies, chicken PGCs were isolated and immediately transformed with 
replication-defective spleen necrosis retrovirus or replication-defective avian leukosis 
virus to generate transgenic chickens with germline transmission of 2-4% suggesting 
PGCs could be useful for genetic modification of the chicken (Vick et al., 1993). Later, 
Van de Lavoir et al. (2006) demonstrated the first successful genetic modification of 
cultured chicken PGCs by demonstrating stable integration of a GFP transgene (van 
de Lavoir et al., 2006). To overcome gene silencing of plasmid containing transgenes, 
the GFP transgene was placed in between two HS4 insulator sequences isolated from 
the chicken β-globin locus (Burgess-Beusse et al., 2002). This approach led to 
generation of stable expression of a GFP containing transgene in PGCs that were 
subsequently cultured for 134 days. Germline transmission frequencies ranging from 
1-92% were obtained from G0 hosts. However, the stable transfection frequency of 
cultured PGCs using vectors with HS4 insulators was very low (0.00002-0.00004%), 
Figure 1.9 Signalling pathways that sustain chicken PGC self-renewal. (From 





and also resulted in random integrations mostly into the 5’ end of genes in the PGC 
genome, (Leighton et al., 2008).  
Subsequently, the ϕC31 integrase system, which catalyses recombination between 
attB- and attP sites, was applied to PGCs as a method to counteract the high levels of 
transgene silencing and very low stable transfection frequency previously observed 
(Leighton et al., 2008).  In this study, the stable transfection frequency was ~0.001% 
with integrations into pseudo-attP sites mostly within repetitive elements of the PGC 
genome, and was 20-fold higher compared to the use of non-integrase vectors with 
HS4 insulator sequences (Leighton et al., 2008). Notably, transgenic chickens 
expressing CRE recombinase have been generated using the ϕC31 integrase system 
(Leighton et al., 2016).  
While the ϕC31 integrase system improved the stable integration frequency, the 
piggyBac and Tol2 transposon system was more efficient in integrating transgenes into 
the PGC genome with no observed transgene silencing and without the requirement of 
insulator sequences to prevent transgene silencing (Macdonald et al, 2012; Park and 
Han, 2012). Using piggyBac and Tol2 transposon vectors, the frequencies of stable 
transfection of PGCs was in the range of 10.5% and 45.2% respectively with 
integrations into transcriptional units and intronic regions, and germline transmission 
of the modified PGCs in the chimaera was generally above 90%  (Macdonald et al., 
2012; Park & Han, 2012). However, the transposon vectors integrate randomly into 
the genome. 
Specific regions of the genome could not be targeted using the genetic vectors 
described above. To address this, the first gene knockout chickens were produced 
using classical gene targeting vectors in PGCs. A targeting cassette containing a 
selection marker and homology arms with a total length of approximately 9kb was 
used to target the immunoglobulin locus to produce immunoglobulin-deficient chicken 
(Schusser et al., 2013). This was the first example of gene targeting in avian species 
and was only possible due to a culture method for chicken PGCs. This method relied 
on spontaneous homologous recombination and could be used to introduce small 
sequence changes but is extremely inefficient as only 1 in 107 transfected PGCs were 





1.3.7 Reprogramming of PGCs  
In animal species that use the process of induction to produce the germ lineage, the 
process of cellular specification leads to development of lineage-restricted PGCs that 
migrate and proliferate for a short time and cease proliferation after gonadal 
colonisation. The growth factors that permit the survival of PGCs in many species 
including human, pig, cattle, rabbit, sheep, mouse and chicken have been identified 
thereby permitting the short term culture of PGCs. For both mammalian and chicken 
PGCs, the growth factors that have been implicated for survival and proliferation 
include LIF, SCF, bFGF, retinoic acid and BMP4 (Dolci et al., 1993; Dolci et al., 1991; 
Farini et al., 2005; Matsui et al., 1991).  
During the culture of mouse PGCs, embryoid bodies (EBs) containing different cell 
types were observed to occasionally spontaneously arise, and these EBs were shown 
to contain many cell types including cells that possess high levels of AP activity and 
stain positively for pluripotency markers such as SSEA-1 (Matsui et al., 1992). Based 
on this initial observation, it was discovered that PGCs cultured in vitro were capable 
of de-differentiating into a pluripotent state. Reprogramming of cultured PGCs from 
many species into embryonic germ (EG) cells and self-renewing pluripotent PGC-
derived stem cells capable of forming chimaeric animals and generating many cell 
types in vitro from the three different germ layer has been demonstrated (Kakegawa et 
al., 2008; Ledda et al., 2010; Macdonald et al., 2010; Matsui et al., 1992; Park & Han, 
2000; Shamblott et al., 1998; Shim et al., 1997). These observations bear resemblance 
to the ground-breaking studies that have shown the reprogramming of lineage-
committed fibroblast cells into induced pluripotent stems (IPS) cells by introducing 
the Yamanaka transcription factors, Oct3/4, Sox2, c-Myc and Klf-4 (Meissner et al., 
2007; Okita et al., 2007; Takahashi & Yamanaka, 2006). Pluripotent PGC-derived 
stem cells are characterised by high levels of AP activity and stain positively for the 
pluripotency marker, SSEA-1, which is used to characterise ES and EG cells 
(Kakegawa et al., 2008; Ledda et al., 2010; Matsui et al., 1992; Park & Han, 2000; 
Shamblott et al., 1998; Shim et al., 1997). Additionally, these pluripotent PGC-derived 
stem cells are karyotypically stable and normal. PGC-derived EG cells and pluripotent 





al., 1997). Importantly, these pluripotent PGC-derived stem cells have been shown to 
give rise to many cell types from all three germ layers including neuron-like, epithelial-
like, fibroblast-like cells, myocardial-like cells which can grow in a monolayer 
(Kakegawa et al., 2008; Ledda et al., 2010; Matsui et al., 1992; Park & Han, 2000; 
Shamblott et al., 1998; Shim et al., 1997). In particular, the reprogramming of chicken 
PGCs into EG cells has been demonstrated and, these PGC-derived EG cells have been 
shown to give rise to EBs that differentiated into many cell types (Park & Han, 2000). 
The ability to generate many cell types of different germ layers from cultured chicken 
PGCs would be useful for generating new and suitable cell lines or cellular models 
that can be used to study gene function in the chicken and investigate avian diseases 
(further discussed in 1.5.2.4). 
 
1.4 GENOME EDITING  
Genome editing refers to the introduction of DNA sequence changes at defined 
locations in the genome of living organisms. The history of genome editing can be 
traced to the pioneering works of Oliver Smithies and Mario Capecchi. In their studies, 
they demonstrated the targeted introduction of DNA sequences into the mammalian 
genome through homologous recombination (HR) by using homologous templates to 
exchange endogenous genomic DNA with exogenous DNA molecules  (Smithie et al., 
1985; Thomas et al., 1986). However, this process was limited by the extremely low 
rate of spontaneous integration of the exogenous DNA into the desired locus. The use  
of selectable markers increased the efficiency of isolating correctly targeted cells 
(Capecchi, 1989a, 1989b). Later, it was discovered that the introduction of DNA 
double-strand breaks (DSBs) at the target locus considerably increased the frequency 
of HR (Hasty et al., 1991; Kucherlapati et al., 1984; Rudin et al., 1989) and lead to the 
development of first site-specific nucleases for genome editing. Therefore, the process 
of genome editing can be characterised by two steps. Firstly, the introduction of DNA 
double-stranded or single-stranded breaks at a defined genomic site using a 
programmed artificial site-specific nuclease. Secondly, the repair of the broken DNA 
by cellular DNA repair machinery leading to the introduction of ‘’base-pair’’ sequence 





or add a defined DNA sequence at the site of the DSB. Genome editing is a powerful 
tool that holds tremendous value for biological research, medicine, agriculture and 
biotechnology. In the following sections, some of the most widely used artificial site-
specific nucleases are discussed. 
 
1.4.1 Artificial site-specific nucleases 
1.4.1.1 Meganucleases  
Meganucleases, also called homing endonucleases,  are a class of highly sequence-
specific endodeoxyribonucleases that were discovered in yeast and are characterized 
by a large DNA recognition site of up to 40 base pairs that is found rarely in the 
genome (Arnould et al., 2011). This specificity makes meganucleases useful for 
genome engineering. Meganucleases are generally encoded within introns or inteins 
and can be customized to target any sequence (Arnould et al., 2011; Julianne Smith et 
al., 2006).  The yeast meganuclease, I-SceI has a recognition site of 18 bp and was 
used in early studies to introduce DSBs into the genome of mouse cells which were 
repaired by nonhomologous and homologous DNA repair mechanisms (Rouet et al., 
1994a, 1994b). I-SceI was shown to increase homologous recombination (HR) by 
approximately 2 orders of magnitude over spontaneous HR (Choulika et al., 1995). 
Although, meganucleases increased the frequency of HR, it was difficult to find a 
meganuclease that targets a selected locus (Adli, 2018; Fernández et al., 2017; Silva 
et al., 2011). A gene targeting strategy involving the introduction of an I-SceI site into 
a desired locus in mouse ES cells was shown to increase the frequency of HR by a 
100-fold over classical gene targeting (Cohen-Tannoudji et al., 1998). This approach 
is complex requiring two consecutive HR steps and two selection markers (Fernández 
et al., 2017). Consequently, meganucleases can only be used to target only a small 
fraction of genomes. A few meganucleases such as I-SceI and I-CreI can be re-
engineered to target a desired locus by mutating individual protein residues contacting 









1.4.1.2 Zinc Finger nucleases (ZFN) 
Given the limitations of meganucleases, the development of DNA targeting nucleases 
evolved for the generation of gene targeting modules consisting of a programmable 
DNA binding domain and a nonspecific DNA endonuclease domain. Zinc finger 
nucleases (ZFN) were devised by fusing engineered zinc finger DNA recognition 
domain with the nonspecific FokI endonuclease domain (Kim et al., 1996). Zinc 
fingers are small protein motifs that bind to DNA in a sequence specific manner and 
are organised in 3D structures by zinc ions, with each module recognising a 3 bp DNA 
sequence (Klug & Rhodes, 1987). The Fok1 restriction enzyme consists of a DNA 
nuclease cleavage domain that must dimerize to generate DSBs and a specific DNA 
binding domain (Kim et al., 1996; Vanamee et al., 2001). To generate ZFNs, the DNA 
binding domain of Fok1 is removed so that the  Fok1 DNA cleavage domain is fused 
to two separate zinc finger protein modules that bind to two target sites next to each 
(Mani et al., 2005; Urnov et al., 2010). This allows the Fok1 nuclease to dimerise and 
generate a DSB at a site that is recognised by  the two separate zinc finger protein 
modules  (Mani et al., 2005; Urnov et al., 2010).  
In early reports, a ZFN was first shown to induce DSBs and stimulate HR in Xenopus 
oocytes (Bibikova et al., 2001). Also,  a ZFN was used to correct the X-linked severe 
combined immune deficiency SCID mutation in human cells using HR with an 
efficiency greater than 18% without selection (Urnov et al., 2005). The first knockout 
rats were generated using ZFN  which was delivered through microinjection of the 
one-cell zygote (Geurts et al., 2009). Subsequently, ZFNs were used successfully for 
genome editing of mice, cattle, goat, sheep and zebrafish (Carbery et al., 2010; 
Hauschild et al., 2011; Sood et al., 2013; Xiong et al., 2013; Yu et al., 2011; Zhang et 
al., 2014). Importantly, ZFNs had a large impact in genetic modification of livestock 
species where ES cells, classically required for achieving HR events, were lacking 
(Fernández et al., 2017; Petersen & Niemann, 2015). Notably, domestic pigs were 
edited using ZFN to carry the warthog variant of the RELA gene in order to introduce 
resilience to African swine fever (Lillico et al., 2016). Also, genome-edited cattle with 
increased resistance to mastitis were generated by targeting the human lysozyme gene 





are also difficult to synthesise and are therefore engineered for a defined DNA-binding 
specificity by commercial laboratories.  
 
1.4.1.3 Transcription activator-like effector nucleases (TALENs) 
TALENs are similar to ZFNs in that both consist of a customizable DNA binding 
domain fused to the Fok1 endonuclease domain. The DNA binding domain of a 
TALEN is composed of highly conserved repeats derived from transcription activator-
like effectors (TALEs) proteins that are naturally secreted by Xanthomonas bacteria 
(Boch & Bonas, 2010; Joung & Sander, 2013). These TALEs bind DNA through 
arrays of highly conserved 33-35 amino acid repeats flanked by additional TALE-
derived domains at the amino- and carboxy-terminal ends of the array. Individual 
TALE repeats in an array each specify a single base of DNA determined by the 
identities of two hypervariable residues typically found at positions 12 and 13 of the 
domain (Joung & Sander, 2013). Since Fok1 must dimerise to generate DSBs like in 
the use of ZFN, a pair of TALENs is designed to induce DSB at a target locus.  
TALEN were first used to generate knockout rats using embryo microinjection  
(Tesson et al., 2011) and was subsequently extended to generate numerous knockout 
mice models (Li et al., 2014; Qiu et al., 2013; Sung et al., 2013; Wang et al., 2013; Wu 
et al., 2013). The use of TALEN for livestock genome editing was first validated 
through embryo injection of pig and cattle zygotes as well as editing of fibroblasts 
followed by nuclear transfer (Carlson et al., 2012; Tan et al., 2013). TALEN have now 
been widely applied to generate genome-edited pig, goat, sheep and cattle (Cui et al., 
2015; Proudfoot et al., 2015; Wei et al., 2015; Xin et al., 2013). Interestingly, the first 
genome-edited chicken was produced using TALEN (Park et al., 2014).  
TALENs overtook ZFNs in usage because of the lower cost and ease of assembly. 
Customised TALEN can be generated in any laboratory using a step-by-step Golden 
Gate assembly cloning protocol (Cermak et al., 2015; Sakuma & Yamamoto, 2016). 
However, this procedure is still long and quite cumbersome requiring numerous 
plasmids (Fernández et al., 2017). Although web-based algorithms for finding the best 
target sequences in both strands of the locus exists, the engineered TALEN must be 






1.4.1.4 Clustered regularly interspaced short palindromic repeats (CRISPR) and 
CRISPR-associated proteins (Cas) 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-
associated (Cas) (abbreviated as CRISPR/Cas) genes constitute an essential adaptive 
immune mechanism used by select bacteria and archaea to respond to and protect 
themselves from foreign genetic materials such as bacteriophages and plasmid DNA 
(Horvath & Barrangou, 2010; Wiedenheft et al., 2012). The breakthrough in genome 
modification came when it was demonstrated that the CRISPR/Cas9 system could be 
reprogrammed to target a desired DNA sequence in bacteria (Gasiunas et al., 2012; 
Jinek et al., 2012). Specifically, the type II CRISPR system from Streptococcus 
pyogenes was adapted for inducing DSBs because of its simplicity (Jinek et al., 2012). 
The first 20 nucleotides (nt) of its crRNA is a guide sequence that is complementary 
to the target DNA and can be customised to target a specific DNA sequence. To induce 
DNA DSBs (Fig. 1.10), the transactivating crRNA (tracrRNA) is partially 
complementary to and hybridizes with the cRNA to form an RNA duplex that acts as 
guide for the Cas9 nuclease. The crRNA spacer in the RNA duplex pairs with the guide 
sequence (protospacer) in the target DNA. The catalytic activity of Streptococcus 
pyogenes Cas9 is restricted by a conserved NGG sequence (N can be any base) that is 
immediately 3’ downstream of the protospacer sequence and is referred to as the 
protospacer adjacent motif (PAM) (Jinek et al., 2012; Sternberg et al., 2014; Swarts et 
al., 2012). Once Cas9 is activated following binding of the cognate gRNA to the target 
DNA, the HNH domain in the midregion of the protein nicks the sense strand while 
the RuvC domain at the amino terminus nicks antisense strand inducing a blunt DSB 
3 bp away from the 5’ end of the PAM (Jinek et al., 2012; Sapranauskas et al., 2011).  
A synthetic guide RNA (sgRNA) was derived through the fusion of the crRNA and 
tracrRNA thus simplifying the CRISPR system for use in genome editing (Fig 1.10) 







Fig. 1.10 Type II CRISPR/Cas9 system. A) Two-RNA structure is formed by an 
activating tracrRNA and site-specific targeting cRNA, which guides Cas9 nuclease to 
cleave double-stranded DNAdsDNA. B) Single chimeric RNA is formed by fusing 







1.4.1.4.1 The application of CRISPR/Cas9 in livestock species 
CRISPR/Cas9 was first used for genome editing in mammalian cell cultures (Cong et 
al., 2013; Jinek et al., 2013; Mali et al., 2013). Subsequently, simultaneous targeting 
of five genes in mouse ESCs and the one-step generation of Tet1/Tet2 double-mutant 
mice with predefined mutations was demonstrated (Wang et al., 2013). CRISPR/Cas9 
has since been applied extensively in livestock. Cashmere goats with longer hair fibre  
and increased secondary hair follicles were generated through disruption of FGF5 
using CRISPR/Cas9 (Wang et al., 2016). CRISPR/Cas9 loss-of-function mutations  
through zygote injections were performed to generate myostatin-deficient lambs with 
greater muscle mass and 20-30% heavier body weights compared to wild-type lambs 
(Crispo et al., 2015). Notably, pigs resistant to the porcine reproductive and respiratory 
virus (PRRS) syndrome were generated using CRISPR/Cas9 (Burkard et al., 2017; 
Whitworth et al., 2015). Also, CRISPR/Cas9 was used to insert a second copy of the 
bovine NRAMP1 gene to generate transgenic cattle with higher expression of 
NRAMP1 and increased resistance to bovine tuberculosis (Gao et al., 2017). Through 
targeting of PGCs, CRISPR/Cas9 has been used to generate ovomucoid-deficient 
chickens and also the generation of chicken bioreactors  in which human interferon 
beta (hIFN-β) was targeted into the chicken ovalbumin locus to produce hIFN-β in egg 
white (Oishi et al., 2016; Oishi et al., 2018).    
The high targeting efficiency and simplicity of assembly of CRISPR/Cas9 compared 
to previous generations of artificial site-specific nucleases has quickly made it the most 
widely used genome editing nuclease (Fernández et al., 2017; Sander & Joung, 2014). 
However, the high mutagenic activity of CRISPR/Cas9 led to concerns about its 
specificity. SpCas9 may cleave a target DNA that is not perfectly complementary to 
the 20-nt guide sequence of the sgRNA and cause mutations at unintended locations, 
usually referred to as ‘’off-targets’’  (Cho et al., 2014; Cradick et al., 2013; Fu et al., 
2013; Hsu et al., 2013). To address concerns of off-target mutagenesis especially with 
respect to human clinical application, SpCas9 variants with enhanced specificity were 
developed.  
1.4.1.4.2 SpCas9 variants with increased specificity  
Following structural crystallography studies of the SpCas9–sgRNA-target DNA 





required for optimal target recognition and cleavage (Anders et al., 2014; Kleinstiver 
et al., 2016; Nishimasu et al., 2014; Slaymaker et al., 2016). Based on this hypothesis, 
two SpCas9 variants engineered generated by making amino acid substitutions 
predicted to reduce target binding affinity so that more stringent complementarity 
between the gRNA and the target DNA was required for nuclease activation. These 
variants include SpCas9-HF1, eSpCas9 1.1 and HypaCas9 which are discussed in the 
next sections. 
1.4.1.4.2.1 SpCas9-HF1 (N497A, R661A, Q695A, Q926A) 
In this variant, alanine substitutions were introduced at four residues (N497, R661, 
Q695, Q926) of SpCas9 that form direct hydrogen bonds with the phosphate backbone 
of the target DNA strand. SpCas9-HF1 was shown to exhibit at least 70% of on-target 
activity observed with wild-type SpCas9 (SpCas9-WT) at the same sites. Genome-
wide off-target mutations were reduced to undetectable levels as validated by GUIDE-
seq and targeted deep sequencing (Kleinstiver et al., 2016). 
1.4.1.4.2.2 eSpCas9 1.1 (K848A/K1003A/R1060A) 
In this variant, alanine substitutions were introduced at three positively-charged 
residues (K848/K1003/R1060) within the groove formed between the HNH, RuvC, 
and PAM-interacting domains of SpCas9. This positively-charged groove was 
suggested to stabilize the nontarget strand of the target DNA. Neutralizing the positive 
charges was predicted to reduce the non-target strand binding affinity. Compared with 
SpCas9-WT, eSpCas9 1.1 showed similar levels of on-target cutting efficiency and 
reduced genome-wide off-target cleavage (Slaymaker et al., 2016). 
1.4.1.4.3 Mechanism of increased specificity in high fidelity Cas9 variants  
Contrary to the suggested mechanism of enhanced specificity of high fidelity Cas9 
variants, it was later discovered that the target binding affinities of SpCas9-HF1 and 
eSpCas9 1.1 for on-target and PAM-distal mismatched substrates were similar to 
SpCas9-WT (Chen et al., 2017). Instead, the high cleavage specificity was attributed 
to the regulated activation of the HNH nuclease domain of SpCas9 (Chen et al., 2017). 
The HNH domain undergoes conformational rearrangement upon target binding which 





by Chen and colleagues (Chen et al., 2017), Förster resonance energy transfer (FRET) 
labelling and imaging of the HNH domain of catalytically active SpCas9-WT, SpCas9-
HF1 and eSpCas9 1.1 bound to double stranded DNA (dsDNA) was used to measure 
HNH activation state at on-target and mismatched substrates. It was discovered that 
the HNH active state of the high-fidelity variants at mismatched targets was reduced 
while the HNH of SpCas9-WT populated the active state at mismatched targets. Also, 
the transition rate from inactive to active state was eight-fold slower in the high-fidelity 
variants at mismatched targets compared to SpCas9-WT. Following the dissection of 
the mechanism of increased specificity, the high fidelity HypaCas9 variant with 
N692A, M694A, Q695A, and H698A mutations was developed (Chen et al., 2017) 
The increased specificity of these high fidelity Cas9 variants make them valuable for 
increasing the efficiency of genome editing and reducing or eliminating unintended 
mutations. High fidelity Cas9 nucleases have not yet been tested in livestock species 
including chicken. 
 
1.4.2 DNA double-strand breaks repair  
DNA double-strand breaks (DSBs) are lethal DNA lesions that occur during exposure 
to exogenous agents such as ionizing radiation and radiomimetic chemicals or 
endogenous products of metabolism such as reactive oxygen species (Danner et al., 
2017; Mladenov et al., 2016). Programmed DSBs also occur during development as 
an intermediate step during meiotic recombination in germ cells and during the 
diversification of B and T lymphocyte antigen receptors (Alt et al., 2013; Borde & de 
Massy, 2013). Cellular responses to DSBs include DNA repair, cell cycle arrest and 
apoptosis (Shiloh, 2003). DSBs are repaired by either canonical non-homologous 
endjoining (NHEJ) or homology-directed repair (HDR) mechanisms (Ceccaldi et al., 
2016). NHEJ uses no sequence homology and is active in all phases of the cell cycle 
(Mao et al., 2008). The HDR mechanisms include alternative end joining (Alt-EJ), 
single strand annealing (SSA) and homologous recombinational (HR) repair 
(Bhargava et al., 2016; Mladenov et al., 2016; Truong et al., 2013). HDR is active in 
cycling cells and occurs in S and G2 phases (Bhargava et al., 2016; Mladenov et al., 
2016; Orthwein et al., 2015; Truong et al., 2013).  DNA DSB repair is completely 





of telomeres (Orthwein et al., 2014). DNA repair pathway choice may also be 
influenced by chromatin structure and damage complexity (Danner et al., 2017; 
Mladenov et al., 2016b). DNA repair mechanisms can be harnessed to introduce 
targeted sequence changes by inducing DSBs with artificial site-specific nucleases. 
The initial steps of DSB repair and signalling are identical for both NHEJ and HDR 
(Danner et al., 2017). The choice of whether the DSB is repaired through NHEJ or 
HDR is determined by the control of the accumulation of 53BP1 (Fig. 1.7) (Daley & 
Sung, 2014; Zimmermann & De Lange, 2014). 53BP1 is a critical protein that mediates 
DNA damage response (DDR). During canonical non-homologous end-joining 
(cNHEJ) repair, 53BP1 localises to the DSB, activating a complex of DNA repair 
proteins to inhibit resection of the free ends of the DNA strands (Mirman et al., 2018). 
 
1.4.2.1 Canonical non-homologous end-joining repair pathway 
Unlike irradiation or radiomimetic chemicals which induce complex DSBs, SpCas9 
induces clean blunt-end DSBs which can result in cNHEJ mutation-free ligation in 
75% of events or higher (Fig. 1.11A) (Bétermier et al., 2014). The cNHEJ pathway 
has been exploited extensively to generate loss-of- function base-pair mutations in 
many organisms including chicken (Beumer et al., 2013; Geurts et al., 2009; Hwang 
et al., 2013; Oishi et al., 2016; Panda et al., 2013; Park et al., 2014; Tesson et al., 2011; 
Wang, et al., 2013; Young et al., 2011). It is also the repair pathway activated to resolve 
large deletions or inversions following the induction of two DBSs and has been 
exploited to perform targeted genomic deletions using artificial site-specific nucleases 
(Burkard et al., 2017; Essletzbichler et al., 2014; Xiao et al., 2013; Zhang et al., 2015; 
Zhou et al., 2014). Furthermore, homology-independent integration of exogenous 
DNA mediated by cNHEJ following DSBs induced by artificial site-specific nucleases 
has also been demonstrated (Auer et al., 2014; Maresca et al., 2013; Suzuki et al., 
2016). In particular, a method called Homology-Independent Targeted Integration 
(HITI) was shown to achieve remarkable efficiency for targeted integrations into non-
dividing neuronal cells and primary cells in vivo compared to HR methods (Suzuki et 
al., 2016). A major drawback with this method for targeted integration is that INDELs 





template in a reversed manner was observed in some targeted cells (Suzuki et al., 
2016). 
 
1.4.2.2 Homologous recombination repair pathway  
In the HR repair pathway, 53BP1 is excluded and the ends of the DSB are resected. 
Eventually, the HR pathway may follow either the SDSA (synthesis-dependent strand 
annealing) pathway or the DSBR (double-strand break repair) pathway, depending 
upon whether one or two Holiday junctions are formed by engaging one or both ends 
of the DSB (Fig. 1.11B)(Mladenov et al., 2016). Repair of DSBs induced by 
CRISPR/Cas9 using single stranded oligodeoxynucleotide donors occurs through the 
SDSA pathway and is useful for introducing defined base-pair changes (Kan et al., 
2017; Paix et al., 2017). Introduction of exogenous DNA ranging from defined base-
pair changes to integration of large kilobase DNA has been widely demonstrated 
following induction of DSBs by artificial site-specific nucleases and subsequent DNA 
repair through HR (Aida et al., 2015; Chu et al., 2016; Inui et al., 2014; Niu et al., 
2018; Yoshimi et al., 2014). 
 
1.4.2.3 Single strand annealing repair pathway 
Single strand Annealing (SSA) involves annealing of homologous repeat sequences 
(>30 bp) that flank a DSB, which causes deletions of up to several hundred base pairs 
between the repeats (Fig. 1.11C) (Bhargava et al., 2016; McVey & Lee, 2008). SSA is 
initiated through a similar form of end resection as HR to generate 3’ ssDNA 
overhangs. SSA has been shown to resolve DSB induced between defined direct repeat 
sequences in mammalian cells (Bhargava et al., 2016; Elliott et al., 2005; Lin et al., 
1984; Stark et al., 2004; Storici et al., 2006). The SSA pathway has a significant 
implication for genome editing when targeting regions of the genome containing many 
direct repeats. Induction of a single DSB in such repeat-rich regions can lead to large 
mutagenic deletions of up to or greater than a hundred base pairs, which can be 







1.4.2.4 Alternative end joining repair pathway 
Alternative end joining (Alt-EJ) (also referred to as microhomology mediated end 
joining (MMEJ)) involves the annealing of short homologous repeats 
(microhomologies of 5-25 nt) that flank a DSB to bridge the break (Fig. 1.11D) 
(Bhargava et al., 2016; McVey & Lee, 2008; Mladenov et al., 2016). Alt-EJ is not a 
fully understood pathway but it is initiated through a similar form of end resectioning 
as HR and SSA to generate 3’ ssDNA overhangs (Bhargava et al., 2016; McVey & 
Lee, 2008; Mladenov et al., 2016). Alt-EJ occurs in the absence of cNHEJ factors such 
as Ku, DNA-PKcs and XRCC4/DNA ligase IV, while RAD52 which is a key player 
in SSA has been shown to be dispensable for Alt-EJ in mammalian cells (Bennardo et 
al., 2008; Kabotyanski et al., 1998; McVey & Lee, 2008). Unlike cNHEJ which uses 
XRCC4/Ligase IV complex , the final ligation step to close the resulting nick is 
performed by Ligase 1 or Ligase 3 with Ligase 3 playing a more dominant role through 
its dispensable interaction with XRCC1 (Soni et al., 2014). INDELs generated by the 
Alt-EJ pathway are similar to those of cNHEJ.  
A method called Precise Integration into Target Chromosomes-PITCh has been 
described for targeted integration of exogenous DNA through Alt-EJ following 
TALEN- and CRISPR-induced DSB (Nakade et al., 2014; Sakuma et al., 2016). The 
PITCh system uses short 5–25 bp microhomologous sequences as homology arms that 
is easier to construct, compared to larger targeting vectors containing greater than 
500bp homology arms for HR-mediated genome editing. The PITCh system has been 
applied in cultured human cells, frog embryos, mouse embryos and silkworm embryos 
with high efficiency of transgene integration (Nakade et al., 2014; Sakuma et al., 
2016). However, the use of the CRISPR-based PITCh system is limited to Cas9 
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1.5 GENOME EDITING OF CHICKEN   
1.5.1 Targeting of cultured chicken PGCs using artificial site-specific nucleases  
1.5.1.1 Targeting of PGCs with TALENs 
The first reported application of artificial site-specific nucleases to produce genome-
edited chickens was demonstrated through the use of TALENs to target the ovalbumin 
locus in PGCs (Park et al., 2014). Ovalbumin mutation rate in transfected PGCs was 
33.3% in which 6- to 29-bp deletions were observed indicating active cNHEJ and Alt-
NHEJ pathways. Healthy ovalbumin-deficient progenies were generated at the rate of 
8% following testcross of a founder with wild type hens. Also, TALENs were also 
used to introduce eGFP into the DDX4 gene in male and female chicken PGCs to 
generate a 30-kb deletion around the DDX4 target site through HR using a targeting 
vector containing total homology arms of ~7 kb (Taylor et al., 2017). Hemizygous 
DDX4-deficient female (ZGFPW) PGCs and monoallelic DDX4-deficient (ZGFPZ) male 
PGCs were isolated and used to produce DDX4-deficient hens that were healthy with 
no obvious abnormality but infertile as a result of DDX4 deficiency. 
1.5.1.2 Targeting of PGCs with CRISPR/Cas9 
The CRISPR/Cas9 system was used to target ovomucoid and ovalbumin genes in 
cultured chicken PGCs (Oishi et al., 2016). Mutation frequencies were greater than 
90% and 1- to 21-bp deletions were observed further confirming active cNHEJ and 
Alt-NHEJ pathways in chicken PGCs. Germline transmission of the targeted PGCs 
from chimaeric roosters was greater ~70% while more than 50% the offspring 
contained the ovomucoid mutations. Also, CRISPR/Cas9 was used to introduce a 
hygromycin-resistance gene into the IgH locus in chicken PGCs through HR using a 
repair template with  total homology arms of  with 100% efficiency in isolated PGC 
colonies (Dimitrov et al., 2016). In another recent study, CRISPR/Cas9 was used to 
introduce a human interferon beta transgene into the ovalbumin locus of chicken PGCs 
using a targeting vector with total homology arms of 6 kb (Oishi et al., 2018). The 
germline transmission frequency of the transgene from two irradiated surrogate 
roosters transplanted with the targeted PGCs was 22.5 and 14.5%, and the progeny 
were healthy with no obvious abnormality. 
These studies showed that CRISPR/Cas9 and TALENs can be used to perform genome 





abnormalities. Also, it appears that CRISPR/Cas9 is more efficient than TALENs for 
performing targeted mutagenesis of cultured chicken PGCs, but this would require 
further investigation. Also, the use of artificial site-specific nucleases significantly 
increased the efficiency of HR using targeting vectors. None of these studies have 
demonstrated the isolation of clonal populations of genome-edited chicken PGCs or 
the generation of defined genetic changes. 
1.5.2 Application of genome editing in the chicken  
1.5.2.1 Investigation of gene function 
As previously highlighted, many molecular pathways that control survival and 
proliferation of mouse PGCs have been unravelled due to the availability of efficient 
gene targeting methods for the mouse. Therefore, the ability to introduced targeted 
mutations into a specific gene in chicken PGCs would be useful for investigating 
and unravelling the genes that control survival, proliferation and migration of 
chicken PGCs. Also, specific chicken models can be created through targeting of 
master regulatory genes in chicken PGCs to study embryonic development and 
biological mechanisms in the chicken.   
1.5.2.2 Trait validation and introgression   
The development of a method to perform genome editing of chicken PGCs to 
introduce defined base-pair mutations into chicken breeds will be useful to 
investigate welfare and productivity traits. Commercial chickens are prone to 
welfare issues such as ascites in broilers, heat stress in broilers maintained in hot 
climates, and skeletal problems particularly lameness in broilers and bone fractures 
in layers (de Jong et al., 2012; Karcher, 2018; Lara & Rostagno, 2013). On the other 
hand, local chicken breeds show poor feed conversion,  poor productivity and low 
fertility (Besbes, 2009; Guèye, 1998). Avian researchers have identified candidate 
SNPs, genes and mutations for welfare traits such as feed conversion, ascites, bone 
traits and feather coverage (Dey et al., 2018; Mignon-Grasteau et al., 2016; Ng et 
al., 2012; Pértille et al., 2017; Wells et al., 2012; Zhang et al., 2011). For instance, 
the chicken scaleless phenotype results in reduced feather coverage which is 
beneficial for chickens in hot climates (Wells et al., 2012). The scaleless phenotype 





chicken FGF20 but this has not been validated in cells or animals (Wells et al., 2012). 
Therefore, genome editing of chicken PGCs to produce chickens with defined 
nucleotide changes can be performed to validate these candidate genetic variations 
prior to introducing them into pedigree populations for trait improvement.  
1.5.2.3 Investigation of disease resistance/resilience 
Genome editing of the chicken be used to investigate the pathobiology of many 
avian diseases to investigate disease resistance and/or resilience. Poultry diseases 
such as avian influenza, salmonella and coccidiosis can infect birds even under the 
best management systems with devastating impacts on the poultry industry. 
Traditional methods of disease control such as the use of antibiotics against bacterial 
diseases have become controversial due to potential antibiotic residues in poultry 
products and the development of antimicrobial resistance (Marshall & Levy, 2011; 
McKenna, 2017; Mehdi et al., 2018; Van Boeckel et al., 2015). Also, prevention of 
some poultry diseases such as coccidiosis, infectious bursal disease and avian 
influenza through vaccination may be inadequate due to variation of pathogens, poor 
resistance after vaccination or inhibition of vaccine immune response by 
maternally-derived antibodies (Berg, 2000; Kim et al., 2010; Sun et al., 2012; 
Williams, 2002). Consequently, there is a great interest in breeding poultry flocks 
for diseases resistance to improve viability.  Using available avian genomics data, 
poultry diseases like avian influenza can be investigated to clarify the molecular 
mechanisms of host-pathogen interactions and identify candidates genes for the 
introduction of disease resistance or resilience through selective breeding (Looi et 
al., 2018; Smith et al., 2016). Once candidate genes are both identified and 
validated, genome editing may form the basis of a rapid approach to introgress the 
beneficial disease resilience or resistance alleles into pedigree lines.  
1.5.2.4 Production of PGC-derived chicken cellular models 
Numerous immortalised mammalian cell lines of many cell lineages and tissue types 
are available for the study of mammalian biology, but in comparison, few 
immortalised avian cell lines are available to date for the study of avian biology. 
Therefore, many studies in avian biology depend on the exogenous expression of 





specific genes that affect avian influenza molecular pathogenesis has been 
performed extensively in mammalian cells such as the human 293T cell line, as 
demonstrated in recent studies of avian ANP32A (Baker et al., 2018; Domingues & 
Hale, 2017; Long et al., 2016). It would be useful to generate suitable avian cell 
lines to study avian gene function and molecular mechanisms within an avian 
cytological environment. A method for differentiating chicken PGCs into fibroblast-
like cells or into embryoid bodies has been developed by Dr Michael J. McGrew 
(unpublished). Therefore, specific chicken fibroblast-like cell lines with defined 
genotypes can be generated from genome-edited chicken PGCs if methods for 
production of specific PGC genotypes through base-pair changes are developed.  
 
1.6 Thesis objectives  
With the continuing rapid advancement of genome sequencing technology and the 
continuing improvement of the genome assembly in avian species, the central question 
that this thesis tries to answer is whether targeted genome editing of the avian germ 
cell lineage using the CRISPR/Cas9 system can be developed as an efficient and 
simple approach to precisely introduce or remove alleles and study gene function in 
birds. This approach is well established for mammalian biology with numerous 
published examples (Fernández et al., 2017). To answer this central question and 
explore this vacuum in avian biology, the approach taken in this thesis is to develop 
tools to precisely change single nucleotides in the genome of PGCs, and also perform 
genome editing to investigate gene function relevant to chicken health and also 
advance the understanding of the development of avian PGCs. Against this 
background, the objectives of this thesis include; 
1. To establish cultured lines of chicken PGCs using published methodologies. 
2. Develop methods to use CRISPR/Cas9 for the introduction of small defined 
base-pair changes into chicken PGCs. 
3. Using CRISPR-targeted chicken PGCs, investigate ANP32A as a potential 
genetic target for introducing resistance to avian influenza. 
4. Investigate the role of CXCR4 and c-Kit genes in the migration of circulatory 







MATERIALS AND METHODS 
2.1 STOCK SOLUTIONS 
2.1.1 GENERAL STOCK SOLUTIONS 
• Tris-acetate-EDTA (TAE) buffer 
To prepare 1 L of 50X TAE buffer; 57.1 ml of glacial acetic acid, 242.0 g of Tris base, 
and 100 ml of 0.5M ethylenediaminetetraacetic acid (pH8.0) (EDTA) were made up 
to a final volume of 1L with double-distilled water. To prepare 100 ml of 1X TAE 
buffer, 10 ml of 50X TAE buffer was added to 90 ml of double-distilled water.  
• Tris/EDTA (TE) Buffer 
1x TE buffer from Invitrogen (Cat. No.: 12090015) was used. The solution contains 
a final concentrations of 10 mM tris hydrochloride (pH8.0) and 0.1 mM EDTA. 
• Luria-Bertani LB 
LB broth consists of 0.5% bacto-yeast extract, 1% bacto-tryptone, 1.5% sugar and 
0.125M NaCl. LB broth was autoclaved after preparation. LB broth was supplemented 
with 15 g/L agar to prepare LB agar and then autoclaved subsequently. Ampicillin was 
added to LB agar and LB broth at 100 µg/ml. 
 
• Super Optimal Broth (SOB) medium 
SOB medium contains 0.5%w/v yeast extract, 2% w/v bacto-tryptone (Fisher 
Scientific), 2.5mM KCl and 8.56mM NaCl made up in double-distilled water. 5M 
NaOH was added as required to adjust the pH to 7.0. The SOB solution was autoclaved 
after preparation. 
 
• Dulbecco’s Phosphate Buffered Saline (PBS) 
10 Oxoid™ phosphate buffered saline tablets (Thermo Fisher Scientific; BR0014) 
were dissolved in 1 L of double-distilled water. The pH was adjusted to 7.4 using 1M 
HCl. The solution was autoclaved after preparation. 
• DNA ladder 






• DNA loading dye 
Gel Loading Dye, Purple (6X), no SDS from NEB (Cat. No. B7025S) was mixed with 
DNA samples which were run on TAE gels 
 
2.1.2 STOCK SOLUTIONS FOR TISSUE FIXATION AND EMBEDDING 
• 0.24M Sodium phosphate buffer 
To prepare 1 L, 27 g of Na2HPO4 and 6.4 g of NaH2PO4.H20 were dissolved in double-
distilled water and the pH adjusted to 7.2 with HCl. The final volume was made up to 
1 L with double-distilled water. 
 
• 0.12M Sodium phosphate buffer/15% sucrose 
0.12M sodium phosphate was made by diluting 0.24M sodium phosphate buffer with 
distilled water at 1:1 ratio. Depending on the volume required, sucrose was added to 
0.12M sodium phosphate buffer to give a final concentration of 15% w/v. The prepared 
solution was stored at -20 °C. 
 
• 0.12M Sodium phosphate buffer /15% sucrose /7.5% gelatine 
Gelatin was added to 0.12M Sodium phosphate buffer/15% sucrose to give a final 
concentration of 7.5% (w/v) and then heated at 37°C to dissolve sucrose and gelatin. 
Aliquoted solutions were stored at -20 °C. 
 
• 4% Paraformaldehyde (PFA) 
To prepare 100ml of 4% PFA solution, 4 g of paraformaldehyde (Sigma-Aldrich:# 
158127) was added to 75 ml of distilled water and heated to 60-65 °C while stirring in 
a fume cupboard. 1M NaOH was added dropwise until the solution clears and the PFA 
dissolves. 10 ml of 10x PBS was added. The final volume was adjusted to 100 ml and 








2.1.3 STOCK SOLUTIONS FOR IMMUNOCYTOCHEMISTRY AND 
IMMUNOHISTOCHEMISTRY 
• 0.05% Tween20/PBS (PBT) 
To prepare 1 L of PBT, 0.5 ml of TWEEN® 20 (Sigma-Aldrich: #P2287) was 
dissolved in 1 L of PBS. 
 
• 0.1%TritonX/0.05% Tween/ PBS (PBT-Tx) 
To make 1L of PBT-Tx, 1.0 ml of Triton™ X-100 (Sigma-Aldrich: #T8787) was 
dissolved in 1 L of PBT. 
 
• Hoechst 33342 nuclear stain 
bisBenzimide H 33342 trihydrochloride (Sigma-Aldrich: #14533) was dissolved in 
distilled water to a final concentration of 1 mg/ml and filtered through a 0.45um filter. 
 
• Antibody buffer/blocking buffer (5% goat serum/PBT) 
0.5 ml of goat serum (Sigma-Aldrich: #G9023) was dissolved in 10 ml of PBT. This 
was used as both antibody buffer and blocking buffer. 
 
2.1.4 STOCK SOLUTIONS FOR WESTERN BLOT  
• 10x PhosSTOP 
1 tablet of PhosSTOP™ (Roche: #4906845001) was dissolved in 1 ml of distilled 
water and stored at -20°C. 
 
• RIPA lysis buffer 
Cell lysis buffer for western blot was prepared using the RIPA Lysis Buffer System 
(sc-24948) manufactured by Santa Cruz Biotechnology. To make 1X RIPA lysis 
buffer, 100ul 10X PhosSTOP, 10ul 200mM PMSF, 10ul protease inhibitor cocktail, 
and 10 ul 100mM sodium orthovanadate were added to 900ul RIPA lysis buffer. 
 
• Protein sample loading buffer 






samples ready for loading on gels. 
• Running buffer 
50 ml of 20X NuPAGE® ® MOPS SDS running buffer (Invitrogen: NP0001) was 
dissolved in 950 ml of distilled water  
 
• Transfer buffer 
50 ml of 20X NuPAGE® ™ Transfer Buffer (Invitrogen: NP00061) by Invitrogen was 
used. 
 
• Tris Buffered Saline with Tween20 (TBST) 
To prepare 1 L of TBST solution, 25.2 ml of 1M Tris pH7.5, 27.2 ml of 5M NaCl, 0.5 
ml of Tween 20, 0.2g of KCl (Sigma-Aldrich) were all made up to a final volume 1 L 
with distilled water. 
 
• TBST blocking buffer/TBST antibody buffer 
To make a 10 ml solution, 5 g of bovine serum albumin (Sigma-Aldrich: #A9647) was 
added to 10 ml of TBST to obtain a 5% w/v solution. 
 
2.1.5 CELL CULTURE SOLUTIONS  
2.1.5.1 KnockOut DMEM (KO-DMEM) 
Avian KnockOut DMEM (#041-96570M) custom-ordered from Life technologies was 
used. Alternatively, KO-DMEM was prepared as follows; 
37.5 ml of DMEM (Life Technologies: #21068-02) 
11.6 ml of cell culture water (Life Technologies: #15230089) 
0.5 ml of 50X MEM amino acids (Life Technologies: #11130051) 
0.5 ml of 100 mM sodium pyruvate (Life Technologies: #11360070) 
0.5 ml of 100X MEM vitamin solution (Life technologies: #11120052) 
 
2.1.5.2 Complete PGC medium  
50 ml of complete PGC medium was prepared as follows; 





1 ml of 50X B27 supplement (Life Technologies: #17504044) 
0.5 ml of 100X MEM non-essential amino acids (Life Technologies: #11140050) 
0.5 ml of 100X GlutaMAX -1 (Life Technologies: #35050-038) 
0.5 ml of 100X EmbryoMax® nucleosides (Merck Millipore: #ES-008-D) 
0.2 ml of 100 mM sodium pyruvate (Life Technologies: #11360070) 
0.1 ml of 50 mM 2-mercaptoethanol (Life Technologies: #31350010) 
0.1 ml of penicillin/streptomycin (10,000 U/ml) (Life Technologies: #15140122) 
0.075 ml of 100 mM CaCl2 dissolved in cell culture water 
0.5 ml of 20% ovalbumin (Sigma-Aldrich: A5503) dissolved in KO-DMEM 
0.1 ml of heparin sodium (50 mg/ml in dissolved in KO-DMEM)  
 
2.1.5.3 FAOT PGC culture medium (Whyte et al., 2015) 
To prepare 10 ml of FAOT PGC medium; 
10 ml of complete PGC medium 
1.6 μl of h-FGF2 (50 ng/μl) (R & D systems) 
10 μl of h-Activin A (25 ng/μl) (R & D systems) 
10 μl of Ovotransferrin (50 ng/μl)  
Filter through a 0.22 µm syringe filter (Merck Millipore; #SLGPO33RS). ‘’FAOT’’ is 
an abbreviation derived from the growth factors used in the preparation of the medium; 
FGF2 (F), Activin A (A) and Ovotransferrin (OT)  
 
2.1.5.4 Conditioned FAOT PGC culture medium  
500,000 PGCs were cultured in 1 ml of FAOT culture medium for 24 hours at 37°C 
and 5% CO2. Subsequently, the cell culture was centrifuged to collect the culture 
supernatant which was filtered through a 0.22 µm syringe filter (Merck Millipore; 
#SLGPO33RS). The filtered supernatant was stored at 4°C for not more than 7 days. 
Conditioned FAOT was prepared as required and used immediately. 
 
2.1.5.5 PGC starvation medium  
50 ml of PGC starvation medium was prepared as follows; 





1 ml of B-27®Minus Insulin supplement (Life Technologies: #A1895601) 
0.5 ml of 100X MEM non-essential amino acids (Life Technologies: #11140050) 
0.5 ml of 100X GlutaMAX -1 (Life Technologies: #35050-038) 
0.5 ml of 100X EmbryoMax® nucleosides (Merck Millipore: #ES-008-D) 
0.2 ml of 100 mM sodium pyruvate (Life Technologies: #11360070) 
0.1 ml of 50 mM 2-mercaptoethanol (Life Technologies: #31350010) 
0.1 ml of penicillin/streptomycin (10,000 U/ml) (Life Technologies: #15140122) 
0.075 ml of 100 mM CaCl2 dissolved in cell culture water 
0.5 ml of 20% ovalbumin (Sigma-Aldrich: A5503) dissolved in KO-DMEM 
0.1 ml of heparin sodium (50 mg/ml in dissolved in KO-DMEM)  
Filter through a 0.22 µm syringe filter (Merck Millipore; #SLGPO33RS). 
 
2.1.5.6 PGC fibroblast medium  
50 ml of reduced PGC medium was prepared as follow; 
43ml of DMEM (Life Technologies: #10829-018) 
0.5 ml of 100X GlutaMAX -1 (Life Technologies: #35050-038) 
0.5 ml of 100X MEM non-essential amino acids (Life Technologies: #11140050) 
0.5 ml of 100 mM sodium pyruvate (Life Technologies: #11360070) 
50 μl of Ovotransferrin (50ng/μl) 
0.1 ml of penicillin/streptomycin (10,000 U/ml) (Life Technologies: #15140122) 
0.5ml of chicken serum (Biosera: #CH-515) 
5ml of ES Cell Qualified FBS, US origin (Life technologies: #16141079) 
Filter through a 0.22 µm syringe filter (Merck Millipore; #SLGPO33RS). 
 
2.1.5.7 Cryopreservation medium 
STEM-CELLBANKER® (Amsbio: #11897) was used for cryopreservation of all 
cells. Alternative cryopreservation medium was prepared as follows; 0.4 ml DMSO 
(Sigma-Aldrich), 0.5 ml chicken serum (Biosera) and 7.5 µl 100 mM CaCl2 added to 
5 ml of KO-DMEM and then filtered through a 0.22 µm syringe filter (Merck 







Doxycycline hyclate (Sigma-Aldrich: #D9891). 50 mg of doxycycline hyclate was 
dissolved in in 5 ml of Hank’s balanced salt solution (ThermoFisher Scientific: 
14185045) to a final concentration of 10 mg/ml. The prepared stock solution was 
stored at 4°C and protected from light. 0.1 mg/ml working stocks were made by 
diluting the 10 mg/ml stock solution with distilled water. 
 
2.1.5.9 Puromycin 
Puromycin dihydrochloride (Sigma-Aldrich: #P7255) was dissolved in double-
distilled water to a concentration of 1 mg/ml. 1 mg/ml aliquots were stored at -20°C 
for long term storage. 0.1 mg/ml working stocks were prepared by further dilution with 
double-distilled water and stored at 4°C. 
 
2.2 CENTRIFUGATION 
Centrifuges used in this project include: 
1.5 ml tubes – Eppendorf Minispin benchtop centrifuge 
1.5 ml tubes – Biofuge Pico (Heraeus) 
0.2 ml PCR strip tubes – Tube-Strip Picofuge (Stratagene) 
1.5 ml tubes at 4°C – Biofuge Fresco centrifuge (Heraeus) 
15 ml and 50 ml tubes – Centrifuge 5810R (Eppendorf) 
 
2.3 ANIMAL METHODS  
2.3.1 Chickens 
Wild type and transgenic GFP fertile chicken eggs were obtained from commercial 
Hyline layer lines maintained by the Roslin Institute (McGrew et al., 2008). 
Commercial and transgenic chicken lines were maintained and bred under UK Home 
Office License. All experiments were performed in accordance with relevant UK 
Home Office guidelines and regulations. The experimental protocol and studies were 








2.3.2 Chick embryos 
Fertile eggs were incubated at 37.5°C for the required period. Embryos were examined 
microscopically and staged using the stages designed by (Hamburger & Hamilton, 
1992). Embryonic stages are referred to as stage ‘N’ HH in this thesis. 
 
2.3.3 Aspiration of chick embryonic blood  
To derive chicken PGC lines, fertile eggs were incubated for 2.5 days to obtain stage 
16 HH embryos. Microcapillary tubes (Harvard Apparatus) were pulled to create 
needles using a moving-coil microelectrode puller (Model 753 – Camden Instruments 
Ltd) and UV-sterilised. To aspirate blood, a hole was made in the blunt end of the egg 
by cutting through the eggshell. The shell membrane was pulled apart to reveal the 
embryo and then the pulled needle was inserted into the aorta to aspirate 1-2 µl of 
blood which was dispensed into 300 µl of FAOT. The aspirated embryonic blood is 
subsequently cultured to propagate PGCs while the red blood cells gradually die out. 
The PGC lines reported in this thesis include 
AK4M, male, GFP heterozygous 
AK2F, female, GFP heterozygous 
AK8M, male, GFP homozygous 
Y2M, male, mCherry heterozygous (derived by  Caroline Zeiger-Poli and published 
in (Glover et al., 2013)) 
12F, female, non-transgenic (derived by Dr Mike McGrew) 
Sex determination of the PGCs was performed by Lorna Taylor. 
 
2.3.4 Injection of PGCs 
PGCs for injection were resuspended in complete medium at the desired concentration. 
Fast green dye (Sigma-Aldrich) was added to the PGC suspension at a ratio of 1:50. 
Eggs were windowed and approximately 1-2 µl of the PGC suspension was injected 
into the aorta of stage 16 HH embryo using a pulled needle. 0.5 ml of PBS with 1x 
penicillin-streptomycin was applied to the surface of the embryo. The windowed eggs 







2.3.5 In ovo doxycycline induction 
A 0.1 mg/ml solution of doxycycline hyclate in Hank’s balanced salt solution 
(ThermoFisher Scientific: 14185045) was first prepared. For injection of stage 30-40 
HH embryos, the doxycycline solution was injected into the amniotic sac. 
 
2.3.6 Dissection of embryos 
To examine stage 18 HH embryos, the eggshell was cut open and the embryo 
transferred into PBS. Subsequently, the embryo was pinned down in petri dish 
embedded with 2% agarose gel and containing PBS, so that the vitelline membranes 
are spread out and the ventral side faced up wards to expose the lateral plate. For stage 
30-32 HH and 39-40 HH, the head of the embryos were first removed and then the 
embryo was immersed in PBS. Subsequently, the embryo was placed on dorsal 
recumbency and a ventral midline incision was made through the abdominal wall to 
expose the abdominal organs. Next, all the abdominal viscera were gently removed to 
expose and dissect the gonads out. Once dissected out the gonads were immediately 
fixed in 4% PFA.  
 
2.4 CELL CULTURE METHODS 
2.4.1 Standard PGC culture 
50,000-100,000 PGCs were seeded in 500 µl of FAOT for culture in a 24-well tissue 
culture plate while cell density was generally maintained at 200,000 cells/well. Cell 
culture medium was replaced every 48 hour and cell density was not allowed to exceed 
400,000 cells.  
For 12-well tissue culture plates, PGCs were seeded at 100,000-200,000/well and 
culture medium was replaced every 48 hours. Cell density was generally maintained 
at 400,000 cells/well while cell density not allowed to exceed 800,000 cells/well. 
During culture, the colour of the medium was monitored to ensure the pH is within 6.9 
to 7.2 and also as indication of culture health.  
 
2.4.2 Single-cell clonal culture 
Single cell plating was performed manually by hand or using the BD FACSAria III 





FAOT in a 96-well plate. After 48 hours, 50-60 µl of FAOT or conditioned FAOT was 
added to the well. Subsequently, 40 µl of the culture medium was gently taken off and 
replaced with 50-60 µl of FAOT. Once the cell confluency reached 30-50%, the cell 
culture was transferred to a 48 well-plate and the final volume increased to 300 µl by 
adding FAOT. Sometimes, conditioned FAOT or 50% conditioned FAOT prepared by 
mixing conditioned FAOT with FAOT was used for cell culture maintenance when 
cell growth appeared retarded or to adjust culture pH. 
 
2.4.3 PGC growth assay  
500 PGCs were seeded into 300 µl of FAOT medium and cultured at 37°C and 5% 
CO2 for 10 days. Every 48 hours, 90 µl of culture medium was withdrawn by directing 
the pipette tip at the periphery and was replaced with 100 µl of FAOT.  
 
2.4.4 Cell count 
Cells were counted in a haemocytometer. To exclude dead cells and count only live 
cells, 10 µl of cell culture was mixed with 10 µl of 0.4% Trypan Blue solution (Sigma-
Aldrich: #T8154). This mixture was pipetted into a haemocytometer and viewed under 
a Nikon Eclipse TS100 inverted microscope. Dead cells take up the Trypan Blue and 
appear blue due to their compromised membranes while live cells appear bright. 
 
2.4.5 PGC transfection with DNA 
DNA was transfected into PGCs using Lipofectamine 2000 (Invitrogen: # 11668019). 
First, 2 µl of Lipofectamine 2000 is mixed with 148 µl of Opti-MEM I reduced serum 
medium (Invitrogen: #31985062). Next, 2-4 µg of DNA suspended in TE buffer is 
mixed with Opti-MEM I reduced serum medium (Invitrogen: #31985062) to give a 
final volume of 150 µl.  The two mixtures are incubated for 20 mins and then mixed 
together gently in a 1.5 ml screw-cap microcentrifuge tube. While the 
DNA/Lipofectamine mixture is incubating, 200,000 PGCs are washed twice with 
Opti-MEM I reduced serum medium and then resuspended in 50 µl of Opti-MEM I 
reduced serum medium. Subsequently, the cell suspension is gently pipetted into the 
DNA/Lipofectamine mixture and then mixed gently by pipetting up and down 5 times. 





the transfection mixture is placed into an incubator at 37°C and 5% CO2 for 5-6 hours. 
At the end of the 6-hour incubation, the transfection mixture is centrifuged for 10 min 
at 2200 RPM in an Eppendorf Minispin benchtop centrifuge at room temperature. 
During centrifugation or prior to centrifugation, FAOT for resuspension of the 
transfected cells is warmed up to room temperature and up to 37°C. Once 
centrifugation is over, the supernatant is gently pipetted out and the cell pellet 
resuspended in 500 µl of pre-warmed FAOT and then incubated at 37°C and 5% CO2.  
 
2.4.6 PGC transfection with CRISPR plasmid and ssODN  
Protocol is the same as in SECTION 2.4.5 except that 1.5 µg of CRISPR plasmid and 
a maximum of 0.4 µg (10µM) of ssODN was used throughout in chapter three. 0.2 µg 
(5µM) per ssODN was used when mixing two donors. ssODN may be lowered to 0.04 
µg (1 µM) with similar efficiency to mix multiple donors. 24 hours after transfection, 
2-3 µl of 0.1 mg/ml puromycin is added to 500 µl of transfected cell culture and then 
incubated for 48 hours. The puromycin-selected cells are then expanded in FAOT. 
 
2.4.7 PGC transfection with piggybac vectors  
Protocol is the same as in SECTION 2.4.5 except that 1 µg of PB-Tet-On-Akt plasmid 
and 1 µg of PB CAG:Hybase were co-transfected into PGCs. 48 hours after 
transfection, 2 µl of 0.1 mg/ml puromycin is added to 500 µl of transfected cell culture 
and then incubated for 48 hours. This is repeated every 48 hours for two weeks to 
select for stably-transfected cells expressing puromycin resistance. 
 
2.4.8 Derivation of PGC fibroblasts 
Wells of 24-well tissue culture plates were coated with 100 µl of 0.1 mg/ml fibronectin 
and then incubated at 37°C for 1 hour. Subsequently, the excess fibronectin was taken 
off and the plate was set at room temperature for 4 hours to allow the wells dry out. 
Next, 100,000 PGCs in 500 µl of FAOT was pipetted into the fibronectin-coated wells. 
8 µl of 100 mM CaCl2 was added to cell culture in each well and then incubated at for 
48 hours. Subsequently, 250 µl of cell culture medium was taken off the side of the 
well and then 250 µl of PGC fibroblast medium was added back. This was repeated 





300 µl of PGC fibroblast medium every 48 hours. Once cell confluency reached 95%, 
the cell culture was split as follows; all the culture medium was taken off and 
discarded. Next, the adherent cells in the well were washed by applying 500 µl of PBS 
and then pipetting it off completely. Subsequently, 50 µl of 1X TrypLE™ Express 
Enzyme (Gibco: #12604013) was added to the washed wells and then incubated at 
37°C for 10 minutes to dissociate the adherent cells. The plate was then rocked gently 
to release the adherent cells from the surface of the well. Subsequently, 450 µl of PGC 
fibroblast medium was added to resuspend the dissociated cells which was further 
diluted by adding 1 ml of PGC fibroblast medium. Finally, 500 µl of cell suspension 
was then dispensed into new wells and then incubated. Cell culture incubation was 
performed at 37°C and 5% CO throughout.  
 
2.5 MOLECULAR METHODS 
2.5.1 Bacterial transformation 
DNA ligation reactions or plasmids were transformed into XL10-Gold® 
Ultracompetent Cells (STRATAGENE: 200314) according to the manufacturer’s 
instructions.  
For pGEM®-T plasmids vectors containing PCR products, 20 µl of transformed 
bacteria were first incubated in 600 µl of SOB medium at 37°C for 1 hour while 
shaking at 250 RPM. This step was performed to increase transformation efficiency 
(Hanahan, 1983). Subsequently, the SOB culture was centrifuged at 5,000 RPM for 1 
minute in a Biofuge Pico bench top centrifuge (Heraeus) and then were plated onto LB 
agar plates containing ampicillin at a concentration of 100 µg/ml and then 400 µl of 
the supernatant was discarded. The cell pellet was then gently resuspended using the 
remaining 200 µl supernatant. 20 µl of IPTG (Sigma: #1284-5ML), 20 µl of 50 mg/ml 
X-Gal and the resuspended cells were then plated onto LB agar plates containing 
ampicillin at a concentration of 100 µg/ml and incubated at 37°C overnight. 
For CRISPR/Cas9 plasmids, the transformed bacteria were plated onto LB agar plates 
containing ampicillin at a concentration of 100 µg/ml and then incubated overnight at 
37°C overnight.  
For small scale plasmid preparation, a single colony was picked and incubated in a 





concentration of 100 µg/ml. Alternatively, colonies were expanded in 250 ml of LB 
broth containing ampicillin at a concentration of 100 µg/ml for large scale plasmid 
preparation. Shaking incubators were set to 250 RPM for bacterial culture in LB broth. 
 
2.5.2 Nucleic acid purification and cloning 
2.5.2.1 Genomic DNA extraction 
Genomic DNA was extracted from cultured cells using QIAMP DNA Micro kit 
(Qiagen; #56304) according to the manufacturer’s instruction. DNA was extracted 
from at least 100,000 cells which were centrifuged to collect pellets that may be stored 
at -20°C.  
 
2.5.2.2 RNA extraction 
RNA was extracted from cultured cells using the RNeasy Plus Micro kit (Qiagen; 
#74034) according to the manufacturer’s instruction. RNA was extracted from at least 
100,000 cells which were centrifuged to collect pellets. Cell pellets may be stored at -
20°C after resuspension in RNAlater™ stabilization solution (Invitrogen: #AM7020).  
 
2.5.2.3 Complementary DNA synthesis 
Complementary DNA (cDNA) was synthesized from RNA using the Reverse 
Transcription System (Promega: #A3500) according to the manufacturer’s instruction. 
 
2.5.2.4 Cloning of PCR products 
Blunt-end PCR products generated with Q5® Hot Start High-Fidelity DNA 
Polymerase or Phusion® High-Fidelity DNA Polymerase were first subjected to an 10 
µl A-tailing reaction containing 5.0 µl of PCR product, 1.0 µl (5 units) of Taq 
polymerase (Thermo Scientific; #EP0402), 2.0 µl of 0.1mM dATP, 0.6 µl of 25 mM 
MgCl2, 1.0 µl of 10X reaction buffer and 0.4 µl of nuclease-free water. The A tailing 
reaction was incubated at 70°C for 20 minutes.  
Next, PCR product was ligated with the pGEM®-T Easy vector (Promega: #A1360) 
in a 10 µl reaction containing 2.0 µl of A-tailed PCR product, 5.0 µl of 2X Buffer, 1.0 





ligation reaction was incubated at 4°C overnight after which it is ready for bacterial 
transformation. 
 
2.5.2.5 Plasmid DNA purification 
For small-scale plasmid preparation, plasmid DNA was purified from overnight 
bacterial culture using the Wizard® Plus SV Minipreps DNA Purification System 
(Promega: #A1460) according to the manufacturer’s instruction.  
For large-scale plasmid preparation, plasmid DNA was purified from overnight 
bacterial culture and eluted in TE buffer using the PureLink™ HiPure Plasmid Filter 
Maxiprep Kit (Invitrogen: #K210017) according to the manufacturer’s instruction. 
 
2.5.2.6 Purification of PCR samples 
Purification of PCR samples was performed using the MinElute PCR Purification Kit 
(Qiagen: #28004) or GeneJET PCR Purification Kit (Thermo Scientific: #K0701) 
according to the manufacturer’s instruction. 
 
2.5.2.7 Purification of DNA from agarose gels 
Extraction of DNA from agarose gels was performed using the PureLink™ Quick Gel 
Extraction Kit (Invitrogen: #K210012) according to the manufacturer’s instruction. 
 
2.5.2.8 Nucleic acid quantification 
DNA and RNA concentration were determined using the NanoDrop® 
Spectrophotometer (Thermo Scientific: #ND-1000). 
 
2.5.3 DNA sequencing  
Sanger sequencing was performed by DNA Sequencing and Services, MRC/PPU, 
College of Life Sciences, the University of Dundee, Dundee, Scotland. For plasmid 
sequencing, 600 ng of DNA and 100 µM of the appropriate primer was used for 
sequencing. For PCR products, PCR samples were first purified the using MinElute 
PCR Purification Kit (Qiagen: #28004) and eluted in 10 µl of nuclease-free water and 





of purified PCR sample and 100 µM of the appropriate primer was used for 
sequencing. Sequencing of the forward and reverse strand was performed in all cases. 
 
2.5.4 Polymerase Chain Reactions (PCR) 
PCR was performed with three different kits in the manner described as follows; 
2.5.4.1 Standard PCR using Q5® Hot Start High-Fidelity DNA Polymerase   
50 or 100 ng of DNA was used in each PCR performed with Q5® Hot Start High-
Fidelity DNA Polymerase kit (NEB: M0493L) according to the manufacturer’s 
instruction using the following thermal cycling profile: 
Initial denaturation 98°C for 30 seconds, 
30 cycles of 98°C for 10 seconds, ‘’A’’ for 20 seconds and 72°C for 30 seconds, 
Final extension 72°C for 2 minutes 
‘’A’’ is the annealing temperature calculated using the online NEB annealing 
temperature calculator (https://tmcalculator.neb.com/). 
Each 25 µl reaction was prepared as follows; 
5.00 µl 5X Q5 reaction buffer  
0.50 µl dNTP mix (10 mM) 
0.25 µl Q5 hot start high-fidelity polymerase 
1.25 µl Forward primer (10 µM) 
1.25 µl Reverse primer  (10 µM) 
11.75 µl Nuclease free water  (Nalgene: #AM9938) 
5.00 µl DNA sample (10-20ng/µl) 
 
2.5.4.2 Standard PCR using Phusion® High-Fidelity DNA Polymerase 
100 ng of DNA was used in each PCR performed with Phusion® High-Fidelity DNA 
Polymerase kit (Thermo Scientific Fisher: F-553L) according to the manufacturer’s 
instruction using the following thermal cycling profile except where stated otherwise: 
Initial denaturation 98°C for 30 seconds, 
30 cycles of 98°C for 10 seconds, ‘’A’’ for 20 seconds and 72°C for 30 seconds, 
Final extension 72°C for 5 minutes 
‘’A’’ is the annealing temperature calculated using the online NEB annealing 





Each 25 µl reaction was prepared as follows; 
5.00 µl 5X HF reaction buffer  
0.50 µl dNTP mix (10 mM) 
0.25 µl Phusion high-fidelity polymerase 
1.25 µl Forward primer (10 µM) 
1.25 µl Reverse primer  (10 µM) 
11.75 µl Nuclease free water  (Nalgene: #AM9938) 
5.00 µl DNA sample (10-20ng/µl) 
 
2.5.4.3 Standard PCR using FastStart™ Taq DNA Polymerase 
FastStart™ Taq DNA Polymerase Kit (Roche: # 12032929001) was used to amplify 
the CXCR4 gene  to check for  deletion (See chapter 5). Each 15 µl reaction was 
prepared as follows: 
1.5 µl PCR reaction buffer + MgCl2  (10X)  
0.3 µl dNTP mix (10 mM) 
0.1 µl FastStart™ Taq DNA Polymerase 
0.3 µl Forward primer (10 µM) 
0.3 µl Reverse primer  (10 µM) 
7.5 µl Nuclease free water  (Nalgene: #AM9938) 
5.0 µl DNA sample (10-20ng/µl) 
The thermal cycling profile used for amplification is as follows; 
Initial denaturation 95°C for 5 minutes, 
30 cycles of 95°C for 10 seconds, 61.3°C  for 30 seconds and 72°C for 1 minute, 
Final extension 72°C for 5 minutes. 
 
2.5.4.4 Thermocyclers  
Biometra Tprofessional thermocycler (Biometra GmBH) 









2.5.4.5 PCR primers 
PCR primers were designed using the primer3 software (http://primer3.ut.ee/) 
(Koressaar & Remm, 2007; Untergasser et al., 2012). Primers were synthesized by 
Invitrogen and diluted in nuclease free water (Nalgene: #AM9938). 








65.0 (2.5.4.2) Chapter 3 
Ovomucoid FP:GCTGGTTTATCACATGGGGAC 
RP:CACCTCTCCATCCTTTTGCTC  
67.0 (2.5.4.1) Chapter 3 
Ovalbumin FP:ACCCAAAAGACAACTGAATGCA  
RP:GAGCTATGCAGTTTCCAAGGG  
66.0 (2.5.4.1) Chapter 3 
FGF20 FP:TGTCAGGTCTACACACTCCTC 
RP:CAAGTTTGAAGGAGGCTGGTC 
67.0 (2.5.4.1) Chapter 3 
GFP FP:TAAACGGCCACAAGTTCAGC 
RP:GATGTTGTGGCGGATCTTGAA 















67.0 (2.5.4.1) Chapter 4 
CXCR4 FP:ATGAAGGGATGGCAAGGGAA 
RP:GCCTATTGGTGATGGTGGAG 
61.3 (2.5.4.3) Chapter 5 
c-Kit FP:AGAAAGTGCCCAGTTGCAGT 
RP:CAGGACACAAGGGCAAGTTT 
67.0 (2.5.4.1) Chapter 5 
Table 2.1 List of primers used in this thesis. Their annealing temperatures are shown 
with the PCR protocol used in bracket. FP-Forward Primer. RP-Reverse Primer 
 
2.5.5 Agarose gel electrophoresis  
To prepare 1% agarose gels, 1.5 g of UltraPure™ Agarose (Invitrogen: #16500500) 
was dissolved in 150 ml of TAE buffer and then heated until the solution was clear. 





agarose solution and poured into a gel casting tray. A gel comb was inserted into the 
agarose solution in the gel casting tray and then allowed to cool. DNA samples were 
mixed with the DNA loading dye (2.1.1) and loaded into the gels which were run at 
100 volts for 1 hour. Gels were visualised under ultraviolet radiation and gel images 
subsequently captured using the Gel Logic 200 Imaging System (Kodak). 
 
2.6 CRISPR/CAS9 VECTORS AND METHODS 
2.6.1 CRISPR plasmids 
PX459 2.0 and HF-PX459 V2.0 plasmids were used in this thesis. PX459 V2.0 was a 
gift from Dr Feng Zhang (Addgene plasmid # 62988) (Ran et al., 2013). HF-PX459 
V2.0 was generated from PX459 V2.0 and VP12 plasmids. VP12 was a gift from Dr 
Keith Joung (Addgene plasmid # 72247) (Kleinstiver et al., 2016). 
 
2.6.2 Construction of HF-PX459 V2.0 
The materials used for the generation of HF-PX459 V2.0 include; 
1 PX459 V2.0 plasmid 
2 VP12 plasmid 
3 ApaI restriction enzyme (NEB: #R0114S) 
4 PmlI restriction enzyme (NEB: #R0532S) 
5 DpnI restriction enzyme (NEB #R0176S) 
6 GeneJET PCR Purification Kit (Thermo Scientific: #K0701) 
7 PureLink™ Quick Gel Extraction Kit (Invitrogen: #K210012) 
8 NEBuilder® HiFi DNA Assembly Cloning Kit (NEB #E5520S) 
The online NEBuilder Assembly Tool (http://nebuilder.neb.com/) was used to design 
primers that overlap the PX459 V2.0 plasmid backbone and amplify the segment of 
VP12 vector containing the SpCas9-HF1 substitutions. The primer sequences are; 
Insert_fwd: 5’-ttccgcatcccctactacgtgggccCCCTGGCCCGAGGGAACTCTC-‘3   
Insert_rev: 5’-tccgggagtccaggatctgtgccacATGCTTTGTGATGGCGCGGGTTTC-3’ 
The annealing temperature for the primers was calculated to be 72.0°C using the online 
NEB tool (https://tmcalculator.neb.com/). Q5® Hot Start High-Fidelity DNA 
Polymerase was used to amplify the VP12 insert as described in section 2.5.2.1. The 





purification Kit according to the manufacturer’s instruction. Subsequently, 1 µg of 
purified PCR DNA was treated with DpnI enzyme to digest the VP12 plasmid 
according to the manufacturer’s instruction. The DpnI-treated PCR product was then 
purified again using the GeneJet PCR purification Kit to produce a purified VP12 PCR 
insert. Next, PX459 V2.0 plasmid was treated with ApaI and PmlI enzymes to excise 
the corresponding region from the vector according to the manufacturer’s instruction 
and subsequently, run on 1% agarose gel. Two bands were visible on examination of 
the agarose gel. The smaller size band was 1430-kb corresponding to the excised 
region while the larger size band was above the ladder. The gel area containing the 
larger band was cut out and purified using the PureLink™ Quick Gel Extraction Kit 
followed by additional purification using the GeneJet PCR purification Kit to produce 
a purified PX459 backbone. Next, vector assembly was performed in a 20 µl reaction 
containing 100 ng of PX459 backbone, 200 ng of VP12 PCR insert, 10 µl of the 
NEBuilder HiFi DNA Assembly Master Mix and made up to a final volume of 20 µl 
using nuclease-free water (Nalgene: #AM9938). The assembly reaction was incubated 
at 50.0°C for 2hourand then cooled to 4.0°C. The assembled DNA was diluted at 1:1 
and 1:10 with nuclease free water. XL10-Gold® ultracompetent bacterial cells were 
then transformed with the different dilutions of the assembled DNA. The transformed 
bacterial cells were then plated on LB agar plates containing 100 µg/ml ampicillin and 
subsequently cultured overnight at 37°C. Single colonies were picked and further 
expanded in LB broth containing 100 µg/ml ampicillin cultured overnight at 37°C in 
a shaking incubator. Plasmid DNA was then extracted from 5 ml of overnight bacterial 
culture in LB broth using the Wizard® Plus SV Minipreps DNA Purification System 
(Promega: #A1460) according to the manufacturer’s instruction. For higher plasmid 
concentration, Plasmid DNA was extracted from 200 ml of the overnight LB broth 
using the PureLink™ HiPure Plasmid Filter Maxiprep Kit (Invitrogen: #K210017) 
according to the manufacturer’s instruction and resuspended in TE buffer. 
The correct insertion of the VP12 PCR insert into the PX459 backbone will eliminate 
the PmlI site.  To confirm successful DNA assembly, the purified miniprep plasmid 
was treated with ApaI and PmlI enzymes and then run on 1% agarose. The appearance 
of a single band tentatively indicates successful assembly. Finally, the plasmid was 








2.6.3 gRNA selection and CRISPR/Cas9 vector assembly  
The CHOPCHOP gRNA design web tool (http://chopchop.cbu.uib.no/) (Labun et al., 
2016; Montague et al., 2014) and the MIT gRNA design web tool 
(http://crispr.mit.edu/) were used to select suitable gRNA sequences except where 
stated otherwise. gRNA oligonucleotides were synthesized by Invitrogen and inserted 
into PX459 V2.0 and HF-PX459 V2.0 vectors using the materials and method 
described by (Ran et al., 2013). The gRNA sequences are listed in the Table 2.2.  
Name 5’                3’ Thesis 
reference 
CXCR4-gRNA caccgACAATGGCTCGGAGGAGAT Chapter 3 
Ovomucoid-gRNA caccgTTTCCCAACGCTACAGACA Chapter 3 
Ovalbumin-gRNA caccgCTCTAGCCATGGTATACCT Chapter 3 
GFP-gRNA caccCTCGTGACCACCCTGACCTA Chapter 3 
FGF20-gRNA1 caccgTACTCCCAGAGATGGAGCA Chapter 3 
FGF20-gRNA2 caccgTGTGAACTTCTGGTGTCTTT Chapter 3 
FGF20-gRNA3 caccgCAGGAAATGTGTGAACTTC Chapter 3 
EX5-gRNA1 caccgAGCTGGAAGCAATATGTACT Chapter 4 
EX5-gRNA2 caccgCATTCCCCTCGCTCCTTCAA Chapter 4 
Knockout-gRNA1 caccgCGGCCATGGACATGAAGAAA Chapter 4 
CXCR4-gRNA1 caccgATGTTTTGAACTTGGCACCC Chapter 5 
CXCR4-gRNA2 caccgGACAATGGCTCGGAGGAGAT Chapter 5 
cKit-gRNA1 caccgCTTGTTGATTCTCTGATCTA Chapter 5 
cKit-gRNA2 caccgGAACGTACAGAGGTCATTCA Chapter 5 
DDX4 S1 gRNA caccgGCTCCGTGTCCCAGTCCTCC APPENDIX D 
 
Table 2.2 List of gRNAs used in this thesis. ‘’cacc’’ is the terminal sequence of the 
U6 promoter in PX459 and HF-PX459 followed by a ‘g’ nucleotide required for 
optimal U6 promoter activity, which is followed by the 19-bp or 20-bp gRNA 












































Table 2.3 Sequences of ssODN donors used in chapter 3 and APPENDIX D & E. 





2.6.4 HDR donors 
Short single stranded oligonucleotides (ssODN) donors were synthesized by Integrated 
DNA Technologies (IDT) as Ultramer® DNA Oligonucleotides. ssODN were 
resuspended in TE buffer and used at a concentration of 10 µM (0.4 µg/µl) for 
transfections (see section 2.4.4). See Table 2.3 for ssODN sequences. 
 
2.6.5 T7 endonuclease I mismatch assay 
PCR samples were first purified using the MinElute PCR Purification Kit (Qiagen: 
#28004) and eluted in 10 µl of the provided elution buffer. Next, a 20 µl hybridization 
reaction is prepared using 5 µl of the purified PCR sample, 2 µl of 10X NEBuffer2 
(NEB; B7002S) and 13 µl of nuclease-free water.  Next, the reaction is run in a 
thermocycler using the following profile;  
Initial denaturation of 95°C for 5 minutes, 
Then anneal by ramping from 95-85°C at -2°C/second, 
Followed by ramping from 85-25°C at -0.1°C/second, finally cool to 4°C. 
Subsequently, 8 µl of nuclease-free water, 1 µl (10 units) of T7 endonuclease I (NEB; 
#M0302S) and 1 µl of 10X NEBuffer 2 are added to the hybridised 20 µl reaction and 
incubated at 37°C for 15-30 minutes and then cooled to 4°C. Subsequently, the 
reaction is resolved on 1% agarose gel containing Gelred® nucleic acid gel stain 
(Biotium) in 1X TAE buffer at 100 volts for 1 hour. ImageJ (https://imagej.net) was 
used to quantitate intensities of the cleaved and uncleaved PCR bands while the 
targeting efficiency was calculated using the values of the band intensities using the 
equation 100 x (1 – (1- fraction cleaved)1/2) (Guschin et al., 2010).  
 
2.6.6 HDR quantification by restriction enzyme digestion 
PCR samples were first purified using the MinElute PCR Purification Kit (Qiagen: 
#28004) and eluted in 12 µl of the provided elution buffer. 20 µl reactions were then 
prepared using 5 µl of the purified PCR product (approximately 200 ng of DNA), 1 µl 
(10 units) of the restriction enzyme (EcoRI-HF (NEB #R3101S), BamHI-HF (NEB 
#R3136S), AfeI (NEB #R0652S) or AatII (NEB #R0117S)), 2 µl of 10X CutSmart® 
buffer (NEB; #B7204S) and 12 µl of nuclease-free water. Digest reactions were 





on 1% agarose gel containing Gelred® nucleic acid gel stain (Biotium) in 1X TAE 
buffer at 100 volts for 1 hour. ImageJ (https://imagej.net) was used to estimate the 
intensities of the cleaved and uncleaved PCR products. The percentage of HDR was 
then calculated using the equation (b + c / a + b + c) × 100, where ‘a’ is the band 
intensity of uncleaved parent DNA substrate and ‘b’ and ‘c’ are the cleavage products. 
  
2.7  STOCK PLASMIDS IN THE McGREW LAB 
2.7.1 PB-Tet-On-Akt 
piggyBac vector containing a CAG promoter driving expression of puromycin 
resistance as well as a reverse tetracycline transactivator protein that induces the 
expression of Akt if doxycycline is present in (Glover et al., 2013). 
2.7.2 PB CAG:Hybase 
piggyBac vector containing a CAG promoter driving the expression of the piggyBac 
transposase (Hybase) (Macdonald et al., 2012). 
2.7.3 PX459 V2.0 
CRISPR/Cas9 plasmid expressing a single guide RNA under the control of the human 
U6 promoter, as well as puromycin resistance and wild type SpCas9 (SpCas9-WT) 
which are driven by a CAG promoter (Ran et al., 2013). 
2.7.4 HF-PX459 V2.0  
CRISPR/Cas9 plasmid expressing single guide RNA under the control of the human 
U6 promoter, as well as puromycin resistance and high fidelity SpCas9-HF1 which are 
driven by a CAG promoter (Idoko-Akoh et al., 2018). 
2.7.5 VP12 
CRISPR/Cas9 plasmid expressing only SpCas9-HF1 under the control of the CMV 
promoter (Kleinstiver et al., 2016). 
2.7.6 FGF20-plasmid HDR donor 
FGF20-plasmid (APPENDIX E) was synthesized by Integrated DNA Technologies as 
MiniGene 25-500 bp. 
 
2.8 FLOW CYTOMETRY 
A minimum of 300,000 cells were resuspended in KO-DMEM and then filtered 





dissociate clumped cells before being subsequently processed by the flow cytometer. 
Quantification of fluorescent cells was performed using the Fortessa X20 flow 
cytometer (BD Biosciences) and the flow cytometry data was analysed using FlowJo® 
V7.0 (FlowJo, LLC). Fluorescent activated cell sorting (FACS) to collect single cells 
or a gated population for culture was performed using the BD FACSAria IIITM sorter 
(BD Biosciences). 
 
2.9 WESTERN BLOT 
Cell culture containing at least 300,000 cells was centrifuged and the supernatant 
discarded. The cell pellet was then resuspended with 1X RIPA lysis buffer (see 2.1.3) 
at 100,000 cells per 20 µl. The concentration of protein in each sample was then 
determined using the Bradford method using the Quick Start™ Bradford Protein Assay 
Kit (BIORAD; #5000202) according to the manufacturer’s instruction (Bradford, 
1976). Subsequently, denaturing electrophoresis and western blotting was carried out 
using the NuPAGE® electrophoresis system (Invitrogen) following the 
manufacturer’s protocol (NuPAGE® Technical Guide; Manual part no. IM-1001; 
MAN0003188, released 29 October 2010). Briefly, electrophoresis samples were 
prepared using a 10 µg of protein sample, 5 µl of 4X NuPAGE® LDS sample buffer, 
2 µl of 10X NuPAGE® reducing agent and made up to a final volume of 20 µl with 
deionised water. The prepared sample was heated at 70°C for 10 minutes. 
Subsequently, the heated samples and MagicMark™ XP western protein standard 
(ThermoFisher Scientific; #LC5602) were loaded into a NuPAGE® Novex® 12% Bis-
Tris (SDS-PAGE) gel and subjected to denaturing electrophoresis using the 
NuPAGE® MOPS SDS running buffer at 200V for 60 minutes in an XCell 
SureLock™ Mini-Cell. Subsequently, western blotting was performed to transfer the 
proteins from the gel to a nitrocellulose membrane using the XCellTM II blot module 
and NuPAGE® transfer buffer. Once protein transfer was complete, the membrane 
was washed in TBST and then incubated in 5% bovine serum albumin/TBST at room 
temperature for 1 hour. Subsequently, the membrane was washed in TBST. Next the 
membrane was incubated with primary antibody diluted in 5% bovine serum 
albumin/TBST at 4°C overnight on a rocking platform. Next, the membrane was 





HRP-conjugated secondary antibody diluted in 5% bovine serum albumin/TBST at 
room temperature for 1 hour. Subsequently, the membrane was washed three times in 
TBST for 15 minutes each and then preserved in TBST to prevent it from drying.  
To detect proteins, the surface of the membrane containing the protein was treated with 
SignalFire™ ECL Reagent (Cell Signalling Technology; #6883) according to the 
manufacturer’s instruction. Subsequently, the membrane was transferred to a western 
development cassette.  The membrane was then exposed to an autoradiography film 
(GE Healthcare: #MU55092A) in the dark and incubated together for the required 
amount of time. The exposed autoradiography film was then developed using a 
Xograph radiograph machine (Konica Minolta: SRX-101A). To detect another protein, 
the membrane was incubated in Restore™ Western Blot Stripping Buffer (Thermo 
Scientific: #21059) at room temperature for 10-15 minutes and washed briefly in 
TBST. Subsequently, all the steps of antibody incubation, washing and radiography 
are performed again as described above. 
 
2.10 AVIAN INFLUENZA MINIGENOME REPLICON ASSAY 
A plasmid-based minigenome reporter was used to measure avian influenza viral 
polymerase function in ANP32A-edited PGC fibroblasts (Chapter 5).  
2.10.1 Transfection of PGC fibroblasts 
24 hours prior to transfection, the medium in each well was refreshed by taking out 
350 µl of culture medium and replacing it with 350 µl of PGC fibroblast medium. Cells 
were at 80-90% confluency on the day of transfection.  
The transfection mixture for a single cell culture maintained in a 24-well tissue culture 
plate was prepared as follows: 2.5 µl of Lipofectamine® LTX (Invitrogen: 15338100) 
is mixed with 22.5 µl of Opti-MEM I Reduced Serum Medium (Gibco®: 11058-021) 
and then incubated for 10-20 minutes at room temperature. While the 
Lipofectamine/Opti-MEM mixture is incubating, a mixture of 6 µl of PlusTM reagent 
(Invitrogen: 15338100) and 100 ng of each plasmid (chicken polI-Firefly minigenome 
reporter, PA, PB1, PB2, NP, Renilla, and ANP32A plasmids) made up to a final 
volume of 25 µl with Opti-MEM I reduced serum medium is prepared and incubated 





Next, the 25 µl Lipofectamine/Opti-MEM mixture is gently mixed with the 25 µl 
DNA/Opti-MEM mixture to obtain the transfection mix which is then incubated for 
15-20 minutes at room temperature. The 50 µl transfection mixture is then added to 
the 500 µl cell culture and subsequently incubated at 37°C and 5% CO2 for 48 hours. 
 
2.10.2 Dual luciferase assay 
Firefly and Renilla Luciferase signals were detected using the Dual-Luciferase® 
Reporter Assay System (Promega: #E1910) according to the manufacturer’s 
instruction as follows;  
48 hours after transfection, the cell culture medium was discarded and then the 
adherent fibroblasts in each well were washed twice with PBS. After removing all PBS 
from the well, 110 µl of 1X Passive Lysis Buffer (Promega) was added to each well 
and then incubated at room temperature on a rocking platform for 1 hour. 
Subsequently, a pipette tip was used to scrape the cells off the well and then lysed cell 
suspension was stored at -20°C or -79°C for a minimum of 24 hours to ensure complete 
cell lysis. Next, the frozen cell lysate was thawed, and then 20 µl of the cell lysate was 
dispensed into a single well of a 96-well white polystyrene microplate. To detect and 
measure luciferase signal, LAR II reagent and Stop & Glo reagent were prepared as 
instructed by the manufacturer’s and then loaded into a EG&G Berthold LB 96 
Microplate Luminometer or the Promega Glomax Multi+Detection System 
luminometer according to the manufacturer’s instruction. The 96-well plate with the 
cell lysate samples was then loaded into the luminometer which was programmed to 
dispense 100 µl of LAR II reagent and 100 µl of Stop & Glo reagent into each well. 
Luciferase signals were finally measured with a 2 second delay and 10 second read 
time to give Firefly and Renilla readings for each well. 
 
2.10.3 Computation of luciferase measurements 
To account for variation in the transfection efficiency between wells and normalise the 
luminescence data, the raw Firefly luciferase reading (F) of each well divided by its 
raw Renilla luciferase reading (R) in using Microsoft® Excel software. Therefore, 
Normalised value = F/R. All other computations and statistical calculations are 





2.11 TISSUE EMBEDDING AND SECTIONING 
2.11.1 Fixation  
Dissected gonads were fixed by incubating in 4% paraformaldehyde at 4°C for 30 
minutes to 1 hour depending on the size of the tissue. Subsequently, the fixed tissues 
were washed with PBS and then transferred into 0.12M sodium phosphate buffer/15% 
sucrose and incubated at 4°C overnight.  
  
2.11.2 Embedding  
First, 0.12M sodium phosphate buffer /15% sucrose /7.5% gelati was thawed to 37°C. 
Next, a gelatin bed was made by evenly applying 2 ml of 0.12M sodium phosphate 
buffer /15% sucrose /7.5% gelatin to completely cover the inside of a 7-ml plastic 
square weight boat and then allowed to cool and solidify. Next, the overnight tissues 
in 0.12M sodium phosphate buffer/15% sucrose are transferred into 0.5 ml of  0.12M 
sodium phosphate buffer /15% sucrose /7.5% gelatin (thawed to 37°C) and incubated 
at 37°C for 1 hour. Next, the tissue sample is poured onto the gelatin bed and 
positioned under a microscope if needed, and then allowed to cool and solidify at 4°C 
for up to 1 hour. The gelatin-embedded tissue are then cut out of the gelation bed as 
blocks and then mounted onto appropriately sized wooden card using optimal cutting 
temperature (OCT) medium (FisherScientific: #23730571).  
Subsequently, the gelatin blocks attached to wooden cards were rapidly frozen by 
submerging into 2-Methybutane (Sigma-Aldrich: #277258) which had been cooled to 
-78.5°C on dry ice. The frozen gelatin blocks were preserved on dry ice until storage 
at -80°C. 
 
2.11.3 Cryosectioning  
Frozen tissues were sectioned to a thickness of 10 µM using the OTF5000 
cryosectioning machine (Bright instruments) with sample and chamber temperatures 
set at -21°C and -25C° respectively. Tissue sections (cryosections) were adhered to 
SuperFrost Plus™ Adhesion slides (Thermo Scientific: #J1800AMNT) and then air-







2.12 IMMUNOCHEMICAL METHODS 
2.12.1 Immunohistochemistry 
Cryosections were washed in PBT for 3 minutes at 37°C. From this point onwards, the 
slides were never allowed to dry. Subsequently, slides were incubated for 5 minutes 
with Hoechst33342/PBT diluted at 1:100 and then washed in PBT. Next, a drop of 
HydromountTM mounting medium (National Diagnostics: #HS-106) was added on the 
tissue section and then covered with a coverslip and then airdried in the dark. Sections 
were viewed with a Leica DMRB fluorescence microscope. 
 
2.12.2 Immunocytochemistry  
500 µl of 4% paraformaldehyde was added to 500 µl of PGC culture (from the 
incubator) and then incubated at room temperature for 10 minutes. Next, the cell 
culture/paraformaldehyde mixture was centrifuged at 1,600 RPM for 4 mins in a bench 
top centrifuge. The supernatant was discarded, and the cell pellet resuspend in 50 µl 
of PBS. 5 µl of the cell suspension was then smeared gently onto SuperFrost Plus™ 
Adhesion slides and airdried for 1 hour. A PAP pen (Sigma: #Z377821) was then used 
to draw a hydrophobic circle around the cell smear on each slide. Slides were then 
incubated in PBT for 10 minutes (from this point onwards, the slides were never 
allowed to dry) followed by a 2-minute incubation in PBT-Tx. Subsequently, slides 
were then blocked by incubating in primary antibody diluted in 5% goat serum/PBT 
for 1 hour. Next, slides were incubated in primary antibody diluted in 5% goat 
serum/PBT at 4°C overnight. Subsequently, three 10-minute washes in using PBT was 
performed on a rocking platform. Then slides were incubated with conjugated 
secondary antibody diluted in 5% goat serum/PBT for 30 minutes at room temperature 
in the dark. Slides were then washed three times for 10 minutes each using PBT on a 
rocking platform. Subsequently, slides were incubated for 5 minutes with 
Hoechst33342/PBT diluted at 1:100 and then washed in PBT. Next, a drop of 
ProLong® Gold antifade mountant (Invitrogen: #P36930) was added to the cell smear 
and then covered with a coverslip. Nail polish was applied around the edge of the 







2.12.3 PGC antibody flow cytometry 
Culture containing 1,000,000 PGCs was decanted into a 2 ml round bottom 
microcentrifuge tube and centrifuged at 1,600 RPM for 4 minutes in a benchtop 
centrifuge. The supernatant was discarded, and the cell pellet washed resuspended in 
KO-DMEM. The cell suspension was centrifuged again at 1,600 RPM for 4 minutes 
and the supernatant discarded. Next, the cell pellet was resuspended and incubated in 
5% goat serum/KO-DMEM at room temperature for 45 minutes. The cell suspension 
was then centrifuged, and the supernatant discarded. Subsequently, the cell pellet was 
resuspended 100 µl of primary antibody in 5% goat serum/KO-DMEM and then 
incubated at 4°C for 1 hour. Next, the 900 µl of KO-DMEM was added to the primary 
antibody incubation and then centrifuged. The supernatant was discarded, and two 
more washes was performed with 1ml of KO-DMEM. Subsequently, the cell pellet 
was resuspended in 100 µl of conjugated secondary antibody in 5% goat serum/KO-
DMEM and then incubated at 4°C for 30 minutes in the dark. Next, the 900 µl of KO-
DMEM was added to the secondary antibody incubation and then centrifuged. The 
supernatant was discarded, and two more washes was performed with 1ml of KO-
DMEM. Finally, the cell pellet was resuspended in 300 ml of KO-DMEM and then 
filtered through a cell strainer with a 35 µM nylon mesh (BD Biosciences: #352235) 
to dissociate clumped cells before being subsequently processed in a flow cytometer. 
 
2.13 MICROSCOPES  
Nikon Eclipse TE2000-U inverted microscope 
Nikon Eclipse TS100 inverted microscope 
ZEISS AXIO ZOOM.V16 fluorescence stereo zoom microscope  
Leica DMRB fluorescence microscope  
Olympus SZX10 stereo zoom microscope 
















Western blot 1/1000 4 
Cvh Rabbit 
IgG 




























Western blot 1/1000 5 
 Table 2.4 List of primary antibodies 
 
 

















HRP CST #7074 Western blot 1/2000 4 & 5 
Anti-
mouse IgG 
HRP CST #7076 Western blot 1/2000 4 & 5 








2.14 STATISTICAL ANALYSIS  
All statistical analysis and graphical computation reported in this thesis was performed 
using GraphPad Prism 7 software (GraphPad Software, Inc.). A description of the 
statistical analysis performed for an experiment in included in the text or figure legend. 
P-values of 0.5 or less were considered as significant. Error bars represent standard 
error of the mean (SEM) except where stated otherwise. 
 
2.15 COMPUTER PACKAGES AND ONLINE RESOURCES 
Blast searches were performed in the UCSC genome database 
(https://genome.ucsc.edu/cgi-bin/hgBlat) or the NCBI genome database 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi).  
DNASTAR® Lasergene 13 software suite was used to perform sequence analysis. 
Immunocytochemical and Immunohistochemical images were captured using Micro-
Manager 1.4 software (http://www.micro-manager.org) programmed to the Leica 
DMRB upright fluorescence microscope while ImageJ software 
(https://imagej.nih.gov/ij/) was used for further image analysis. 
Flow cytometry data was analysed using FlowJo® V7.0 software (FlowJo, LLC). 
Stage 18 HH images (Chapter 5) were captured and analysed using the ZEN software 
programmed to the ZEISS AXIO ZOOM.V16 fluorescence stereo zoom microscope. 
Cell culture images (CHAPTERS FOUR and FIVE) were captured using Scion 












CHAPTER 3  
PRECISE AND RAPID ALLELE INTRODUCTION IN THE CHICKEN 
THROUGH EDITING OF PRIMORDIAL GERM CELLS 
3.1 Introduction 
3.1.1 Livestock breeding 
The development of superior animal lines is a major objective in livestock breeding. 
Structured breeding programmes guided by estimated breeding values and now 
using genomic tools (GS) are currently employed to enrich for traits that enhance 
productivity and welfare (Dekkers & Hospital, 2002; Hayes et a., 2013; Wolc et al., 
2016). Until recently, traditional crossbreeding has been the only possible method 
used to achieve an increase in selected alleles in many livestock species including 
poultry. Once a trait of interest is identified, allele selection is performed through 
traditional crossbreeding with the aim of fixing the desired genetic loci in a recipient 
pedigree population (Wall et al., 2005). This procedure of allele selection through 
crossbreeding is time-consuming requiring several generations. Also, it is not 
always successful as undesirable traits tightly linked to the gene of interest co-
segregate with the desired allele (Dekkers & Hospital, 2002). Additionally, 
recurrent backcrossing is problematic and in poultry may result in inbreeding 
problems associated with low genetic variation, low fertility and  reduced 
survivability (Charlesworth & Willis, 2009; Kulkarni et al., 2015). Furthermore, the 
transfer of beneficial alleles between species is impossible through traditional 
crossbreeding (Hayes et al., 2013). For example, the RELA gene which is 
hypothesised to confer resistance to African swine fever in warthogs cannot be 
transferred into domestic pigs which are susceptible to the disease through breeding, 
even though warthog and domestic pig RELA are highly conserved but differ by 
only 13 nucleotides and 3 amino acids (Palgrave et al., 2011).  
With the availability of robust genomic information for the chicken and many avian 
species, these challenges of allele selection in conventional crossbreeding can be 
surmounted through the application of genome editing to introduce small sequence 





3.1.2 Using CRISPR/Cas9 to introduce small nucleotide changes  
Double-stranded breaks (DBSs) induced by CRISPR/Cas9 are repaired either through 
the error-prone non-homologous end joining (NHEJ) mechanism or the error-free 
homology-directed repair (HDR) mechanism. The HDR synthesis-dependent strand 
annealing (SDSA) mechanism has been shown to repair DSBs when short single 
stranded oligodeoxynucleotides (ssODN) donors are provided as repair templates (Kan 
et al., 2017; Paix et al., 2017). Small sequence changes have been accurately 
introduced into the genome of many organisms using CRISPR/Cas9 and ssODN 
donors (Armstrong et al., 2016; Inui et al., 2014; Niu et al., 2018; Paquet et al., 2016; 
Tan et al., 2013; Xiaoyang et al., 2015). However, HDR accuracy is often reduced and 
insertion/deletion mutations are incorporated into the repaired site in another round of 
repair if CRISPR/Cas9 re-induces a DSB at the target site (Bialk et al., 2016; Merkle 
et al., 2015). CRISPR/Cas9 recleavage can occur if the PAM site and/or the seed 
sequence (the first 8-12 PAM-proximal nucleotides) of the gRNA target are preserved 
after DSB repair at the target site (Sternberg et al., 2014).  
To prevent further CRISPR/Cas9 activity after recombinational repair, Cas9-blocking 
mutations can be introduced into the PAM (Paquet et al., 2016). Cas9-blocking 
mutations may also be placed in the gRNA target but are reported to have variable 
efficacy (Paquet et al., 2016). Consequently, accurately recreating conservative small 
sequence changes for allele introgression is difficult to perform if the desired change 
does not block CRISPR/Cas9 re-cleavage. Furthermore, wild type CRISPR/Cas9 has 
been reported in other cell types to possess high catalytic activity that usually results 
in the mutation of the sister chromosomes and other homologous regions (Paquet et 
al., 2016; Wang et al., 2013). This makes the creation of accurate monoallelic changes 
to generate specific heterozygous genotypes difficult to perform. The introduction of 
specific monoallelic changes may be justified for alleles that are semi-dominant or 
lethal if they are homozygous in either PGCs or differentiated germ cells during 
ontogenesis. 
To address these challenges, the use of a high fidelity Cas9 nuclease for making small 
defined sequence changes in the chicken germline genome was investigated. High 
fidelity CRISPR/Cas9 nucleases with enhanced editing specificities were developed 





(Chen et al., 2017; Kleinstiver et al., 2016; Slaymaker et al., 2016). Off-target cleavage 
activity of high fidelity Cas9 is inhibited if mismatches are present in the gRNA target 
sequence and this mechanism is reviewed in CHAPTER ONE. It was therefore 
hypothesized that this pre-cleavage mechanism of proof-reading by high fidelity 
CRISPR/Cas9 may be co-opted to introduce small conservative monoallelic or 
biallelic changes such as SNPs without the need to introduce unwanted additional 
Cas9-blocking mutations in the PAM or seed sequence of the gRNA. 
Against this background, the major objective of the experiments presented in this 
chapter was to test and establish the use of ssODN donors and high fidelity 
CRISPR/Cas9 in genome editing of cultured chicken PGCs for the purpose of making 
small defined sequence changes.  To achieve the experimental objective, I designed 
and performed all the experiments under the supervision of Dr Michael J. McGrew. 
Lorna Taylor performed some of the initial experiments to optimize PGC transfection. 
I wrote the manuscript of the study which was reviewed and edited by Prof. Helen M. 
Sang and Dr Michael J. McGrew. The manuscript was published by Scientific Reports 
on October 11, 2018 under title ‘’High fidelity CRISPR/Cas9 increases precise 
monoallelic and biallelic editing events in primordial germ cells’’ (Idoko-Akoh et al., 
2018).  
3.2 Experimental aims; 
1. To test the hypothesis that enhancing the specificity of CRISPR/Cas9 will increase 
HDR efficiency in chicken PGCs by developing a high fidelity CRISPR/Cas9 
vector, co-expressing the Cas9 nuclease and sgRNA. 
2. To test the hypothesis that ssODN donors are suitable as repair template for 
correction of CRISPR/Cas9-induced DSBs in cultured chicken PGCs 
3. To test the hypothesis that CRISPR/Cas9 and ssODN donors can be used for the 
introduction of specific monoallelic and biallelic small sequence changes in 
chicken PGCs 
4. To test the hypothesis that beneficial agricultural alleles can be accurately 
introduced into the chicken germline using the CRISPR/Cas9 system 
3.3 PUBLICATION: Scientific Reports volume 8, Article number: 15126 (2018) 
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High fidelity CRISPR/Cas9 increases 
precise monoallelic and biallelic 
editing events in primordial germ 
cells
Alewo Idoko-Akoh, Lorna Taylor, Helen M. Sang & Michael J. McGrew  
Primordial germ cells (PGCs), the embryonic precursors of the sperm and egg, are used for the 
introduction of genetic modifications into avian genome. Introduction of small defined sequences 
using genome editing has not been demonstrated in bird species. Here, we compared oligonucleotide-
mediated HDR using wild type SpCas9 (SpCas9-WT) and high fidelity SpCas9-HF1 in PGCs and show 
that many loci in chicken PGCs can be precise edited using donors containing CRISPR/Cas9-blocking 
mutations positioned in the protospacer adjacent motif (PAM). However, targeting was more 
efficient using SpCas9-HF1 when mutations were introduced only into the gRNA target sequence. 
We subsequently employed an eGFP-to-BFP conversion assay, to directly compare HDR mediated by 
SpCas9-WT and SpCas9-HF1 and discovered that SpCas9-HF1 increases HDR while reducing INDEL 
formation. Furthermore, SpCas9-HF1 increases the frequency of single allele editing in comparison 
to SpCas9-WT. We used SpCas9-HF1 to demonstrate the introduction of monoallelic and biallelic 
point mutations into the FGF20 gene and generate clonal populations of edited PGCs with defined 
homozygous and heterozygous genotypes. Our results demonstrate the use of oligonucleotide donors 
and high fidelity CRISPR/Cas9 variants to perform precise genome editing with high efficiency in PGCs.
The chicken is a useful animal model for biological research and can be used to produce biopharmaceutical prod-
ucts that cannot be produced in mammalian bioreactor systems1,2. Chicken meat and eggs derived from 70 billion 
chickens yearly are an important source of high quality protein, vitamins and minerals in the global economy3. 
The ability to precisely edit the chicken genome to introduce or test genetic variants will aid the study of gene 
function, define combinatorial allelic contribution to disease resistance/resilience and production phenotypes 
and will lead to the uncovering of beneficial alleles which could be introduced into breeding programmes for the 
improvement of poultry welfare and sustainable production.
The application of precision genome editing to bird species has failed to keep pace with that of other mam-
malian species. In mammals, germline genetic engineering may be achieved through pronuclear injection of 
the zygote4, injection of genetically modified embryonic stem cells into the blastocyst5, and somatic cell nuclear 
transfer of genetically modified somatic cells (SCNT)6,7. These methods are not regularly practised in bird spe-
cies because the single-cell zygote is difficult to access and manipulate and cultured avian embryonic stem cells 
do not contribute to the formation of the germ lineage8,9. In contrast to other species, heritable genetic changes 
may be introduced into chicken through the genetic manipulation of primordial germ cells (PGCs), the stem cell 
precursors of the sperm and egg, which can be propagated in culture and will contribute to the germline when 
reintroduced into surrogate host chick embryos10–12.
Targeted genetic modification in chicken PGCs was first demonstrated through classical gene targeting by 
homologous recombination (HR) to generate immunoglobulin-knockout chickens13. The observation that DNA 
Double-stranded breaks (DSBs) stimulate and increase the frequency of HR led to the development of artifi-
cial site-specific nucleases including ZFNs, TALENs and CRISPR/Cas9 with the goal of improving the efficiency 
of site-specific gene targeting14,15. Artificial site-specific nucleases are guided to a specific genomic site by pro-
grammable DNA-binding modules where they create a DSB. The cleaved DNA is immediately repaired by either 
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non-homologous end-joining (NHEJ) or the HR pathway16–18. NHEJ is the predominant pathway that repairs 
DSBs that occur in all phases of the cell cycle and often leads to the generation of insertion/deletion (INDEL) 
mutations19. The HR or homology-directed repair (HDR) pathway is active in the S and G2 phase of the cell 
cycle and is used to repair a double-stranded DNA break when there is an available DNA donor containing a 
region that is homologous to the region surrounding the severed DNA ends16,20,21. The high fidelity of HDR is 
constrained by the nucleotide composition of the repair template and this constraint is exploited in genome engi-
neering to introduce a desired nucleotide change. TALENs and CRISPR/Cas9-mediated NHEJ have been used 
to produce several knockout-chickens through the generation of INDELs in chicken PGCs22,23. Homologous 
recombination mediated by TALENs and CRISPR/Cas9 have also been performed in chicken PGCs to introduce 
targeted transgenes24,25. However, the use of site-specific nucleases to perform precision editing of a single to few 
nucleotides has not been demonstrated in avian species.
Genome editing mediated by CRISPR/Cas9 and short single stranded oligodeoxynucleotides (ssODN) donors 
has been used to perform small precise genetic changes in many cell types and organisms26–37 and in a chicken 
somatic cell line38. However, use of ssODN donors for gene correction can be toxic to cells by causing a G2/M cell 
cycle arrest39, and activating cellular immune responses40. HDR targeting therefore requires careful optimization 
for each cell type. Following CRISPR/Cas9-induced DSBs, DNA repair with ssODN donors occurs through the 
synthesis-dependent strand annealing (SDSA) pathway of HDR41. However, the accuracy of HDR editing may 
be distorted by the incorporation of INDELs at the target site in a second round of repair due to re-cleaving by 
CRISPR/Cas942,43. Previous studies have shown that the introduction of Cas9-blocking mutations in the PAM are 
effective in preventing re-editing of genetic loci while blocking mutations positioned in the gRNA target sequence 
have variable efficacy35.
High fidelity CRISPR/Cas9 nucleases with improved specificity have been developed to reduce the frequency 
of off-target events associated with wild type Streptococcus pyogenes Cas9 (SpCas9-WT)44–46. These high fidelity 
Cas9 variants harbour amino acid substitutions that significantly reduce activation of cleavage at target sites 
that are not perfectly complementary to the gRNA sequence. Here, we investigated a high fidelity Cas9 variant, 
SpCas9-HF145, for introducing defined nucleotide changes in chicken PGCs using ssODN donors. First, we opti-
mised the use of ssODN donors as repair templates for CRISPR/Cas9-mediated HDR in cultured chicken PGCs. 
We then directly compared HDR editing between SpCas9-WT and SpCas9-HF1 using ssODN donors containing 
CRISPR/Cas9-blocking mutations positioned in the PAM and show that many loci in chicken PGCs can be effi-
ciently edited using SpCas9-HF1. Using ssODN donors containing mutations in the guide sequence only, we also 
showed that SpCas9-HF1 is more efficient than SpCas9-WT in introducing precise genome edits in the absence 
of CRISPR/Cas9-blocking mutation in the PAM. We subsequently used a eGFP-to-BFP conversion assay47 to 
directly compare HDR mediated by SpCas9-WT and SpCas9-HF1 and found that SpCas9-HF1 increases the 
efficiency of accurate HDR editing while reducing INDEL formation at the target site. Finally, we combined 
SpCas9-HF1 and ssODN donors to demonstrate precise biallelic and monoallelic introduction of the chicken 
scaleless genetic variant associated with the heat tolerance featherless phenotype by introducing two defined 
nucleotide substitutions into the FGF20 gene48–50. Our results demonstrate the use of high fidelity CRISPR/Cas9 
variants to perform precise HDR genome editing with high efficiency in chicken PGCs.
Results
High fidelity Cas9 variant, SpCas9-HF1, shows efficient HDR editing in chicken PGCs. We first 
tested SpCas9-WT and high fidelity SpCas9-HF1 to edit multiple loci in chicken PGCs. SpCas9-HF1 contains 
4 amino acid substitutions that prevent activation of the nuclease at mismatched targets45. To directly com-
pare SpCas9-HF1 and SpCas9-WT, we transferred the codon-changing mutations from the VP12 vector which 
encodes SpCas9-HF1 into PX459 vector which encodes a mammalian-codon optimised SpCas9-WT as well as 
puromycin resistance33 (Fig. 1). We named this modified vector HF-PX459.
To compare HDR editing between SpCas9-WT and SpCas9-HF1 in chicken PGCs, we designed gRNAs to 
target exon 3 of FGF20 (FGF20-gRNA1) and exon 2 of CXCR4 (CXCR4-gRNA), and used previously described 
gRNAs to target exon 3 of ovalbumin (OVA) and exon 1 of ovomucoid (OVM) (OVA-gRNA for ovalbumin and 
OVM-gRNA for ovomucoid)23 (Fig. 2). In order to directly analyse HDR efficiency without sequencing PCR prod-
ucts, we used antisense repair templates that introduce an EcoRI recognition site for RFLP analysis51,52. CXCR4 
is expressed in chicken PGCs while FGF20, ovalbumin and ovomucoid are transcriptionally inactive. To target 
each locus, we used ssODN donors containing mutations of the gRNA seed sequence and PAM to insert an EcoRI 
recognition sequence (122-nt CXCR4-ssODN for CXCR4, 126-nt FGF20-ssODN for FGF20, 127-nt OVA-ssODN 
for ovalbumin and 128-nt OVM-ssODN for ovomucoid; Fig. 2). We co-transfected the corresponding ssODN 
donor and gRNA with SpCas9-HF1 or SpCas9-WT into PGCs and then treated with puromycin to select for 
Cas9-transfected cells. We performed two independent targeting experiments for each locus. To analyse HDR, 
we PCR amplified the target site and performed EcoRI RFLP digest assay on the PCR products to estimate HDR 
efficiency. In CXCR4, we observed an average HDR efficiency of 50.5% in PGCs targeted with SpCas9-HF1 
and 35.5% with SpCas9-WT (Fig. 2A and Supplementary Fig. S2). For ovomucoid, the average HDR efficiency 
was 42.5% using SpCas9-HF1 and 39.5% with SpCas9-WT (Fig. 2B and Supplementary Fig. S2), whereas the 
average HDR efficiency was 63.5% with SpCas9-HF1 and 62.5% with SpCas9-WT for ovalbumin (Fig. 2C 
and Supplementary Fig. S2). For FGF20, we also tested the NHEJ inhibitors, SCR7 and L755507, reported to 
increase HDR efficiency34,53. We observed an average HDR efficiency of 48.5% and 3.5% with SpCas9-HF1 and 
SpCas9-WT respectively without using NHEJ inhibitors while no HDR improvement was observed with either 
SCR7 or L755507 treatment (Fig. 2D and Supplementary Fig. S2). Thus, NHEJ inhibitors do not increase targeting 
efficiency in PGCs and targeting efficiencies were equal or slightly better using SpCas9-HF1 in combination with 
donor containing PAM mutations.
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We next tested whether introducing single-nucleotide blocking mutations into the PAM-distal region of the 
gRNA target sequence was sufficient to achieve high HDR without introducing a blocking mutation in the PAM. 
Cleavage activity of Cas9 was shown to be severely reduced when mismatches are present in the seed region 
(first 8–12 nucleotides proximal of the PAM) of the gRNA target sequence54–57. However, mismatches were tol-
erated in the PAM-distal non-seed region of the gRNA target and are associated with off-target mutagenesis by 
SpCas9-WT58–60. To test the efficiency of accurate HDR when introducing single nucleotide mutations into the 
non-seed region of the gRNA target sequence, we designed ssODN donors containing one to three substitu-
tions of the last 14–20 PAM-distal nucleotides (120-nt CXCR4-ssODN2 for CXCR4, 128-nt OVM-ssODN2 for 
ovomucoid, 127-nt OVA-ssODN2 for ovalbumin, 127-nt OVA-ssODN3 for ovalbumin and 126-nt FGF20-ssODN2 
for FGF20; Fig. 2, right panels). The substitutions introduce a restriction site for RFLP analysis. We transfected 
and analysed cells as above. For CXCR4, we observed an average HDR efficiency of 17.5% using SpCas9-HF1 
and 0.0% with SpCas9-WT when CXCR4-ssODN2 was supplied as repair template (Fig. 2A and Supplementary 
Fig. S2). For ovomucoid, the average HDR efficiency was 34.0% using SpCas9-HF1 and 0.5% with SpCas9-WT 
when OVM-ssODN2 was supplied as repair template (Fig. 2B and Supplementary Fig. S2). For ovalbumin, the 
average HDR efficiency was 58.5% using SpCas9-HF1 and 53.5% using SpCas9-WT when OVA-ssODN2 was 
supplied as repair template (Fig. 2C and Supplementary Fig. S2). When OVA-ssODN3 was used as a repair tem-
plate containing a single base pair change in the PAM distal guide region, we observed an average HDR efficiency 
of 43.5% using SpCas9-HF1 and 1.0% using SpCas9-WT (Fig. 2C and Supplementary Fig. S2). For FGF20, we 
observed an average HDR efficiency of 37.5% with SpCas9-HF1 and 3.5% with SpCas9-WT when FGF20-ssODN2 
was supplied as repair template (Fig. 2D and Supplementary Fig. S2). We also compared symmetrical and asym-
metrical ssODNs as well as a double stranded repair template carried in plasmid but observed similar levels of 
HDR at FGF20 (data not shown). Our results show that SpCas9-HF1, in comparison to SpCas9-WT, is effective 
for achieving precise introduction of single nucleotide changes into the non-seed region of the gRNA target 
sequence. These results demonstrate the accuracy and versatility of SpCas9-HF1.
SpCas9-HF1 reduces INDEL formation at target site in comparison to SpCas9-WT. To better 
quantitate HDR and INDEL formation mediated by SpCas9-WT and SpCas9-HF1, we used an assay that con-
verts enhanced green fluorescent protein (eGFP) to blue fluorescent protein (BFP) after editing events47. The 
eGFP-to-BFP conversion assay simultaneously quantifies total HDR and NHEJ events in a targeted population. 
We targeted PGCs isolated from homozygous transgenic chicken ubiquitously and constitutively expressing 
eGFP (GFP-PGCs; Fig. 3A) with a validated gRNA (GFP-gRNA) which was co-delivered with SpCas9-WT or 
SpCas9-HF1 and a ssODN donor carrying three nucleotide substitutions (BFP-ssODN; Fig. 3A) designed to con-
vert eGFP to BFP47. In this case the 20 nucleotide GFP-gRNA begins with a C nucleotide which reduces tran-
scription from the U6 promoter61. BFP-ssODN donor contains a C-to-G substitution that converts Threonine 
(T) to Serine (S), a T-to-C substitution that converts Tyrosine (Y) to Histidine (H) and a synonymous T-to-G 
substitution. The C-to-G substitution (the 1st nucleotide of the gRNA seed sequence) and the T-to-C substitution 
(1st nucleotide of the PAM) serve as Cas9-blocking mutations to prevent re-editing and increase HDR accuracy 
of SpCas9-WT. eGFP is converted to BFP by a Y66H amino acid substitution. Error-free editing of the eGFP 
sequence will lead to the expression of BFP while the presence of INDELs, even after recombinational repair, will 
result in no BFP or eGFP expression due to a shift in the reading frame. Before transfection, 99.9% of gated living 
cells expressed eGFP. Transfection with SpCas9-WT vector resulted in 30.3% of PGCs expressing BFP and the 
remaining 69.7% did not express GFP indicating INDEL formation. In contrast, transfection with SpCas9-HF1 
vector resulted in 68.2% of PGCs expressing BFP and the remaining 31.7% did not express eGFP (Fig. 3B). The 
HDR and INDEL levels obtained with SpCas9-WT in this assay are consistent with reports by other researchers 
Figure 1. Schematic representation of CRISPR/Cas9 vectors used in this study. HF-PX459 and PX459 vectors 
differ by only four amino acids in the encoded Cas9 protein. HF-PX459 vector encodes SpCas9-HF1 while 
PX459 encodes SpCas9-WT. The U6 promoter drives sgRNA expression while expression of Cas9 protein and 
puromycin resistance (PuroR) is driven by the CAG promoter.
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using human cell lines47,62. Two distinct populations of BFP-expressing PGCs were observed for both SpCas9-WT 
and SpCas9-HF1 (Fig. 3C, top panel) and determined their median fluorescent intensity (MFI). We determined 
that the population with the lower MFI of approximately 2000 units was monoallelic for BFP and contained 
Figure 2. Efficient oligonucleotide-template HDR editing across multiple loci using SpCas9-HF1. Left panels: 
PAM-region mutated templates. Right panels: Guide-region mutated templates. All HDR ssODN donors were 
complementary to the gRNA target strand and were symmetric around the cut site except for FGF20-ssODN. 
gRNA sequences are highlighted in blue. PAMs are highlighted in purple. Blue arrowheads indicate Cas9 
cleavage sites. Insertions, deletions and substitutions in HDR donors are highlighted in red. Black arrowheads 
indicate undigested PCR substrate. Red arrowheads indicate digested PCR products. (−) untreated substrate. 
(+) treated substrate. (See Figure S9 for uncropped images).
www.nature.com/scientificreports/
5SCIEnTIfIC RepoRts |  (2018) 8:15126  | DOI:10.1038/s41598-018-33244-x
Figure 3. SpCas9-HF1 increases HDR by reducing INDEL formation. (A) An eGFP expression cassette was 
integrated in the MAD1L1 gene. CAG promoter drives eGFP expression. The gRNA sequence is highlighted in 
blue while the PAM is highlighted in purple. Blue arrowhead indicates Cas9 cleavage site. Substitutions in the 
BFP-ssODN donor are highlighted in red. BFP-ssODN is a 122-nt HDR template that is complementary to the 
target strand. (B) Flow cytometric detection of BFP-expressing PGCs and non-fluorescent PGCs to quantify 
HDR and INDEL levels respectively. (C) Flow cytometric quantification of BFP-expression PGCs (top panels) 
and mean fluorescent intensity of BFP-expressing PGCs (bottom panels). (D) Alignment of sequences of cloned 
PCR products from PGCs in quadrants Q1 and Q4.
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INDELs on the second GFP allele while the population with an MFI of approximately 4000 units was biallelic for 
BFP by TIDE analysis63 of the PCR sequencing traces of these populations (Fig. 3C, bottom panel, Supplementary 
Fig. S3). Interestingly, we noticed that the proportion of BFP PGCs transfected with SpCas9-HF1 that was biallelic 
for BFP was 53.9% while 44.7% was monoallelic for BFP. For PGCs transfected with SpCas9-WT, 25.4% of BFP 
PGCs was biallelic for BFP while 73.6% was monoallelic for BFP. This indicates that SpCas9-HF1 increases the 
efficiency of biallelic HDR by up to two-fold by reducing INDEL formation. Also, the absence of PGCs express-
ing only eGFP or co-expressing eGFP and BFP is indicative of the high mutagenic activity of CRISPR/Cas9 and 
is similar to previous observation47,62. Our results show that using SpCas9-HF1 with ssODN donors containing 
Cas9-blocking mutations positioned in the gRNA sequence increases HDR levels by more than 2-fold with a 
concomitant decrease in INDEL formation in comparison to SpCas9-WT.
SpCas9-HF1 efficiently introduces heterozygous biallelic edits in comparison to 
SpCas9-WT. In the experiment above (Fig. 3), we observed that less than 0.2% of PGCs were heterozygous for 
eGFP and BFP using SpCas9-HF1 while no BFP-eGFP heterozygotes were obtained using SpCas9-WT. This obser-
vation reflects the experimental difficulty in generating specific heterozygous mutations since most CRISPR/Cas9 
editing events are biallelic and cells with monoallelic HDR edits usually contain INDELs on the second allele35,64. 
A strategy that has been employed for editing single alleles in human IPS cells uses a mixture of two ssODN donor 
templates containing Cas9-blocking mutations with an observed efficiency of 0.1%35. Since SpCas9-HF1 increases 
HDR levels as well as the efficiency of biallelic HDR by reducing INDEL formation (Fig. 3B and C), we reasoned 
that SpCas9-HF1 could increase the efficiency of editing individual alleles using two ssODN donors. We com-
pared SpCas9-WT and SpCas9-HF1 by performing eGFP-to-BFP editing of single eGFP alleles in GFP-PGCs to 
produce eGFP/BFP heterozygote cells. We designed a second repair template (GFP-ssODN) containing three syn-
onymous nucleotide substitutions to preserve the amino acid sequence of eGFP (Fig. 4A). GFP-PGCs were then 
transfected with SpCas9-WT or SpCas9-HF1 vectors and equimolar amounts of GFP-ssODN and BFP-ssODN 
donors and then analysed by flow cytometry for expression of BFP and eGFP. The results from two independent 
experiments are shown in Fig. 4B. 1.5% of PGCs targeted with SpCas9-WT co-expressed eGFP and BFP while 
9.2% of PGCs targeted with SpCas9-HF1 were eGFP/BFP co-expressing cells reflecting an almost 7-fold increase 
in HDR frequency in comparison to SpCas9-WT. Direct sequencing of PCR products from single-cell clones 
co-expressing eGFP and BFP confirmed incorporation of nucleotide changes in ssODN donors into the individ-
ual eGFP alleles (Fig. 4C). Similar to our previous result (Fig. 3B), we observed that 74.4% of PGCs targeted with 
SpCas9-WT did not express eGFP or BFP in comparison to 31.8% for PGCs targeted with SpCas9-HF1 (Fig. 4B). 
These results illustrate that SpCas9-HF1 increases the frequency of editing individual alleles by increasing HDR 
efficiency while reducing INDEL formation.
Precise biallelic introgression of a genetic variant into chicken PGCs. We next demonstrated the 
introgression of specific genetic variants into PGCs. The scaleless mutation (sc/sc) is a single A-to-T substitution 
in exon 3 of FGF20 (535A > T) which creates a premature stop codon resulting in a truncated FGF20 protein that 
leads to a complete loss of feather development48. We selected three gRNAs (Supplementary Fig. S1) targeting for 
the location of the scaleless variant but only gRNA1 (FGF20-gRNA1) containing a cut site that is 12 bp away from 
the target nucleotide was active with both SpCas9-WT and SpCas9-HF1 (Fig. 5A and Supplementary Fig. S1). 
We designed an ssODN donor (Sca-ssODN) containing a Cas9-blocking synonymous point mutation in the PAM 
(AGG → AGA) and the scaleless mutation (535A > T) which was 6 bp downstream of the 3′ end of the PAM 
(Fig. 5A). We anticipated that the 12 bp distance from the cut site to the edit site (cut-to-edit distance) would 
reduce editing accuracy. It has previously been shown that the efficiency of heterologous DNA incorporation 
is reduced as the distance between the site of edit and Cas9 cleavage site increases and the highest efficiency is 
achived within a distance of 8 to 10 bp27,35,65. To address the cut-to-edit distance, we used an asymmetric design 
for the ssODN donor containing a left homology arm (HA) of 36 bp and right HA of 91 bp to provide increased 
homology on the side containing the edited PAM and the 535A > T mutation. This asymmetric repair template 
design was previously described to increase HDR efficiency in human HEK293 and K562 cell lines by up to 60%66.
To introduce the 535A > T (sc/sc) gene variant, we transfected PGCs with FGF20-gRNA1 and SpCas9-HF1 or 
SpCas9-WT with Sca-ssODN and then sequenced PCR products directly from 38 single-cell clonal populations 
isolated from two independent experiments to analyse their mutational status and zygosity. The results are shown 
in Table 1 and Fig. 5B.
We found that 7.9% of isolated clones transfected with SpCas9-WT contained precise monoallelic intro-
duction of the PAM substitution and the scaleless mutation on one chromosome while the other chromosome 
contained INDELs. The other 92.1% of isolated clones contained INDELs on both chromosomes with no incor-
poration of the scaleless mutation. We note that this frequency is much higher than the INDEL frequency meas-
ured for this guide using the T7 endonuclease I assay (Fig. S1). We attribute this difference to inefficiencies of 
the T7 endonuclease I assay67. In contrast, 41.8% of single-cell clones transfected with SpCas9-HF1 were precise 
biallelic HDR clones. We discovered that 36.8% of the SpCas9-HF1 clones contained accurate biallelic incor-
poration of the PAM substitution and the 535A > T (sc/sc) mutation (Fig. 5B). We also noted that the PAM and 
535A > T mutation was incorporated into only one chromosome (sc/+) in two SpCas9-HF1 clones (5.3% of 
isolated clones), while the second chromosome only contained the PAM substitution. Furthermore, we observed 
that 18.4% of the total SpCas9-HF1 clones were precise monoallelic HDR clones containing the PAM substitution 
and 535A > T mutation on one chromosome while the other chromosome contained INDELs. The high rate of 
biallelic editing is similar to observations in human IPSCs and mouse ES cells targeted with SpCas9-WT35,64. We 
noted that the 535A > T mutation was incorporated into 37 out of 39 HDR alleles (94.9%) in SpCas9-HF1 clones.
We next attempted to introduce the 535A > T gene variant into a single allele (sc/+) by providing two repair 
templates. Our previous result (Fig. 4B) showed that SpCas9-HF1 increases the overall efficiency of editing 
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individual alleles using two ssODN donors whereas isolation of biallelically edited heterozygotes was barely 
detectable when SpCas9 was used. Consequently, we only tested SpCas9-HF1 in the following experiment. We 
designed two donors to introduce silent mutations on one allele while incorporating the 535A > T mutation 
Figure 4. SpCas9-HF1 increases the frequency of single allele editing (A) GFP-ssODN contains three 
synonymous substitutions to preserve that amino acid sequence of eGFP. Substitutions in ssODN donors are 
highlighted in red. gRNA target sequence is coloured blue, PAM is highlighted in purple, blue arrowhead 
indicates Cas9 cleavage site. (B) Flow cytometric detection and quantification of PGCs co-expressing GFP and 
BFP. (C) Sanger sequencing traces of direct PCR products from representative isolated single cell clones co-
expressing GFP and BFP. Red box encloses region containing edits.
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into the second allele using Sca-ssODN (Fig. 5A). The first silent donor (Silent-ssODN) contained 2 synony-
mous substitutions in the PAM (AGG → CGC) to preserve the FGF20 amino acid sequence. In the second silent 
donor (Silent2-ssODN), the PAM mutation was the same as in Sca-ssODN (AGG → AGA) while a synonymous 
Figure 5. Introgression of scaleless 535A > T mutation into FGF20. (A) Strategy for introduction of 535A > T 
mutation into Exon 3. The gRNA directs cleavage 12 bp from the position of the targeted nucleotide change. 
Substitutions in ssODN donors are highlighted in red. PAM is highlighted in purple. Blue arrowhead indicates 
Cas9 cleavage site. All ssODN donors are complementary to the target strand. (B–D) Frequency of the mutation 
genotypes of isolated single-cell clones based on ssODN donor used for allelic repair. Representative sequence 
traces show mutation genotypes of HDR clones. Black arrows indicate PAM mutations, red arrows indicate Sc 
mutations, blue arrow shows biallelic 535A > C mutation.
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substitution 535A > C was made in the same position as the 535A > T mutation 12 bp from the cleavage site to 
maintain the cut-to-edit distance between templates. Since Silent-ssODN showed more complementarity to the 
target region than Sca-ssODN due to the 535A > T substitution, we asked whether the two silent repair templates 
would be used at different frequencies for allelic repair when used with Sca-ssODN.
We transfected SpCas9-HF1 with FGF20-gRNA1 and an equimolar mixture of Sca-ssODN donor and 
Silent-ssODN (Sca-ssODN/Silent-ssODN mixture) or an equimolar mixture of Sca-ssODN and Silent2-ssODN 
(Sca-ssODN/Silent2-ssODN mixture) for comparison. We performed two independent experiments and iso-
lated a total of 18 single-cell clonal populations in each experiment. The results are shown in Tables 2 and 3 and 
Fig. 5C,D.
Biallelic HDR editing with the co-incorporation of PAM mutations into the two alleles was observed in 
69.5% of the clones targeted with the Sca-ssODN/Silent-ssODN mixture in contrast to 55.5% observed with the 
Sca-ssODN/Silent2-ssODN mixture (Fig. 5C). Remarkably, 25% of the clones contained the heterozygous edit for 
535A > T (sc/+) in which the two alleles were independently repaired by the two ssODN templates (Sca/Silent 
and Sca/Silent2; Tables 2 and 3). 13.9% of the isolated clones targeted with the Sca-ssODN/Silent-ssODN mixture 
were biallelically repaired by Sca-ssODN (Sca/Sca) whereas 25.0% of the clones were biallelically repaired by 
Silent-ssODN (Silent/Silent) (Table 2 and Fig. 5C). One clone (Sca/Sca*Wt) was biallelically repaired by Sca-ssODN 
and was homozygous for the PAM substitution but heterozygous for 535A > T (sc/+) indicating partial introduc-
tion of edits in one chromosome (Table 2). We noted that 30 out of the 53 HDR alleles (56.6%) were repaired by 
Silent-ssODN when Sca-ssODN and Silent-ssODN were used together. Similarly, Silent2-ssODN repaired 57.7% of 
the 52 HDR alleles generated when it was used with Sca-ssODN. Using Sca-ssODN and Silent2-ssODN together, we 
also observed that 22.2% of the total isolated clones were biallelically repaired by Silent2-ssODN (Silent2/Silent2) 
while 13.9% were biallelically repaired by Sca-ssODN (Sca/Sca and Sca/Sca*Wt). We identified 2 clones bialleli-
cally harbouring the AGG → AGA PAM substitution on the two alleles but containing 535A > C mutation on only 
one allele indicating partial introduction of edits. While the proportion of biallelically edited heterozygous clones 
were the same using the two ssODN donor mixtures (Sca-ssODN/Silent-ssODN and Sca-ssODN/Silent2-ssODN 
mixtures), we observed that clones with monoallelic HDR contained INDELs on the other allele. The 535A > T 
substitution was incorporated into 22 out of 23 HDR alleles (95.7%) repaired by Sca-ssODN in clones targeted 
with Sca-ssODN/Silent-ssODN mixture. Similarly, the 535A > T substitution was incorporated into all 22 HDR 
alleles (100.0%) repaired by Sca-ssODN in clones targeted with Sca-ssODN/Silent2-ssODN mixture.
Discussion
The validation of many genotypes requires the accurate creation of specific biallelic or monoallelic combinations 
by the introduction of single to several nucleotide changes. Building on previous work, our results illustrate an 
efficient strategy for introducing defined sequence changes into PGCs using the CRISPR/Cas9 system. We show 
that ssODNs serve as efficient donors for precision genome editing in chicken PGCs. To the best of our knowl-
edge, this has not been previously demonstrated for avian species or for germline stem cells. Following CRISPR/
Cas9-induced DSBs, DNA repair with ssODN donors occurs through the synthesis-dependent strand annealing 
(SDSA) pathway41. We observe that HDR efficiencies with ssODN donors in chicken PGCs are up to 5-fold higher 
than previously reported using double stranded templates24,25. Previous reports show that Cas9 activity may be 
Clone genotype Sca/Sca Sca/Sca*Wt Sca/INDEL INDEL/INDEL Total
SpCas9-WT clones 0 0 3 (7.9%) 35 (92.1%) 38 (100%)
SpCas9-HF1 clones 14 (36.8%) 2 (5.3%) 7 (18.4%) 15 (39.5%) 38 (100%)
HDR Biallelic Biallelic Monoallelic N/A N/A
Table 1. Edits of the FGF20 gene based on ssODN donor used for allelic repair in single-cell clones targeted 
with Sca-ssODN and SpCas9 or SpCas9-HF1 (Supplementary Figs S4 and S5).
Clone genotype Sca/Silent Sca/Sca Silent/Silent Sca/Sca*Wt Sca/INDEL Silent/INDEL INDEL/INDEL Total
SpCas9-HF1 clones 9 (25.0%) 5 (13.9%) 10 (27.8%) 1 (2.8%) 2 (5.6%) 1 (2.8%) 8 (22.2%) 36 (100%)
HDR Biallelic Biallelic Biallelic Biallelic Monoallelic Monoallelic N/A N/A
Table 2. Edits of the FGF20 gene based on ssODN donor used for allelic repair in single-cell clones targeted 
with SpCas9-HF1 and a mixture of Sca-ssODN and Silent-ssODN (Supplementary Fig. S6).
Clone genotype Sca/Silent2 Sca/Sca Silent2/Silent2 Silent2/Silent2*Wt Sca/INDEL Silent2/INDEL INDEL/INDEL Total
SpCas9-HF1 clones 9 (25.0%) 5 (13.9%) 8 (22.2%) 2 (5.6%) 3 (8.3%) 1 (2.8%) 8 (22.2%) 36 (100%)
HDR Biallelic Biallelic Biallelic Biallelic Monoallelic Monoallelic N/A N/A
Table 3. Edits of FGF20 gene based on ssODN donor used for allelic repair single-cell clones targeted with 
SpCas9-HF1 and a mixture of Sca-ssODN and Silent2-ssODN (Supplementary Fig. S7).
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repressed in transcriptionally inactive targets in heterochromatin and nucleosomal DNA68–70. We found that 
HDR efficiency was unaffected by the transcriptional state of the targeted gene in PGCs (Fig. 2).
Similar to a recent report in human cells71, we observed using the GFP-to-BFP conversion assay that 
SpCas9-HF1 increases HDR levels while reducing INDEL formation (Figs 3 and 4). Since enhanced specificity 
Cas9 variants discriminate against targets bearing mismatches in the non-seed region of the gRNA target and pre-
vent nuclease activation44–46, the higher HDR efficiency observed with SpCas9-HF1 in our results can be attrib-
uted to the high fidelity of the nuclease which proof-reads the gRNA target sequence before activating cleavage, 
thereby reducing re-editing of the repaired target site and leading to higher levels of HDR in the two alleles and 
lowering INDEL formation. As a consequence, base pair changes can be efficiently introduced into the non-seed 
sequence of the guide region using SpCas9-HF1 without introducing a blocking mutation into the neighbouring 
PAM site (Fig. 2). This enhancement in HDR accuracy by SpCas9-HF1 directly increases the efficiency of editing 
single alleles to generate PGCs with specific heterozygous genotypes (Figs 4 and 5C,D).
In human IPS cells, use of SpCas9-WT and ssODN donors containing appropriate CRISPR/Cas9-blocking 
mutations positioned in the PAM site increased HDR levels by up to a 100-fold while mutations positioned in the 
gRNA target sequence showed variable efficacy35. At this observed efficiency, one correctly edited homozygous 
clone was isolated for every 20 to 40 single-cell clones targeted using a single ssODN template, whereas hundreds 
of single cell clones were needed to isolate a biallelically edited heterozygous clone repaired using two ssODN 
templates35. In contrast to these results, using a single ssODN repair template containing CRISPR/Cas9-blocking 
PAM mutations and SpCas9-HF1 to introduce the scaleless mutation into the FGF20 locus, we found that 4 to 
5 correctly edited clones were isolated for every 10 clones screened. In contrast, we were unable to isolate a 
clone with precise biallelic HDR using SpCas9-WT from the number of clones that we screened which suggests 
that many more clones will need to be picked. In our attempt to introduce the scaleless mutation into one allele 
(sc/+), we were able to isolate 2 correctly edited clones containing heterozygous biallelic edits for every 10 clones 
screened. It must be noted that we performed single cell culturing in a growth-factors-optimised, serum-free and 
feeder-free culture medium11. In our protocol, chicken PGCs proliferate more rapidly (21-hr doubling time) than 
the PGCs cultured in high-serum chicken PGC medium10.
A major requirement for the use of SpCas9-HF1 is that the 20-nt gRNA sequence must be perfectly comple-
mentary to the genomic target to achieve high on-target editing efficiency45. When using the U6 promoter to 
drive sgRNA expression, the requirement for a 5′- G base in the sgRNA sequence limits the use of SpCas9-HF1 in 
targets that do not have a 5′G, and adding an extra G significantly reduces on on-target efficiency45,72. However, it 
has been shown that using alternative promoters such as the U3 promoter to express sgRNA, expressing sgRNAs 
from synthetic tRNA-sgRNA constructs or using hammerhead ribozyme-linked sgRNAs leads to similar levels of 
on-target efficiencies SpCas9-WT72,73.
In targeting the FGF20 gene with SpCas9-HF1, we found that the scaleless 535A > T nucleotide change located 
6 bp downstream of the PAM and 12 bp away from the cut site of the gRNA was incorporated biallelically at a rate 
of >90% in isolated HDR clones containing PAM mutations. In comparison to our results, a 12 bp cut-to-edit 
distance was shown to result in <20% biallelic incorporation of the edit in biallelic HDR clones in human IPS 
cells35. Surprisingly, we also observed that all INDEL clones targeted using SpCas9-WT and Sca-ssODN did not 
contain the 535A > T substitution or PAM mutation suggesting that these clones never underwent HDR editing 
event. The only CRISPR/Cas9-blocking mutation in the Sca-ssODN template is a single nucleotide substitution 
in the PAM (AGG → AGA) which may not be sufficient to block re-cutting of the repaired site by Cas9. It has 
been shown in human cells that NGA PAMs may have up to 40% activity in some loci74,75. Interestingly, we 
also observed that some clones contained the 535A > T substitution on only one allele while the PAM mutation 
was present on the two alleles suggestive of partial or incomplete HDR and has been reported by others27,31,35. 
This may be indicative of a cut-to-distance dependence mechanism in the incorporation of single nucleotide 
edits in chicken PGCs as previously reported in human cells and mouse zygotes27,35. Furthermore, we observed 
that Silent-ssODN was used more frequently for allelic repair when it was mixed with Sca-ssODN whereas 
Silent2-ssODN and Sca-ssODN were used at almost equal frequency. The absence of the distal mutation 12 bp 
away from the cut site in Silent-ssODN may have favoured this donor and has been previously observed in 
human cells35. Also, we did not see any evidence of template switching for allelic repair between Sca-ssODN and 
Silent-ssODN which has been reported to occur in human cells41. While we used an asymmetric ssODN donor to 
introduce scaleless 535A > T nucleotide change into FGF20 (Fig. 5A) based on the reported ability of this template 
design to increase HDR66, we are unable to tell from our results if asymmetric repair templates are more efficient 
than symmetric templates in enhancing HDR in chicken PGCs and therefore may require further investigation. 
We also tested the use of SCR7 and L755507 to increase HDR in PGCs but we did not observe any improvement 
or toxicity. SCR7 and L755507 are small molecules reported to increase CRISPR-mediated HDR by inhibiting 
NHEJ in some cell types34,53. Concentration of these inhibitors may need to be optimised for PGCs. Use of these 
inhibitors and other reported HDR enhancers such as RS-176 merit further investigation in PGCs.
Why we do observe such high HDR rates in avian PGCs using SpCas9-HF1? It is possible that many PGCs 
targeted with SpCas9-WT do not survive due to the induction of another round of cleavage of the HDR-edited 
site. Germ cells from many vertebrate species have been shown to undergo programmed cell death when exposed 
to reagents causing DSBs as a mechanism to protect the integrity of the germline genome77–81. In our experiments, 
we used plasmid delivery of SpCas9-WT which has been shown to have some toxicity in human embryonic stem 
cells compared to ribonucleoprotein (RNP) delivery82. In human pluripotent stem cells, it has been reported that 
the induction of a single DSB by SpCas9-WT is toxic even in the absence of the induction of multiple DSBs or 
off-target mutagenesis83. This toxicity is P53-dependent and the induction of P53 by Cas9 leads to apoptosis or 
cell cycle arrest in the G1 phase where NHEJ is predominant thereby reducing the efficiency CRISPR/Cas9 preci-
sion genome editing83,84. Depending on the gRNA and loci, the sustained expression of SpCas9-WT from a plas-
mid increases the potential for re-cleaving of HDR-edited chromosomal targets as well as off-target mutagenesis. 
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Since the SpCas9-WT nuclease spends up to 6 hrs tightly bound to the cut ends of the DNA duplex66, the long 
residence time coupled with the high cleavage activity of SpCas9-WT probably increases the severity of genotoxic 
insult by preventing DNA repair, which may result in a stalled replication fork leading to cell cycle arrest or apop-
tosis and a decrease in overall HDR events. Indeed, inhibition of P53, a pro-apoptotic protein that is activated by 
DNA damage85, has been shown to increase the rate of HDR in human cells by preventing DNA damage response 
that results in apoptosis and allowing the cell cycle to progress83,84.
Conclusion
Our results demonstrate possible rapid introgression of specific haplotypes into primordial germ cells. These 
genomic tools will allow the validation of SNP and other chromosomal changes in poultry.
Materials and Methods
CRISPR Plasmids. PX459 V2.0 vector33 was used for expression of SpCas9-WT and sgRNA. The 
equivalent expression cassette (HF-PX459 V2.0) for SpCas9-HF1 and sgRNA was generated by transfer-
ring the domain containing the point mutations of SpCas9-HF1 into the coding sequence of SpCas9-WT 
in PX459 V2.0. A 1.4 kb region of the coding sequence of SpCas9-WT in PX459 V2.0 was excised using 
ApaI and PmlI restriction digest and replaced with a homologous 1.4 kb overlapping PCR fragment (Left 
primer, 5′-TTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGAGGGAACTCTC-3′ and right primer 
5′-TCCGGGAGTCCAGGATCTGTGCCACATGCTTTGTGATGGCGCGGGTTTC-3′) from the coding 
sequence of SpCas9-HF1 in VP12 vector45 using NEBuilder® HiFi DNA Assembly (New England Biolabs). PX459 
V2.0 was a gift from Feng Zhang (Addgene plasmid # 62988) while VP12 was a gift from Keith Joung (Addgene 
plasmid # 72247).
gRNA design and CRISPR/Cas9 vector construction. gRNA sequences were selected using 
CHOPCHOP gRNA design web tool (http://chopchop.cbu.uib.no/)86,87 and MIT gRNA design web tool (http://
crispr.mit.edu/) except where described otherwise. gRNA oligonucleotides were synthesized by Invitrogen and 
inserted into PX459 V2.0 and HF-PX459 V2.0 vectors using methods previously described in33. gRNA sequences 
are listed in Supplementary Table S1.
ssODN donors. ssODN donors were Ultramer® DNA Oligonucleotides synthesized by Integrated DNA 
Technologies (IDT). Donors were used at a concentration of 10 µM for transfections. See Supplementary Table S2 
for sequences of ssODN donors.
Animal usage. Fertile eggs were obtained from a flock of commercial Hyline layer hens maintained at the 
Roslin Institute. The GFP+/+ germ cells used in the experiments shown in Figs 3 and 4 were obtained by crossing 
the Roslin Green (ubiquitous GFP) line of transgenic chicken88 to produce homozygous fertile eggs for PGC 
derivations. Commercial and transgenic chicken lines were maintained and bred under UK Home Office License. 
All experiments were performed in accordance with relevant UK Home Office guidelines and regulations. The 
experimental protocol and studies were reviewed by the Roslin Institute Animal Welfare and Ethical Review 
Board (AWERB) Committee.
PGC culture. PGC lines were derived and cultured in FAOT medium as described in Whyte et al.11. Briefly, 
fertile eggs from Hyline layer lines or the Roslin Green line of transgenic chickens88 were incubated for 2.5 days 
and then 1 μl of embryonic blood was taken from the vasculature of stage 16 HH chick embryos89 and placed into 
FAOT medium. FAOT medium contains 1 × B-27 supplement (Thermo Fisher Scientific), 2.0 mM GlutaMax 
(Thermo Fisher Scientific), 1 × non-essential amino acids (Thermo Fisher Scientific), 1 × EmbryoMax nucle-
osides (Merck Millipore), 0.1 mM β-mercaptoethanol (Thermo Fisher Scientific), 0.2% ovalbumin (Sigma), 
1.2 mM pyruvate (Thermo Fisher Scientific), 0.15 mM CaCl2, 0.01% sodium heparin (Sigma), 4 ng/ml FGF2 
(R&D Systems), 25 ng/ml activin A (Peprotech) and 5 µg/ml ovotransferrin (Sigma) in Avian Knockout DMEM 
(osmolality: 250 mOsmol/kg, 12.0 mM glucose, calcium chloride free; Thermo Fisher Scientific, a custom mod-
ification of Knockout DMEM). PGC lines were expanded to 2.4 × 105 cells in 5 weeks before use in targeting 
experiments. GFP-PGCs were derived from transgenic chickens created by lentiviral methods88 and maintained 
at the National Avian Research Facility, Midlothian, UK.
PGC transfection. 200,000 PGCs were transfected with 1.5 µg of CRISPR vector and 0.4 µg of ssODN donor 
using Lipofectamine 2000 transfection reagent (Thermo Fisher Scientific). Cells were washed in Optimem I 
(Thermo Fisher Scientific) and incubated in suspension in Optimem I mixed with DNA and transfection reagent 
for 6 h. PGCs were then centrifuged and resuspended in FAOT medium. PGCs were treated with 0.6 µg/ml puro-
mycin 24 h post-transfection for 48 h to enrich for transfected cells and then expanded in culture for two weeks to 
eliminate transient CRISPR expression and then used to isolate genomic DNA to measure targeting efficiencies 
or isolate single cells. To test NHEJ inhibitors, PGCs were treated with SCR7 (Sigma-Aldrich) at a concentration 
of 1 mM or L755507 (Sigma-Aldrich) at a concentration of 5 µM for 24 h after transfection followed by puromycin 
treatment for 48 h.
Isolation of single-cell clonal populations. PGCs were seeded manually or sorted using a FACSAria III 
(BD Biosciences) into 96-well plates at 1 cell per well in 110 µL FAOT medium and cultured for 2 weeks. Once 
cell density reached 30–50%, PGCs were transferred into a 48-well plate and subsequently into a 24-well plate for 
further expansion to isolate genomic DNA for analysis of mutation genotype.
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Genomic DNA isolation and PCR amplification of target region. Genomic DNA was extracted from 
PGCs using QIAMP Micro Kit (Qiagen) according to the manufacturer’s instruction. Specific primers for PCR 
amplification of sgRNA target sites were designed using primer3 software (http://primer3.ut.ee/)90,91. Primers 
were designed to anneal outside the homology arms of HDR templates. List of primer sequences are listed in 
Supplementary Table S3. All PCR amplifications were performed using 100 ng of genomic DNA and Q5® Hot 
Start High-Fidelity DNA polymerase (NEB) or Phusion® High-Fidelity DNA polymerase (NEB) according to 
the manufacturer’s protocol. Primer annealing temperatures were calculated using the online NEB Tm calculator 
(https://tmcalculator.neb.com).
Analysis of gRNA targeting efficiency by T7 endonuclease I mismatch assay. T7 endonucle-
ase I assay was performed by treating 200 ng of PCR DNA with 10 units of T7 endonuclease I in NEBuffer™ 2 
buffer and incubated according to the manufacturer’s instruction (NEB). The digestion products were resolved 
on 1% agarose gel containing Gelred® nucleic acid gel stain (Biotium) and ImageJ (https://imagej.net) was used 
to quantitate band intensities. The targeting efficiency was calculated using the equation 100 × (1 − (1 − fraction 
cleaved)1/2)92.
HDR quantification by EcoRI restriction digestion. Restriction site sequences were incorporated into 
the target site to quantify HDR. All restriction enzyme digestion reactions were performed by treating 200 ng 
of PCR DNA with 10 units of restriction enzyme (EcoRI-HF (NEB #R3101S), BamHI-HF (NEB #R3136S), AfeI 
(NEB #R0652S), AatII (NEB #R0117S)) in CutSmart buffer (NEB) incubated at 37 °C for 1 h. The digestion prod-
ucts were resolved on 1% agarose gel containing Gelred® nucleic acid gel stain (Biotium). ImageJ software was 
used to quantitate band intensities. The percentage of HDR was calculated as described in51 using the equation 
(b + c/a + b + c) × 100, where ‘a’ is the band intensity of uncleaved DNA substrate and ‘b’ and ‘c’ are the cleavage 
products.
HDR and INDEL quantification by flow cytometry. Live cells were gated and then GFP and BFP fluo-
rescence was detected using a Fortessa X20 (BD Biosciences). Cytometry data was analysed using FlowJo® V7.0 
(FlowJo, LLC).
DNA sequencing and bioinformatic analysis. PCR products were directly sequenced to analyse muta-
tion genotypes of single cell clones using PCR primers or PCR products were cloned into pGEM-T Easy vector 
(Promega #A137A) and sequenced using T7 promoter forward primer by Sanger sequencing. Sequencing data 
was analysed and viewed using SeqMan Pro 13 (Lasergene 13, DNASTAR) and FinchTV 1.4.0 (Geospiza, Inc.). 
PCR Sanger sequencing traces were analysed with the TIDE analysis web tool (https://tide.deskgen.com/) to 
detect INDELs in a population.
Data Availability
Plasmid HF-PX459 V2.0 will be available from Addgene. Data sharing is not applicable to this article as no data-
sets were generated or analysed during the current study.
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The introduction of small defined sequence changes into the genome of cultured 
chicken PGCs using the CRISPR/Cas9 system was investigated in this chapter. To 
enable optimal application of CRISPR/Cas9, transfection optimization was performed 
(APPENDIX D). My results showed that ssODN donors are toxic to chicken PGCs in 
high concentrations as transfecting up to 100 µM of ssODN donor resulted in massive 
mortality so that it took 2 months to recover and expand any surviving puromycin-
resistant cells which showed no evidence of HDR editing (APPENDIX D; Figure A4). 
ssODN donor concentrations ranging from 1 to 10 µM resulted in significantly higher 
PGC survival so that puromycin-resistant cells were successfully expanded within 2 
weeks and showed successful HDR editing (APPENDIX D; Figure A4).  
The high fidelity Cas9, SpCas9-HF1, mediated higher HDR efficiency than the wild 
type Cas9, SpCas9-WT, for the introduction of small base pair (bp) changes. This 
finding that SpCas9-HF1 increases HDR is supported by a recent report in human cells 
(Kato-Inui et al., 2018). The use of the high fidelity CRISPR/Cas9 is also advantageous 
as it, in principle, addresses concerns of off-target mutagenesis while also increasing 
HDR efficiency in chicken PGCs. Although off-target mutations were not analysed in 
this study, it is highly unlikely that SpCas9-HF1 induced off-target mutations, but this 
should be investigated in chicken PGCs in future studies. Using SpCas9-WT, the 
introduction of 1- or 2-bp changes outside the PAM or seed sequence of the gRNA 
target was inefficient in chicken PGCs, similar to observations by others (Armstrong 
et al., 2016; Paquet et al., 2016). To address the low HDR efficiency mediated by 
SpCas9-WT, small molecule inhibitors of NHEJ such as SCR7 and L755507 have 
been investigated in other cell types (Maruyama et al., 2015; Yu et al., 2015). SCR7 
and L755507 failed to increase HDR efficiency in chicken PGCs at the specific 
concentrations used in this study but this result could be investigated further by trying 
a range of different concentrations of inhibitors in future studies.  
The remarkable capacity of SpCas9-HF1 to mediate 1- or 2-bp changes without 
mutating the PAM is useful for the introduction of small sequence variations such as 





alleles. The introduction of Cas9-blocking mutations in the PAM or gRNA target may 
not be compatible in coding regions if the changes are non-synonymous substitutions.  
SpCas9-HF1 also showed a remarkable ability to mediate the introduction of specific 
heterozygous mutations. In a previous study, an efficient two-step method termed 
‘’CORRECT’’ was described for introducing specific heterozygous mutations using 
SpCas9-WT (Kwart et al., 2017). CORRECT is an acronym for ‘’consecutive re-
guide or re-Cas steps to erase CRISPR/Cas-blocked targets’’. CORRECT 
involves the introduction of the intended mutation and a Cas9-blocking mutation in 
the first editing step. Successfully edited cells are clonally isolated and then a second 
step of targeting is performed on the isolated cells using a donor to remove the Cas9-
blocking mutation and restore the genetic sequence to the parental status while 
preserving the intended mutation.  The CORRECT method may be applied in chicken 
PGCs but will take twice the amount of time compared to the single-step use of 






SpCas9-HF1. It may be useful to use SpCas9-HF1 with the CORRECT method for 
difficult single base pair changes to increase the efficiency of HDR editing.  
The use of short ssODN as repair template for small sequence changes in chicken 
PGCs was demonstrated for the first time in this Chapter. Compared to short ssODN 
donors, double-stranded DNA donors especially plasmids have been associated with 
random integrations into the genome (Vasquez et al., 2001). However, a few studies 
have now reported random integrations of ssODN donors as well as genomic segments 
deleted using two gRNAs which may result in genome duplication or inversion events 
(Boroviak et al., 2017; Codner et al., 2018; Lanza et al., 2018). Random integration of 
the ssODN donors or the CRISPR plasmids was not investigated in this study but 
should be investigated in future studies in chicken PGCs. Furthermore, short ssODN 
donors which may be commercially synthesized to a maximum length of 200-bp were 
used in this study. However, longer ssODN donors of up to 5-kb can now be 
commercially synthesized and have been used as repair templates for CRISPR/Cas9-
mediated HDR in mammalian models (Codner et al., 2018; Lanza et al., 2018; Miura 
et al., 2017). These long ssODN donors were not investigated in this study but it is 
likely that they are highly transfectable like short ssODN donors. It may be possible 
to delete long stretches of DNA of up to 2 kb using two gRNAs in chicken PGCs and 
then replace the deleted interval via HDR using long ssODN donors. It may also be 
possible to use these long ssODN donors to introduce numerous SNPs spanning a large 
region in a single step but these needs to be investigated in chicken PGCs. 
Additionally, the use of plasmid vectors to deliver the Cas9 nuclease and sgRNA could 
be replaced with mRNAs or reconstituted ribonucleoproteins (RNP) complexes. 
Currently, there is no report showing mRNA or RNP delivery of CRISPR/Cas9 in 
cultured chicken PGCs and should be investigated as this will eliminate concerns 
associated with random integration of plasmid DNA.  
The ssODN donors used to introduce the 535A>T mutation into FGF20 were 
asymmetric around the cut site. This repair template design (left arm (LA) of 35-bp 
and right arm (RA) of 91-bp) was reported to increase HDR efficiency with SpCas9-
WT in human cells (Richardson et al., 2016). My results showed that HDR was still 
inefficient using SpCas9-WT and the asymmetric Sca-ssODN donor for editing of 





91-bp), symmetric ssODN donor (LA and RA - 63-bp) and a plasmid donor (LA and 
RA – 250bp) containing 3-nucleotide substitutions around the PAM for the 
introduction an EcoRI restriction sequence into FGF20 (APPENDIX E). The result 
showed that HDR was inefficient using SpCas9-WT and similar (<8%) between the 
three templates (APPENDIX E; Figure A5). However, HDR efficiency using SpCas9-
HF1 was greater than 40% using the ssODN donors and 58% with the plasmid 
template. This preliminary result shows that the symmetry of the repair template may 
have little effect in significantly increasing in chicken PGCs, but this needs to be 
further investigated in future studies. 
The accurate monoallelic and biallelic introduction of the 535A>T mutation into the 
FGF20 gene in chicken PGCs was demonstrated using SpCas9-HF1. The 535A>T 
mutation in chicken FGF20 gene is hypothesized to be the direct cause of the scaleless 
phenotype associated with featherlessness and absence of scales on the feet (Abbott & 
Asmundson, 1957; Wells et al., 2012). The scaleless phenotype is beneficial for 
chickens bred in hot climates as feathered chickens are susceptible to heat stress which 
reduces their productivity and depresses their immune system (Azoulay et al., 2011; 
Lara & Rostagno, 2013). Featherless broilers were shown to survive better in hot 
temperatures above 30°C as they were able to prevent significant elevation of their 
body temperature compared to their feathered siblings and commercial broilers that 
experienced significant mortality (Azoulay et al., 2011). In another study, the body 
weight (BW) of featherless broilers and their feathered siblings derived from four 
cycles of backcross to contemporary broiler stocks were compared to that of 
contemporary commercial broilers (Hadad et al., 2014). Under normal temperature, 
commercial broilers achieved their expected superior BW maximally surpassing the 
crossbred groups. However, the BW of the featherless broilers was unaffected in hot 
conditions while the BW of the two feathered group decreased by up to 25% (Hadad 
et al., 2014). In this situation, precise genome editing could be used to introgress the 
beneficial scaleless allele into commercial broiler lines destined for hot regions in a 
single generation to maximally conserve the superior broiler genetics and make them 
adaptable for meat production in hot climates.  
In conclusion, the results in this chapter demonstrate the enormous potential to use 



















VALIDATING ANP32A AS A TARGET FOR GENETIC RESISTANCE TO 
AVIAN INFLUENZA IN CHICKEN 
4.1 INTRODUCTION 
Avian influenza (AI) is a viral disease of birds caused by the influenza A virus (IAV).   
IAVs are classified into subtypes according to their haemagglutinin (HA) and 
neuraminidase (NA) surface proteins. Currently, 16 HA and 9 NA subtypes have been 
identified in the wild waterfowl natural reservoir, with each IAV having a combination 
of one HA and one NA protein (Fig. 4.1) (Bouvier & Palese, 2008; Long et al., 2018). 
AI is a zoonotic disease with a pandemic potential, and controlling the disease in birds, 
especially widely-farmed poultry such as chicken, is an essential strategy for 
preventing human infection (Horimoto & Kawaoka, 2001; OIE, 2018; WHO, 2018). 
Wild waterfowl and some bat species are natural reservoirs that harbour diverse IAVs. 
These viruses can infect other species including poultry, humans, pigs and horses and 
usually cause sporadic viral outbreaks (Cauldwell et al., 2014; Fouchier et al., 2005; 
Keawcharoen et al., 2008; Tong et al., 2012; Tong et al., 2013; Webster et al., 1992). 
Based on the pathogenicity of the disease caused, IAVs are classified into high 
pathogenic avian influenza (HPAI) viruses which cause severe multi-systemic disease 
with mortality as high as 100% and low pathogenic avian influenza (LPAI) viruses 
which cause milder and primarily respiratory disease which may be exacerbated by 
other infections or environmental conditions (Alexander, 2000; Capua & Marangon, 
2006).  
Outbreaks of AI in poultry often have significant and adverse economic impacts 
(Alexander, 2007; Capua & Marangon, 2006; Swayne & Suarez, 2000). The major 
strategy used by most countries to control or eradicate HPAI in poultry includes 
vaccinations, epidemiological surveillance through targeted sampling especially for 
LPAI, maintaining strict biosecurity to prevent introduction of the virus and massive 
depopulation of farms in geographical regions (stamping-out programme) when 
outbreaks occur (Swayne & Suarez, 2000). However, major outbreaks associated with 
novel viral strains continue to occur even with the implementation of these strict 







Figure 4.1 Circulation of IAV serotypes. All subtypes of Influenza A viruses that 
have been identified circulate in the wild bird reservoir. Many animal species can be 
infected by several subtypes. Intermediate hosts play a major role in enabling adaptive 
mutations (light blue arrows) to occur and infect other species. Certain subtypes are 
prevalent in some specific species (dark blue circles). In humans, H2N2 viruses no 
longer circulate. Humans exposed to infected poultry have been infected by avian 
influenza viruses of H5, H6, H7, H9 and H10 subtypes but are not currently 
transmittable between humans. H17 and H18 subtypes have been identified only in 





As a consequence to the dangers posed by AI, there is great interest in selective 
breeding of poultry flocks for genetic resistance to AI. However, this would require 
the discovery and validation of new resistance alleles for AI since the red jungle fowl 
and commercial breeds derived from RJF have poor innate resistance to HPAI 
(Balkissoon et al., 2007; Barber et al., 2010; Short et al., 2014; Smith et al., 2015). 
Therefore, the discovery of new resistance alleles may depend on the use of molecular 
methods, which once identified may be difficult or impossible to introgress using 
conventional breeding into pedigree lines. Genome editing of PGCs can be used to 
permit rapid and precise introduction of highly heritable disease resistance alleles, 
including those potentially identified in resistant bird species, without distorting or 
diluting existing production characteristics in the recipient bird population. 
4.1.1 Replication of Influenza A virus (IAV) 
IAVs are negative-sense single-stranded RNA viruses whose genome contain eight 
viral RNA segments that encode at least 12 proteins (Fig. 4.2a) (Bouvier & Palese, 
2008).  Some viral proteins are determinants of host range and these include the viral 
surface proteins (haemagglutinin (HA) and neuraminidase (NA)), the viral polymerase 
proteins (vPol) (polymerase acidic (PA), polymerase basic 1 (PB1), and polymerase 
basic 2 (PB2)), the viral nucleoprotein (NP) and the viral nuclear export protein (NEP) 
(Cauldwell et al., 2014). The 5’ and 3’ ends of each viral genomic segment function 
as the viral promoter which is bound to the RNA-dependent RNA polymerase (vPol). 
The rest of the viral genomic segment is coated by the viral nucleoproteins to form a 
viral ribonucleoprotein complex (vRNP) (Fig. 4.2b). After virus entry into the host 
cell,  the vRNPs are released into the cytoplasm (Fig. 4.2c). The vRNPs are then 
trafficked from the cytoplasm into the nucleus where enzymatic coordination of viral 
mRNA synthesis and genome replication mediated by the vPol takes place  (Fodor, 
2013; Manz et al., 2013). 
Replication of IAV is characterized by a high rate of mutation and consequently, high 
variability in viral genomic sequence which enables the virus to evade the host’s 
immune system as well as enabling adaptation to new hosts following interspecies 






Figure 4.2 Replication of influenza A virus (IAV).  During IAV replication, viral 
proteins interact with several negative and positive cellular host proteins. These 
interactions determine the success or failure of virus infection and replication. RIG-I, 
MxA, DDX17, HAX1, TUFM and MAVS are cellular proteins that antagonise avian 
influenza virus. IMPα7 and ANP32A are host factors reported to permit avian influenza 
replication. TRIM22 has been shown to be antagonistic to human influenza viruses 





The activities of the vPol  and the PB2 polymerase subunit in particular, are  major 
determinants of host adaptation (Cauldwell et al., 2014). Particularly, position 627 in 
the C-terminal region of PB2 is a key determinant of host range (Subbarao et al., 1993). 
Many avian vPol have glutamic acid (E) at position 627 in PB2, and a switch to lysine 
(K) enables adaptation to permit replication in human/mammalian cells in which avian 
vPol activity is restricted (Long et al., 2016; Moncorgé et al., 2010).  
A minigenome vPol reconstitution assay can be used to demonstrate the host range 
restriction of  avian vPol in vitro (Long et al., 2016; Moncorgé et al., 2010). In the 
minigenome assay, the vPol proteins (PA, PB1, PB2 and NP) and a negative-sense 
virus-like RNA reporter (minigenome) are transcribed by the host-cell RNA 
polymerase I from a species-specific RNA pol I promoter (Moncorgé et al., 2010; 
Pleschka et al., 1996). The noncoding and conserved viral promoter sequences of the 
heterotrimeric vPol flank the minigenome. Reconstitution of the vRNPs is required to 
drive transcription of the negative-sense minigenome RNA which takes place in the 
nucleus. Using the minigenome assay, vPol possessing E or K at position 627 in PB2 
are active in avian cells whereas only vPol bearing K at position 627 are active in 
human cells (Long et al., 2016; Mehle & Doudna, 2008). Substitution of E with K at 
PB2 position 627 significantly increases the activity of reconstituted avian vPol in 
mammalian cells (Mehle & Doudna, 2008; Moncorgé et al., 2010). Additionally, 
heterokaryons formed by fusing avian and humans cells supported the activity of avian 
vPol (PB2/627E), indicating the presence of a positive host factor present in avian cells 
that is either absent or different in mammalian cells (Moncorgé et al., 2010). 
 
4.1.2 Molecular basis of host restriction of IAV viral polymerase 
To identify the vPol-permissive host factor in avian cells, Long et al. (2016) screened 
a panel of chicken genome radiation hybrid hamster cell lines and identified ANP32A 
as the host-cell factor that is required to support IAV vPol function (Long et al., 2016). 
ANP32A is a member of the acidic (leucine-rich) nuclear phosphoprotein 32 (ANP32) 
family which is composed of small, evolutionarily conserved proteins characterized 
by an N-terminal leucine-rich repeat domain and a C-terminal low-complexity acidic 





suggested for ANP32 family members (ANP32A, ANP32B, and ANP32E) including 
apoptotic caspase modulation, chromatin modification and remodelling, protein 
phosphatase inhibition and the regulation of intracellular transport (Reilly et al., 2014). 
ANP32A is highly conserved in vertebrates, however, avian ANP32A, with exception 
of ratites, has a unique 33-amino acid insert in the C-terminal half of the protein which 
is missing in mammalian ANP32A. Long et al. (2016) showed that RNA knockdown 
of chicken ANP32A in chicken cells significantly reduced avian vPol (PB2/627E) 
activity and expression of avian ANP32A (except ratite ANP32A) in human cells 
supported avian vPol (PB2/627E) activity (Long et al., 2016).  
Expression of chicken ANP32A lacking the 33-amino acid (aa) insertion did not 
support avian vPol activity in human cells whereas expression of the long chicken 
isoform as well as a fusion human ANP32A and ANP32B containing the avian 
insertion supported vPol activity (Long et al., 2016). While it is clear from the 
experiment by Long et al. that ANP32A containing the 33-aa avian insert is essential 
for the activity of avian vPol, the mechanism by which ANP32A supports the vPol 
function is not understood. Interestingly, chicken ANP32B did not support avian vPol 
activity even when the 33 amino acids from chicken ANP32A was inserted. 
By generating chimeric human and chicken ANP32B proteins, Dr Jason Long and 
colleagues personally communicated to me that the fifth leucine rich repeat (LRR) of 
chicken ANP32B may be responsible for this loss of avian vPol activity (Dr Jason 
Long et al., unpublished data). The fifth LRR of human ANP32A differs from that of 
human ANP32B by one amino acid (https://www.uniprot.org/uniprot/). In contrast, the 
fifth LRR of chicken ANP32B differs from that of chicken ANP32A by five amino 
acids (Fig. 4.3). No role has yet been clarified for the LRR of ANP32A in the 
interaction with IAV vPol. A survey of the functions of LRR proteins suggests that the 
Figure 4.3 Alignment of the fifth LRR region of ANP32A and ANP32B from 





major function of the LRRs may be to provide a structural framework for the formation 
of protein–protein interactions (Kobe & Kajava, 2001). Chicken ANP32B has 
isoleucine at position 129 (I129) in its fifth LRR. Dr Long discovered in preliminary 
studies that a chicken ANP32A mutant (N129I-ANP32A) bearing an asparagine (N) 
to isoleucine (I) mutation at position 129 (N129I) in the fifth LRR failed to support 
avian vPol when it was expressed in human cells but required further investigation 
especially in chicken cells (Long and colleagues, personal communication). 
4.1.3 Investigating AI viral polymerase activity in genome-edited PGC-derived 
cell lines 
PGCs can be reprogrammed into pluripotential embryonic stem cells which can further 
be differentiated into cellular derivatives of all three embryonic germ layers (Chapter 
1: 1.3.7). Using a protocol developed by Dr Michael J. McGrew, cultured chicken 
PGCs can be differentiated into a monolayer culture of avian influenza-infectible 
fibroblast-like cells (sometimes described as PGC fibroblasts in this thesis) which can 
be cultured for many months (Dr Michael J. McGrew, unpublished data; Dr Nikki 
Smith, unpublished data; Dr Jason Long, unpublished data). Therefore, genome 
editing of chicken PGCs can be performed to generate a PGC-derived cell line with a 
defined genotype to study gene function and investigate host-pathogen interaction. In 
this regard, PGC-derived avian cell lines may potentially serve as an alternative to 
other avian cell lines. However, this has not been demonstrated. 
As discussed in the sections above, heterologous expression of avian genes in 
mammalian cell lines and RNA knockdown in avian cell lines are the only methods 
that have been used to investigate the role of ANP32A in avian influenza host-
pathogen interaction.  However, RNA knockdown only reduces gene function but does 
not completely eliminate it, and is also a transient process (Mocellin & Provenzano, 
2004). Furthermore, heterologous expression such as the expression of an avian gene 
in mammalian cells to study its role in host-pathogen interaction may not be ideal 
because transcriptional regulation, post-translation modification, protein folding and 
protein expression levels are unique in every species (Lambertz et al., 2014). Also, 





factors in a heterologous expression system may confound any observation which may 
lead to misleading conclusions.  
Therefore, the aim of the experiments described in this chapter is to use CRISPR/Cas9 
to edit ANP32A in chicken PGCs in order to generate specific cell lines for the 








4.2 EXPERIMENTAL AIMS 
1. To test the hypothesis that chicken ANP32A is necessary for vPol activity in 
chicken cells by generating a chicken PGC line harbouring a complete loss-of-
function mutation of ANP32A 
2. To test the hypothesis that the unique avian 33-amino-acid insertion in ANP32A 
is necessary for avian vPol function in chicken cells by generating a chicken PGC 
line harbouring deletion of the region encoding the unique 33 amino acid insertion 
of chicken ANP32A. 
3. To test the hypothesis that an N129I mutation in chicken ANP32A will abolish 
vPol activity in chicken cells. 
4. To test the hypothesis that PGC-derived cell lines are useful for IAV studies by 
performing avian influenza minigenome replication assays in cell lines derived 








4.3.1 Deletion of the 33-amino acid avian insertion in chicken ANP32A 
4.3.1.1 Transfection of PGCs and isolation of single-cell clonal populations 
Exon 5 of chicken ANP32A encodes the 33 amino acid present in non-ratite bird 
species. Two gRNAs (Ex5-gRNA1 and Ex5-gRNA2; Table 2.2) were selected to 
target sites in intron 4 and intron 5 of ANP32A in order to perform a 400bp deletion 
of the genomic region containing exon 5 (Fig 4.4A). A precise deletion of exon 5 was 
predicted to create a deletion of the domain of chicken ANP32A protein that represents 
the 33-amino acid avian insertion without disrupting the open reading frame of 
ANP32A. It must be noted that a chicken expressing only the short ANP32A isoform 
lacking the avian insertion can potentially become a reservoir for human influenza 
viruses. Each gRNA was cloned into the PX459 V2.0 using the materials and methods 
described in (Ran et al., 2013). To delete exon 5, 1µg of Ex5-gRNA1 plasmid and 1µg 
of Ex5-gRNA2 plasmid were co-transfected into a male PGC line constitutively 
expressing Green Fluorescent Protein (GFP) (AK4M-WT PGC line) (Section 2.4.5). 
24 h after transfection, the transfected PGCs were treated with puromycin for 48 h and 
then propagated for 10 days to increase the population of puromycin-selected cells. 15 
single-cell cultures were then established from the mixed pool of puromycin-selected 
PGCs (Section 2.4.2). After 3 weeks of culture, 2 single-cell clonal lines (clone 1 and 
clone 2) were successfully derived.  
4.3.1.2 PCR analysis for loss-of-function genomic deletions 
To identify edited clones, primers annealing outside the intended region of deletion 
and flanking the double-strand break (DBS) sites of the gRNAs were designed (Section 
2.5.4.5; Table 2.1). PCR amplification of genomic DNA isolated from each clone was 
performed to confirm successful deletion of exon 5. The result, shown in Fig. 4.4, 
confirmed successful bi-allelic deletion of exon 5 in only clone 2 represented by a PCR 
band that is 400 bp smaller than the wild type control (AK4M-WT line) and confirmed 
by subsequent sequencing of PCR products (Fig 4.5). Next, total RNA was extracted 
from clone 2 and used to synthesize complementary DNA (cDNA) in order to verify 
the deletion of exon 5 in spliced RNA. PCR amplification of cDNA from clone 2 and 
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confirmed the deletion of exon 5 in clone 2 represented by a PCR band that is 100 bp 
smaller than the wild type control (Fig. 4.6A).  A second PCR band similar in size to 
that of clone 2 was also observed in the wild type control indicating the presence of a 
splice variant lacking exon 5. Sanger sequencing cDNA PCR products verified the 
deletion of exon 5 in clone 2 (henceforth referred to as AK4M-DEL33 line) and the 
absence of exon 5 in the smaller wild type PCR product (Fig. 4.6B). 
 
4.3.2 Generation of complete loss-of-function mutation in ANP32A 
To generate chicken PGC lines harbouring complete loss-of-function mutation in 
ANP32A, a gRNA (knockout-gRNA1; Table 2.2) was selected to target exon 1 to 
create a frameshift mutation. Knockout-gRNA1 was predicted to create a DSB 9-bp 3’ 
downstream of the start codon of ANP32A relative to its PAM. To create a frameshift 
INDEL mutation in exon 1, knockout-gRNA1 was cloned into the PX459 V2.0 vector 
and 2µg of the plasmid was transfected into AK4M PGCs. 24 h after transfection, the 
transfected PGCs were treated with puromycin for 48 h and then propagated for 10 
days to increase the population of puromycin-selected cells. 10 single-cell cultures 
were then established from the mixed pool of puromycin-selected PGCs. After 3 weeks 
of culture, 7 single-cell clonal lines were successfully derived. To verify the generation 
of a frameshift INDEL mutation, PCR primers flanking exon 1 were used to amplify 
a 238 bp region of the genomic DNA isolated from the single-cell clonal lines (Fig. 
4.7B) (CHAPTER TWO, Section 2.5.4.5; Table 2.1). The size of the genomic region 
that could be amplified was limited by the presence of long tracts of A repeats in intron 
1 sequence and GC rich sequences upstream of exon 1 of chicken ANP32A. Direct 
sequencing of PCR products was performed but failed repeatedly to yield analysable 
sequencing traces. Consequently, the PCR products were subcloned into pGEMT 
plasmids and then sequenced using the T7 primer (Table 2.1). The results, shown in 
Fig. 4.7C, confirmed the presence of bi-allelic INDELs in 6 out of 7 clones. Clone 3 
(henceforth referred to as AK4M-KO line) which contained an 8-bp frameshift 








    
Figure 4.7 Sequence analysis of isolated single cell clonal PG
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4.3.3 Differentiation of cultured chicken PGCs into fibroblast-like cells 
A method to differentiate cultured chicken PGCs into adherent fibroblast-like cells 
(hence referred to as ‘PGC fibroblast’ or ‘fibroblast’) was developed by Dr Michael J. 
McGrew (Chapter 2; 2.4.8). Using this method, AK4M-WT PGCs, AK4M-KO PGCs 
and AK4M-DEL33 PGCs were differentiated into fibroblast-like cells which were 
cultured in Knockout DMEM medium containing 10% foetal bovine serum and 1% 
chicken serum (Chapter 2; 2.1.5.6; Fig. 4.8). These cells proliferated for several 
months in culture and were split 1:4 every four days in culture. 
 
4.3.4 Analysis of ANP32A expression in edited PGC fibroblast lines  
In order to confirm the modification of ANP32A in the edited PGCs, a western blot 
analysis was performed to check for loss of expression in the knockout line (AK4M-
KO PGC line) and the deletion of the 33 amino acid avian insertion in AK4M-DEL33 
PGC line. As there is currently no antibody developed specifically against chicken 
ANP32A epitopes, a polyclonal antibody against human ANP32A was used (Table 
2.4). As shown in Fig. 4.9A, the immunogenic region of the anti-antibody used is 
conserved between chicken and human ANP32A. The mass of chicken ANP32A 
(ANP32A281) was estimated to be 32.17 kDa from coding frame analysis whereas the 
mass of the modified chicken ANP32A (ANP32A248) lacking exon 5 was calculated 
to be 28.49 kDa using its amino acid sequence 
(http://www.bioinformatics.org/sms/prot_mw.html). In comparison, human ANP32A 
has a mass of 28.59 kDA (https://www.uniprot.org/uniprot/P39687). Western blot 
analysis was performed to check for expression of ANP32A281 in fibroblasts 
differentiated from AK4M-WT PGCs, loss of expression in AK4M-KO PGCs and 
modification of ANP32A (and expression of ANP32A248) in AK4M-DEL33 PGCs. A 
32 kDa band was observed for wild type AK4M-WT PGC fibroblasts (Fig. 4.9B). No 
band was observed for AK4M-KO PGC fibroblasts whereas a 28 kDa band indicating 
expression of ANP32A248 was observed for AK4M-DEL33 PGC fibroblasts. To 
confirm that similar levels of protein were loaded for western blot analysis, the 
expression level of β-actin was assayed, and approximately equal levels were detected 
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4.3.5 Assessment of avian influenza polymerase function in chicken cells 
Chicken fibroblasts lacking ANP32A or expressing only the 28 kDa isoform 
(ANP32A248) were assessed for their ability to support the activity of reconstituted 
HPAI H5N1 A/turkey/England/50-92/91 (50-92) avian vPol (PB2/627E) compared 
with the human-adapted vPol (PB2/627K) using a dual luciferase assay system (Fig. 
4.10). AK4M-WT, AK4M-KO and AK4M-DEL33 PGC fibroblasts were transfected 
in triplicates with a chicken polI-Firefly minigenome reporter plasmid and 50-92 vPol 
plasmids encoding PB1, PA, NP and either PB2/627E or PB2/627K or an empty 
plasmid (Fig. 4.10). The expression of the Firefly reporter protein was driven by the 
chicken pol I promoter and only occurs when vRNPs are reconstituted (Fig. 4.10). The 
amount of vRNPs produced is directly proportional to the amount of Firefly proteins 
produced. A Renilla luciferase expression plasmid was also co-transfected as an 
internal transfection control. All plasmids were kindly provided by Dr Jason Long. For 
each well, PGC fibroblasts were transfected when cells were at 90% confluency using 
an optimised transfection method (Chapter 2; 2.10.1) and incubated at 37 °C and 5% 
CO2 for 48 h. The transfected cells were lysed and then Firefly and Renilla luciferase 
bioluminescence was measured (Chapter 2; 2.10.2). Renilla bioluminescence was 
strongly detected in all samples indicating a successful transfection. To measure vPol 
activity, Firefly luciferase units were normalised to Renilla luciferase units. 50-92 
PB2/627E and 50-92 PB2/627K vPol produced high luciferase activity in AK4M-WT 
fibroblasts (Fig. 4.11A). Compared to the wild-type AK4M-WT fibroblasts, the 
luciferase levels for both 50-92 PB2/627E and 50-92 PB2/627K vPol in AK4M-KO 
fibroblasts were reduced to background levels (Fig. 4.11B). For AK4M-DEL33 PGC 
fibroblasts, the luciferase levels of 50-92 PB2/627K vPol was comparable to that of 
AK4M-WT PGC fibroblasts whereas the luciferase readout for 5092 PB2/627E was 
significantly reduced (7.0 % of the levels of AK4M-WT fibroblasts) (Fig. 4.11C & F). 
This result indicates that AK4M-KO fibroblasts are incapable of supporting the vPol 
activity of 50-92 PB2/627E and 50-92 PB2/627K AIV.  Also, the vPol activity of 50-
92 PB2/627E AIV was significantly reduced with shorter chicken ANP32A isoform 
(ANP323A248) in chicken cells but this vPol activity was rescued by the mammalian-






   
Figure 4.10 Avian influenza minigenome replication assay. A) The minigenome 
plasmid contains the antisense Firefly reporter sequence flanked by the 5’ and 3’ non-
coding viral promoter (vp) sequence, fused between the chicken RNA pol I promoter 
and terminator sequences. The CAG promoter (pCAGGS) drives expression of Renilla, 
NP, PA, PB1 and PB2 plasmids. (B) After plasmid transfection, Renilla, NP, PA, PB1 
and PB2 are transcribed in the nucleus and their mRNAs are exported to the cytoplasm 
for translation (1). The viral proteins are then trafficked back to the nucleus (2). In 
chicken cells, the RNA polymerase I specifically requires the presence of the chicken 
RNA polymerase I (Pol I) promoter sequence and terminator sequence to initiate and 
terminate transcription of the negative-sense virus-like minigenome containing the 
reporter sequence (Firefly) (3). The antisense minigenome RNA produced associates 
with the viral proteins in the nucleus to reconstitute the viral-like RNP (4), which then 
replicates through an intermediate sense complementary RNP (5). Successful vRNP 
reconstitution also results in transcription of the minigenome to produce mRNAs (6), 







    
 
Figure 4.11. Long ANP32A isoform is essential for avian influenza polymerase 
function in chicken cells. A, B & C data are H5N1 50-92 AIV vPol activity 
normalised to Renilla; D, E & F data are firefly activity normalised to Renilla plotted 
as % of the wild-type (AK4M-WT values). One-way ANOVA, comparisons to Empty 
vector (A,B,C); ns= not significant, **p<0.01, ****p<0.0001; error plotted as 
standard error of mean (SEM) of the ratio; n=3 biological replicates. Error bars are 






4.3.6 Assessment of the ability of N129I-ANP32A to support avian influenza 
polymerase function  
Chicken cells transfected with a chicken ANP32A mutant bearing an asparagine (N) 
to isoleucine (I) mutation at position 129 (N129I-ANP32A281) were assessed for their 
ability to support the activity of avian and human-adapted vPol compared with the 
human-adapted isoform (PB2/627K). AK4M-WT, AK4M-KO and AK4M-DEL33 
PGC fibroblasts were transfected in triplicates with 50-92 AIV vPol plasmids (with 
627E or 627K or empty PB2) and a mutant N129I-ANP32A281 cDNA expression 
plasmid or chicken ANP32A cDNA expression plasmid (encoding the ANP32A281 
isoform) to rescue vPol activity in the edited PGC fibroblast lines. Luciferase activity 
was measured 48 h after transfection. Expression of the long ANP32A isoform 
(ANP32A281) in AK4M-KO and AK4M-DEL33 PGC fibroblasts significantly rescued 
PB2/E627 and PB2/K627 vPol activity to wild type levels (Fig. 4.12 B & C). In 
contrast, expression of the mutant N129I-ANP32A281 cDNA in AK4M-KO fibroblasts 
failed to rescue PB2/E627 and PB2/K627 vPol activity beyond background levels (Fig. 
4.12B). Also, there was no difference in luciferase readout for PB2/627K in AK4M-
DEL33 fibroblasts with and without the expression of N129I-ANP32A281 indicating a 
failure to rescue vPol activity (Fig. 4.12C). This result shows that a N129I mutation in 
ANP32A281 inhibits the activity of both PB2 E627 and K627 vPol in chicken cells.  






Figure 4.12 N129I mutation in ANP32A inhibits avian influenza polymerase 
function in chicken cells. PGC fibroblasts were transfected with H5N1 50-92 AIV 
vPol and chicken ANP32A or mutant N129I-ANP32A281 expression plasmid. Data 
are H5N1 50-92 AIV vPol activity normalised to Renilla; One-way ANOVA, 
comparisons to Empty vector. ns= not significant, **p<0.01, ***p<0.001, 
****p<0.0001. Error plotted as SEM of the ratio; n=3 biological replicates. 
C.  AK4M-DEL33  






In this chapter, I have demonstrated the use of genome-edited chicken PGCs in 
illuminating the role of the chicken ANP32A gene in promoting the activity of avian 
vPol. ANP32A is an essential host factor that is required to support AIV replication 
and a species difference between avian and mammalian ANP32A restricts avian vPol 
activity in mammalian cells (Long et al., 2016). In avian tissues, three ANP32A splice 
isoforms have been identified with differing abilities to stimulate avian vPol activity 
(Baker et al., 2018). Two transcripts (ANP32A281 and ANP32A278) contain exon 5 but 
differ by the absence of 12 nt in ANP32A278 that encode four hydrophobic residues 
which form a SUMO interaction motif (SIM)-like sequence at the N terminus of the 
33-aa insert in ANP32A281. The third mammalian-like isoform, ANP32A248, lacks 
exon 5 which is a duplication of exon 4. In this study, ANP32A248 transcript was 
detected in wild type cells by PCR of cDNA (Fig. 4.6) but the protein encoded from 
this shorter isoform was not detected in western blot analysis of total protein from wild 
type cells (Fig 4.9). ANP32A248 has been reported in some passerines, the Japanese 
quail (19% of all transcripts) and mallard (1% of all transcripts), and constitutes up to 
70% of ANP32A transcripts in the swan goose (Baker et al., 2018). Contrarily, only 
ANP32A281 and ANP32A278 was reported in chicken DF-1 cells (immortalized 
chicken fibroblasts) using RNA sequencing analysis (RNA-seq) (Baker et al., 2018). 
This may reflect differential splicing patterns in different tissue types resulting in the 
presence/absence or differential concentration of the different ANP32A splice 
isoforms within the host which may be associated with tissue-specific functions 
(Black, 2003).  
Long et al. (2016) showed that the activity of avian vPol (PB2/627E) was decreased 
in DF-1 cells after knockdown of ANP32A using short hairpin RNA and short 
interfering RNA (Long et al., 2016). Using the CRISPR/Cas9 genetic loss-of-function 
approach, the results of this chapter extends the finding of Long et al. (2016) by 
showing that the complete loss of ANP32A expression in chicken cells results in 
complete failure of the activity of both avian vPol (PB2/627E) and human-adapted 
avian vPol (PB2/627K) (Fig. 4.11) (Long et al., 2016). On the other hand, 
CRISPR/Cas9-modified chicken cells expressing only the mammalian-like 





vPol (PB2/627E) (Fig. 4.11), which is in agreement with previous reports in human 
cells expressing exogenous chicken ANP32A248 (Long et al., 2016).  
Recent studies have shown that ANP32A directly interacts with the 627 domain of 
PB2 in in vitro binding assays (Baker et al., 2018). In particular, a SIM-like sequence 
(VLSLV) in the 33-aa insert and the amino acid residues 221-235 (LCAR221-235) in 
the C-terminal part of chicken ANP32A which comprises the low-complexity acidic 
region (LCAR) have been shown to be critical for interaction and activity of avian 
vPol (Domingues & Hale, 2017). After exogenous expression in human cells, 
ANP32A281 and ANP32A278 were able to support avian vPol activity but with 
ANP32A281 stimulating 10-fold greater activity, indicative of the essential role played 
by host SUMOylation of ANP32A through the 33-aa insert (Baker et al., 2018). 
Chicken ANP32A248 was also shown to bind and interact with avian vPol and permits 
the activity of human-adapted avian vPol (PB2/627K), however, the 33-aa insert is 
critical for overcoming PB2/627E restriction, reflecting my observations in 
CRISPR/Cas9-edited chicken cells expressing only ANP32A248 (Fig. 4.11C) 
(Domingues & Hale, 2017). 
The failure of avian and human-adapted vPol activity in ANP32A-deficient chicken 
cells strongly indicates that chicken ANP32B does not compensate for the loss of 
ANP32A expression. In contrast, both human ANP32A and human ANP32B support 
the activity of both human and avian vPol in human cells (Sugiyama et al., 2015). 
Human ANP32A and ANP32B were shown to interact directly with the vPol in GST 
pull down assays (Sugiyama et al., 2015).  It is likely that chicken ANP32B does not 
support avian vPol activity, however, it needs to be confirmed that ANP32B is 
expressed in differentiated chicken PGCs (PGC fibroblasts).  
My results also showed that the exogenous expression of N129I-ANP32A in 
ANP32A-deficient chicken cells failed to rescue the activity of avian and the human-
adapted adapted vPol from background levels (Fig. 4.12B). This suggests that there is 
an interaction between the N129 residue in ANP32A and the vPol. The introduction 
of isoleucine (I), a very hydrophobic amino acid, to replace the polar residue 





between ANP32A and the vPol. The evidence for a direct interaction between N129 
of ANP32A and the vPol can be determined using a co-immunoprecipitation assay.  
ANP32A has important functions in mammals such as apoptotic caspase modulation, 
chromatin modification and remodelling, protein phosphatase inhibition and the 
regulation of intracellular transport (Reilly et al., 2014). Although the function of 
ANP32A in chickens has not been investigated, its reported functions in mammals 
may be conserved in the chicken. Therefore, ANP32A-deficient chickens may possess 
some deficit in cellular function that may negatively affect their fitness, which is 
undesirable in commercial poultry production. In future studies, it will be useful to 
investigate the functions of ANP32A in the chicken. Furthermore, the CRISPR/Cas9 
system may be used to perform precise genome editing of chicken PGCs to substitute 
asparagine (N129) with isoleucine (I) in chicken ANP32A. Functional studies can then 
be performed to determine if the natural ANP32A function is conserved in cells 
expressing N129I-ANP32A before moving ahead to produce the edited chickens to 
test for IAV resistance.  
Ratite bird species such as the ostrich possess the short ANP32A isoform (ANP32A248) 
and it has been reported that H5N1 IAV infection in the ostrich may lead to the 
selection of mammalian-adapted mutants and the conversion of low pathogenic AI 
virus to a highly pathogenic virus (Shinya et al., 2009; Lai et al., 2013).  Therefore, 
chickens expressing only the short ANP32A isoform (ANP32A248) lacking the avian 
33-aa insert may potentially serve as hosts that accelerate the emergence of 
mammalian-adapted IAVs. As a consequence, the use of genome editing to generate 
chickens lacking the avian 33-aa insert in ANP32A may be a human health risk.  
Finally, the results in this chapter demonstrate the usefulness of PGCs for generating 












CRISPR/CAS9-AIDED INVESTIGATION OF CXCR4 AND C-KIT 
SIGNALLING IN MIGRATION OF CIRCULATORY CHICKEN PGCs  
5.1 INTRODUCTION 
Long distance cellular migration in many organisms is guided by a response to an 
extracellular chemical stimulus in a process known as chemotaxis.  During this 
migratory process, cell survival and motility is sustained through autocrine and/or 
paracrine derived extracellular signals. Using a similar mechanism, primordial germ 
cells in many organisms migrate from their site of origin to the site of the developing 
gonads. In the mouse, PGCs are specified during gastrulation and are located in the 
dorsal root of the developing allantois from where they move into the hindgut 
endoderm. They subsequently migrate through the hindgut mesentery and eventually 
colonise the genital ridges (Ara et al., 2003; Wylie, 1999).  
In avian species, the migratory pathway of PGCs is more complex (Fig. 5.1). Chicken 
PGCs are segregated in the epiblast in the central zone of the area pellucida (Eyal-
Giladi et al., 1981). From there they move anterior into the germinal crescent at stage 
4-5 HH. By stage 8-11 HH, they are incorporated into the developing blood vessels 
and are found in the circulatory system from stage 12 to 17 HH. From stage 15 HH, 
chicken PGCs begin exiting the vasculature to finally colonise the genital ridges where 
they undergo sex-specific differentiation (Nakamura et al., 2013; Tsunekawa et al., 
2000). This route of migration of PGCs through the embryonic circulation is exclusive 
to avian species (Glover & McGrew, 2012). In model organisms such as the mouse, 
Drosophila, Xenopus and zebrafish, PGCs migrate through tissues guided by chemical 
signals and surrounded by a gradient of survival factors. These migratory and survival 
factors have not yet been identified for avian PGCs although SDF-1 and SCF are 






5.1.1 THE ROLE OF CXCR4 SIGNALLING IN PGC MIGRATION 
CXCR4 (C-X-C Motif Chemokine Receptor 4) is a 7-transmembrane G protein-
coupled receptor (GPCR) that is located on the cell surface. It selectively binds the 
CXC chemokine, CXCL12 also known as Stromal Cell-Derived Factor 1 (SDF-1). 
CXCR4 is well studied as a co-receptor or primary receptor for some HIV isolates as 
well as promoting cancer metastasis (Burger & Kipps, 2006; Murakami & Yamamoto, 
2010).  
CXCR4/SDF-1 interaction provides directional cues for migrating germ cells in 
zebrafish, mouse, and Xenopus embryos (Ara et al., 2003; Doitsidou et al., 2002; 
Molyneaux et al., 2003; Takeuchi et al., 2010). In CXCR4-deficient mouse embryos, 
only 20% of the total PGCs were observed to colonise the genital ridges with no 
ectopic migration observed (Molyneaux et al., 2003). A similar pattern was also 
observed in SDF-1 knockout mouse embryos (Ara et al., 2003). Similarly, morpholino 
knockdown of CXCR4 in zebrafish and Xenopus PGCs resulted in the failure of the 
migrating PGCs to colonise the genital ridges, which was accompanied by 
Figure 5.1. PGC migration in the chick embryo. (a) PGCs are not easily identified 
before the formation of the primitive streak. (b,c) After formation of the primitive 
streak, PGCs accumulate in the germinal crescent by stage 4 HH. (d) PGCs 
transmigrate into the vascular network between stages 8-11 HH. (f) By stage 18 HH, 
majority of PGCs have left embryonic circulation and colonised the lateral plate 





directionless migration and ectopic localization of PGCs (Doitsidou et al., 2002; 
Takeuchi et al., 2010).  
Chicken PGCs migrate towards a gradient of SDF-1 in vitro, and a correlation between 
SDF-1 gradients and PGC locations during the exit from the vasculature to the area of 
the developing genital ridges has been demonstrated using in situ hybridization for 
SDF-1 message (Stebler et al., 2004). SDF-1 expression occurs caudally in the 
ectoderm overlaying the genital area (lateral plate mesoderm, paraxial mesoderm and 
intermediate mesoderm) between stages 12-15 HH suggesting that PGCs may be 
attracted to concentrate in this region by the SDF-1 chemokine signal (Rehimi et al., 
2008; Stebler et al., 2004). At stage 18 HH, SDF-1 expression is confined to the lateral 
plate mesoderm and overlaps with the position of the PGCs (Rehimi et al., 2008; 
Stebler et al., 2004). However, it is still not unknown what factors attract circulatory 
PGCs to concentrate in the lateral plate mesoderm and guide their final migration to 
the genital ridges. 
 
5.1.2 THE ROLE OF C-KIT SIGNALLING IN PGC MIGRATION 
Proto-oncogene c-Kit (also known as mast/stem cell growth factor, tyrosine-protein 
kinase  or CD117) is a member of the type III receptor tyrosine kinase (RTK) family  
(Yarden et al., 1987). c-Kit and other members of type III RTK  possess a 23-amino 
acid signal peptide followed by an extracellular ligand-binding domain containing five 
immunoglobulin-like domains, which is followed by a single hydrophobic 
transmembrane domain and a relatively large cytoplasmic domain (Opatowsky et al., 
2014; Yarden et al., 1987). Chicken c-Kit is a 52.25 kb gene containing 21 exons 
located on chromosome 4 and produces only one splice variant that encodes a 960 
amino-acid protein (Ensembl 93/Gallus_gallus-5.0).  The binding of the kit ligand 
(also known as stem cell factor, SCF) to c-Kit causes dimerization and 
autophosphorylation of the c-Kit receptor which subsequently phosphorylates 
different substrates and activates a cascade of several signalling pathways (Blume-
Jensen et al., 1991; Lemmon et al., 1997; Roskoski, 2005). Mammalian SCF has two 
isoforms that occur due to alternative splicing; a soluble secreted isoform which is the 





membrane-bound isoform which is a shorter isoform lacking the cleavage domain 
(McNiece & Briddell, 1995). In chickens, four isoforms of SCF (chSCF1-4) resulting 
due to alternative splicing have been reported (Wang et al., 2007). chSCF1 is the 
longest isoform of chicken SCF and is considered to be the secreted form (Miyahara 
et al., 2016; Wang et al., 2007). chSCF2 lacks the cleavage domain encoded by exon 
6 and is considered to be the membrane-bound isoform (Miyahara et al., 2016; Wang 
et al., 2007). chSCF3 lacks the domain encoded by exon 4 while chSCF4 lacks the 
domains encoded by exon 4 and exon 6 (Wang et al., 2007). No role has yet been 
identified for chSCF3 and chSCF4. 
In many cell types, c-Kit/SCF signalling activates Src signalling, phosphatidylinositol 
3-kinase (PI3K)/AKT signalling, mitogen-activated protein kinase kinase 
(MEK)/mitogen-activated protein kinase (MAPK) signalling, the Janus kinase 
(JAK)/signal transducer and activator of transcription (STAT) signalling pathways 
(Rönnstrand, 2004). C-Kit/SCF signalling is thought to support mouse PGC survival 
through phosphatidylinositol 3′-kinase (PI3-kinase)-independent activation of AKT 
(Blume-Jensen et al., 2000; De Miguel et al., 2002; Kissel et al., 2000).  
In mouse embryos, c-Kit/SCF signalling has been directly implicated in the migration 
of mouse PGCs as a factor required for both survival and motility. SCF mutant and c-
Kit mutant mice with severe loss of function mutations die in late gestation while mice 
with mild loss of function mutations are viable to maturity but have a white coat, are 
severely anaemic and sterile indicating the importance of this pathway in 
haematopoiesis, melanogenesis and gametogenesis (Motro et al., 1991). Sterility is 
observed in these mutant mice due to a retarded colonisation of the genital ridges by 
migrating PGCs and impairments in differentiation during spermatogenesis and 
oogenesis (Buehr et al., 1993; Kissel et al., 2000; Matsui et al., 1990). Similar to what 
is observed in vivo, mouse PGCs do not survive in the absence of SCF during short 
term culture in vitro (Dolci et al., 1991; Godin et al., 1991). Homozygous steel-dickie 
mutant mice encoding only the soluble SCF are sterile and mouse PGCs in these 
mutants fail to migrate normally and undergo premature aggregation starting in the 
allantois at ED 7.5 leading to a reduced number of PGCs that reach the gonad 





mouse PGC proliferation in vitro whereas the soluble form supports mouse PGC 
survival without proliferation for 3 days after which PGCs begin to apoptose (Dolci et 
al., 1991; Godin et al., 1991). This suggests that the membrane-bound isoform of SCF 
can support both PGC migration and proliferation while the soluble isoform is only 
able to support survival (Gu et al., 2011). In zebrafish, the c-Kit pathway consists of 
two pairs of homologues for both the ligand (SCFa and SCFb) and receptor (Kita and 
Kitb) believed to have arisen through a genome duplication event during vertebrate 
evolution (Mellgren & Johnson, 2005; Parichy et al., 2000; Yao & Ge, 2010). In 
contrast to mammalian PGCs, in situ hybridization studies show that zebrafish PGCs 
do not express Kita or Kitb indicating that the Kit signalling pathway plays no direct 
role in zebrafish PGC migration (Mellgren & Johnson, 2005; Parichy et al., 2000).  
Like mammalian PGCs, chicken PGCs express the c-Kit receptor and chSCF1 has 
been shown to enhance chicken PGC proliferation only in cooperation with FGF2 in 
vitro (Miyahara et al., 2016). Interestingly, it has been shown that chicken PGCs 
polarized, formed persistent membrane protrusions and exhibited significant 
directional migration towards gradients of SCF in vitro (Srihawong et al., 2015). 
However, it is still unclear if c-Kit/SCF signalling plays a role in the colonisation of 
the gonads by chicken PGCs.  
5.1.3 DISSECTING GENE FUNCTION IN CHICKEN PGCS USING 
CRISPR/Cas9 
The advent of next generation sequencing technologies has resulted in the sequencing 
and annotation of the genome of several organisms. While the sequences and location 
of many genes are now known, the functions of some genes are not known or well 
understood. Reverse genetics is a valuable approach to illuminate gene function and 
may require the generation of targeted loss-of-function mutations. The introduction of 
targeted mutations was first demonstrated in chicken PGCs through classical gene 
targeting by homologous recombination but this method is cumbersome and inefficient 
due to the low frequency of homologous recombination (Capecchi, 1989a; Schusser et 
al., 2013).  
Artificial site-specific nucleases have simplified and increased the efficiency of 





the CRISPR/Cas9 system is easy to assemble and apply and has been used to create 
targeted mutations in many cell types to elucidate gene function (Doudna et al., 2014; 
Sander & Joung, 2014; Tschaharganeh et al., 2016). Accurate genomic deletion of 
regions encoding protein domains can be performed using two CRISPR gRNAs and 
successful editing events are easily identifiable by PCR. The introduction of 
CRISPR/Cas9 for genome editing of chicken PGCs has simplified the process of 
introducing targeted genetic changes. Chicken PGCs have been efficiently edited using 
CRISPR/Cas9 to generate chickens with specific loss-of-function mutations in 
ovomucoid and G0/G1 switch gene 2 (G0S2) genes (Oishi et al., 2016; Park et al., 
2018). These studies demonstrate the usefulness of CRISPR/Cas9 for investigating 
gene function in the chicken through targeting of chicken PGCs. 
The objective of the experiments described in this chapter is to investigate the role of 
CXCR4 and c-Kit genes in migrating circulatory chicken PGCs using the 
CRISPR/Cas9 system. Gene-specific gRNAs were cloned into a CRISPR/Cas9 vector 
that also encodes puromycin as a transfection selection marker. Chicken PGCs were 
transiently transfected and then single-cell culturing was performed to isolate pure 
clonal populations of edited cells. The migratory behaviour of edited chicken PGCs 







5.2 EXPERIMENTAL AIMS  
1. To test the hypothesis that CXCR4 and c-Kit receptors are not required for 
survival or proliferation of chickens PGCs in in vitro culture by using 
CRISPR/Cas9 to generate chicken PGC lines containing CXCR4 loss-of-
function mutation and a chicken PGC line containing c-Kit loss-of-function 
mutation. 
2. To test the hypothesis that CXCR4 and c-Kit signalling are necessary for 
efficient migration of chicken PGCs from the embryonic vascular system 
to the developing genital ridges. 
3. To test the hypothesis that c-Kit signalling is required for proliferation or 






5.3 RESULTS  
5.3.1 Generation of CRISPR/Cas9 vectors for CXCR4 and c-Kit 
Two gRNAs (CXCR4-gRNA1 and CXCR4-gRNA2) were selected to target exon 2 of 
CXCR4 to generate an estimated 874 base pair (bp) deletion of the region encoding 
the transmembrane domain of CXCR4 (Table 2.2). For c-Kit, two gRNAs (Kit-gRNA1 
and Kit-gRNA2) were selected to target exon 3 to create a frameshift mutation in the 
region encoding the second immunoglobulin-like domain of the extracellular region 
of the receptor (Table 2.2). Each gRNA was cloned into the PX459 V2.0 vector using 
the materials and method described in (Ran et al., 2013).  
 
5.3.2 Generation of loss-of-function deletions in CXCR4 and c-Kit 
5.3.2.1 Transfection of PGCs and isolation of single-cell clonal populations 
A male PGC line (AK4M line) and female PGC line (AK2F line) constitutively 
expressing Green Fluorescent Protein (GFP) were derived and cultured in FAOT 
medium as described in CHAPTER TWO (Section 2.4.1). To target CXCR4, 1µg of 
CXCR4-gRNA1 plasmid and 1µg of CXCR4-gRNA2 plasmid were co-transfected 
into male and female PGCs (Section 2.4.5). In a similar manner, 1µg of Kit-gRNA1 
plasmid and 1µg of Kit-gRNA2 plasmid were co-transfected into male and female 
PGCs to target c-Kit (Section 2.4.5). 24 h after transfection, the transfected PGCs were 
treated with puromycin for 48 h. PGCs were washed to remove puromycin and then 
propagated for 10 days to increase the population of puromycin-resistant cells. 15 
single-cell subcultures were then established from each mixed pool of puromycin-
selected PGCs (See Section 2.4.2 for single-cell clonal culture). For CXCR4, 13 
single-cell clonal populations were established from the AK4M CXCR4-targeted 
mixed pool whereas only one single-cell clonal population was established from the 
AK2F CXCR4-targeted mixed pool. For c-Kit, seven single-cell clonal populations 
were established from the AK4M c-Kit-targeted mixed pool whereas five single-cell 







5.3.2.2 PCR analysis for loss-of-function genomic deletions 
PCR amplification of genomic DNA isolated from each clone was performed to 
identify edited clones (CHAPTER TWO, Section 2.5.4.5; Table 2.1). The results are 
shown Fig. 5.2 and 5.3. The expected size of the PCR product for wild type CXCR4 
is 1172 bp while the deleted CXCR4 was estimated to yield a PCR product of 298 bp 
assuming each DSB occurs exactly 3 bp upstream of the PAM. For c-Kit, the estimated 
size of the wild type PCR product is 445 bp while the deleted c-Kit was estimated to 
yield a PCR product of 281 bp assuming each DSB occurs exactly 3 bp away from the 
PAM. For AK4M CXCR4 clones, only one clone (Clone 9) contained an apparent 
biallelic deletion while all other clones contained monoallelic deletions (Fig 5.2B). 
Sanger sequencing of the PCR products of AK4M Clones 7, 9 and 12 confirmed the 
deletions (Fig. 5.2D).  The only AK2F CXCR4 clone contained a biallelic deletion and 
was verified by direct Sanger sequencing of the PCR product (Fig 5.2C, D). For AK4M 
c-Kit clones, 6 out of 7 clones contained biallelic deletions while one clone contained 
a monoallelic deletion (Fig. 5.3B). Direct Sanger sequencing of the PCR products 
confirmed the deletions (Fig. 5.3B&D). For AK2F c-Kit clones, 3 of out 5 clones 
contained biallelic deletions while the remaining 2 clones contained monoallelic 
deletions (Fig. 5.3C). The deletions in these clones were also verified by direct Sanger 
sequencing of the PCR products (Fig. 5.3E). It should be noted that the isolated clones 
containing an apparent biallelic deletion may contain larger deletions that result in the 
loss of PCR priming sites. CXCR4-/- AK4M clone 9, CXCR4-/- AK2F clone 1, c-Kit-
/- AK4M clone 2 and c-Kit-/- AK2F clone 10 were used for subsequent downstream 
experiments. These edited lines will occasionally be referred to as CXCR4-knockout 
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5.3.3 Analysis of the loss-of-function phenotype of the edited clonal lines in 
culture 
5.3.3.1 Assessment of the proliferation rate of the edited clonal PGC lines in 
culture 
All knockout lines analysed showed a normal cellular phenotype in culture in 
comparison to the wild type cell lines (Fig. 5.4A). Although these knockout lines 
appeared to proliferate normally in culture, a growth assay was performed to compare 
the proliferation rate between the wild type mixed population and the edited clonal 
lines. To perform the growth assay, 500 PGCs were seeded into 300 µl FAOT in a 48 
well tissue culture plate and cultured at 37°C and 5% CO2 for 10 days. Every 48 hrs, 
90 µl of medium was taken out of from the side of the well and replaced with 100 µl 
of FAOT medium in order to refresh the culture. Male AK4M Wild-type (AK4M-
WT), male AK4M-CXCR4-/-and male AK4M-c-Kit-/- lines were assayed in 
triplicates and two independent experiments were performed. At the end of the 10-day 
culture period, the total number of live PGCs was counted and compared between 
samples. In a similar manner, two independent growth assays were also performed for 
female AK2F Wild-type (AK2F-WT), female AK2F-CXCR4-/-and female AK2F-c-
Kit-/- lines. The total live cell count after 10 days was averaged and presented in Fig. 
5.4B. The results showed that there was no significant difference between the knockout 
lines and the wild-type line for both male and female PGCs (P>0.1) indicating that the 
loss of CXCR4 or c-Kit receptor expression in chicken PGCs does not affect their 
proliferation in FAOT medium. 
5.3.3.2 Analysis of the expression of chicken vasa homologue in knockout lines 
To confirm that the edited lines maintained a germ cell identity, immunocytochemical 
staining for cytoplasmic expression of PGC determinant, chicken vasa homologue 
(Cvh) was performed (CHAPTER TWO, Section 2.12.2). PGCs were fixed with 4% 
paraformaldehyde for 10 mins and then permeabilised with 0.1% Triton X in tris 
buffered saline (TBS) for 1 min. The permeabilised PGCs were treated with anti-Cvh 
antibody to stain for Cvh and Hoechst 33342 nucleic acid stain to detect the nuclei of 
stained cells. Both male and female CXCR4-deficent and c-Kit-deficient lines stained 






Figure 5.4 Culture phenotype of CXCR4-deficient and c-Kit-deficient PGCs A) 
CXCR4 and c-Kit-Knockout PGCs have a normal cellular phenotype. B) Growth assays 
show similar the proliferation rate between wild type and knockout PGCs; n=6, two 
replicates; error-standard error of the mean (SEM). C) Immunocytochemical staining 
of knockout PGC lines for cytoplasmic expression of chicken vasa homologue (CVH) 









5.3.3.3 Analysis for loss-of-expression of CXCR4 and c-Kit in edited PGC lines 
Flow cytometry was performed to confirm the loss-of-expression phenotype of the 
edited lines (CHAPTER TWO, Section 2.12.3). To achieve this, live PGCs were 
blocked in 5% goat serum in avian knockout Dulbecco’s modified eagle medium (5% 
AK-DMEM) for 45 mins at room temperature. This was followed by incubation of the 
PGCs with mouse anti-chicken CXCR4 antibody (1:1000) or mouse anti-chicken c-
Kit antibody (1:50) for 1 hour at 40C. Subsequently, the cells were washed three times 
using 5% AK-DMEM and then incubated for 30 mins at 40C with goat anti-mouse IgG 
to conjugated Alexa Fluor® 647 fluorescent dye (See Tables 2.4 and 2.5 for antibody 
information). Flow cytometric detection and quantification for surface expression of 
CXCR4 or c-Kit was then performed. The results confirmed loss of surface expression 
of CXCR4 in male AK4M-CXCR4 -/- and female AK2F-CXCR4 -/- PGC lines (Fig. 
5.5). Also, loss of surface expression of c-Kit was confirmed in male AK4M-c-Kit -/- 
and female AK2F-c-Kit -/- PGC lines (Fig. 5.6).  
Figure 5.5 Analysis of expression of CXCR4 by antibody flow cytometry. 10,000 
live cells were gated to detect Alexa Flour® 647 fluorescence using BD Fortessa X20 
flow cytometer. Cytometry data analysis was analysed using FlowJo (V7.10). No 
primary control was stained with only secondary antibody. Result was consistent in 







5.3.4 Analysis of in vivo migratory behaviour of PGCs between stage 16-18 HH 
embryos 
Chicken PGCs accumulate in vascular networks of the lateral plate mesoderm between 
stage 15-18 HH and then exit the blood vessels to migrate through the dorsal mesentery 
and then into the left and right coelomic epithelium (Fujimoto et al., 1976; Stebler et 
al., 2004; Tagami et al., 2017). The colonisation of the lateral plate by circulatory 
CXCR4-expressing PGCs is suggested to be driven by the expression of SDF-1 in the 
lateral plate region (De Melo Bernardo et al., 2012; Stebler et al., 2004). The ability of 
the CXCR4-/-PGCs to accumulate and colonise the lateral plate region was therefore 
analysed. To do this, fertile wild-type host eggs were incubated for 2.5 days. 
Subsequently, 2000 wild-type or CXCR4 -/- GFP-PGCs mixed with 1000 RFP-PGCs 
were injected into the aorta of stage 16 HH host chick (control embryos were injected 
Figure 5.6 Analysis of expression of c-Kit by antibody flow cytometry. 10,000 
live cells were gated to detect Alexa Flour® 647 fluorescence using BD Fortessa 
X20 flow cytometer. Cytometry data analysis was analysed using FlowJo (V7.10). 
No primary control was stained with only secondary antibody. Result was consistent 





with AK2F-WT PGCs while CXCR4 test embryos were injected with AK2F-CXCR4-
/-PGC line). RFP-expressing PGCs constitutively expressing mCherry were generated 
using piggybac transgenesis by Caroline Zeiger-Poli and were co-injected as migration 
control (Glover et al., 2013). The manipulated embryos were sealed and incubated at 
37.8 ºC for 4 hrs to develop the embryos to stage 18 HH. Subsequently, the 
manipulated embryos were sacrificed and washed in phosphate buffered saline (PBS) 
to remove contaminating PGCs on the surface of the embryo. The ventral surface (yolk 
side) of the embryo was then examined to detect GFP-PGCs and RFP-PGCs along the 
lateral plate. Two independent experiments were performed. In all manipulated 
embryos, GFP-PGCs and RFP-PGCs were detected on the left and right lateral plate 
mesoderm and no difference was observed in the distribution of cells between wild 
type and CXCR4-/- PGCs (Fig. 5.7). This result shows that CXCR4-/- PGCs can 
migrate through the vascular system and concentrate in the lateral plate mesoderm in 







Figure 5.7 Ventral side of stage 18 HH chick embryos showing colonisation of the 
lateral plate mesoderm by injected PGCs. A) AK2F-WT PGCs (green signal) and 
wild type RFP-PGCs (red signal) n=8 B) AK2F-CXCR4-/- PGCs (green signal) and 





5.3.5 Analysis of gonadal colonisation by edited chicken PGCs 
To analyse the ability of the edited PGCs to migrate and colonise the gonads, the edited 
cells were injected into wild-type surrogate embryos at stage 16 HH in ovo. To do this, 
fertile wild-type host eggs were incubated for 2.5 days. Subsequently, 500 wild-type 
or CXCR4-/- or c-Kit-/- GFP-PGCs mixed with 500 RFP-expressing male PGCs (a 
total of 1000 PGCs) were injected into the aorta of the host chick embryo as described 
in CHAPTER TWO (Section 2.3.4). After injection, manipulated embryos were sealed 
and incubated at 37.8 ºC for additional 4.5 days (incubation day 7) or 11.5 days 
(incubation day 14). On incubation day 7, the manipulated embryos at stage 32-33 HH 
were sacrificed and then 10 µm cross-sections of the gonads were prepared to 
histologically examine the gonads and count the number of exogenous gonadal PGCs 
(CHAPTER TWO, Section 2.3.6). Embryos incubated till day 14 were also sacrificed 
and the gonads harvested to generate 10 µm cross-sections to histologically examine 
the distribution and number of exogenous gonadal PGCs. All tissue sections were 
treated with Hoechst 33342 nuclear stain to detect nuclei of cells. The results are 
described in the following subsections and are representative of 2 independent 
experiments. 
 
5.3.5.1 Analysis of in vivo migratory behaviour of male CXCR4-deficient and c-
Kit-deficient PGCs in stage 32-33 HH embryos (Incubation day 7) 
10 host embryos (control embryos) were injected with male AK4M-WT PGCs 
whereas male AK4M-CXCR4-/-PGC and male AK4M-c-Kit-/- PGCs were injected 
into 5 host embryos each (CXCR4 test embryos and c-Kit test embryos). In control 
embryos, the average number of AK4M-WT PGCs and RFP-PGCs per gonadal section 
was 6.2 and 6.7 respectively indicating that AK4M-WT PGCs and RFP-PGCs 
colonised the gonads at approximately equal ratio (Fig. 5.8A). In c-Kit test embryos, 
an average of 4.8 AK4M-c-Kit-/- PGCs were observed per gonadal section whereas 
the corresponding number of RFP-PGCs was 11.9 indicative of an unequal 














In CXCR4 test embryos, AK4M-CXCR4-/-PGCs were not observed in the gonads or 
the surrounding extragonadal areas whereas an average of 11.9 RFP-PGCs were 
observed per gonad per section (Fig. 5.8C).  GFP-PGC counts were normalised to 
RFP-PGC counts in order to directly compare the number of gonadal wildtype and 
edited PGCs at incubation day 7.  There was a significant difference between the 
number of gonadal AK4M-WT PGCs and AK4M-CXCR4-/-PGCs (p<0.0001), and 
similarly, there was a significant difference between the number of gonadal AK4M-
WT PGCs and AK4M-c-Kit-/- PGCs (p<0.0001) (Fig. 5.8D). Notably, the deletion of 
CXCR4 reduced male gonadal PGC count by 100% while the deletion of c-Kit reduced 
male gonadal PGC count by up to 60% (Fig. 5.7E). This result indicates that CXCR4 
signalling is essential for migration of male PGCs from the vascular system in the 
lateral plate to the forming gonad. Furthermore, c-Kit signalling is not essential but 
needed for efficient gonad migration. 
 
5.3.5.2 Analysis of in vivo migratory behaviour of female CXCR4-deficient PGCs 
between stage 16-32 HH embryos 
To analyse the migratory behaviour of female PGCs, 6 host embryos (control embryos) 
were injected with female AK2F-WT PGCs and 4 host embryos were injected with 
female AK2F-CXCR4-/- PGCs  (CXCR4 test embryos). In control embryos, the 
average number of AK2F-WT PGCs and RFP-PGCs per gonadal section was 4.6 and 
6.4 respectively (Fig. 5.9A). The ratio between gonadal AK2F-WT and RFP-PGCs 
was 1:1.4, however, this difference was not significant (Fig. 5.9A). Similar to AK4M-
CXCR4 -/- PGCs, AK2F-CXCR4-/-PGCs were almost entirely absent from the gonads 
Figure 5.8 Analysis of gonadal colonisation by male CXCR4-deficient and c-Kit-
deficient PGCs. Representative gonadal sections of;  A) control embryos injected with 
AK4M-WT PGCs and RFP-PGCs B) CXCR4 test embryos injected with AK4M-
CXCR4-/- PGCs and RFP-PGCs  C) c-Kit test embryos  injected with AK4M-c-Kit-/- 
PGCs and RFP-PGCs. Data are number of injected PGCs per gonadal section. P-value: 
Student’s test comparison ns-not significant ****p<0.0001  D) Data are GFP-PGC 
count/section normalised to RFP-PGC/section. P-value: One-way ANOVA Tukey’s 
multiple comparison’s test *p<0.05, ****p<0.0001. E) Data are GFP-PGCs normalised 
to RFP-PGCs, plotted as a percentage of the wild type (AK4M-WT). White dashes 





or the surrounding extragonadal areas in sections of CXCR4 test embryos, whereas an 
average of 7.0 RFP-PGCs was observed per gonadal section (Fig. 5.9B). This result 
indicates that CXCR4 signalling is also essential for the migration of female PGCs to 
the gonads. To directly compare the number of female gonadal wild-type and CXCR4-
deficient PGCs, the number of GFP-PGCs in each section was divided by the number 
of RFP-PGCs in other to normalise the data. After normalisation, the average number 
of wild-type PGCs was significantly different from the number of CXCR4-deficient 
PGCs (p<0.0001) (Fig 5.9C). From the normalised data, it was observed that the 
deletion of CXCR4 reduced the gonadal female PGC count by up to 90% (Fig. 5.9D). 
 
5.3.6 Analysis of the growth pattern of post-migratory c-Kit-deficient PGCs 
between stage 30-40 HH 
To assess the growth rate of c-Kit-deficient PGCs after gonadal colonisation, 
manipulated embryos were incubated till day 14 (Stage 39-40 HH). Male AK4M-WT 
PGCs and male AK4M-c-Kit-/- PGCs were injected into several embryos in two 
independent experiments (control embryos contained AK4M-WT PGCs while c-Kit 
test embryos contained). In control embryos, the average number of male wild-type 
PGCs observed was 153.2 per gonadal section while the corresponding number of 
control RFP-PGCs was 189.1 (Fig. 5.10A). In c-Kit test embryos, an average of 15.5 
male c-Kit-deficient were observed per gonadal section whereas the corresponding 
number of control RFP-PGCs was 356.0 (Fig 5.10B). Compared to the number of 
gonadal PGCs at incubation day 7, the average number of wild-type PGCs increased 
25-fold whereas a 3-fold increase in PGC numbers was observed for c-Kit-deficient 
PGCs (Fig 5.10C). There was a significant difference (p<0.0001) between the number 
of gonadal wild-type PGCs and c-Kit-deficient PGCs after normalising GFP-PGC 
counts to RFP-PGC counts (Fig. 5.10D). This result indicates that c-Kit signalling is 









Figure 5.9 Analysis of gonad colonisation by female CXCR4-deficient PGCs. 
Representative gonadal sections of A) control embryo injected with AK4M-WT PGCs 
and RFP-PGCs B) CXCR4 test embryos injected with AK4M-CXCR4-/- PGCs and 
RFP-PGCs. Data are number of injected PGCs per gonadal section. P-value: Student’s 
test comparison ns-not significant ****p<0.0001  C) Data are GFP-PGC count/section 
normalised to RFP-PGC/section. P-value: Mann-Whitney test ****p<0.0001. D) Data 
are GFP-PGCs normalised to RFP-PGCs, plotted as a percentage of the wild type 
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5.3.7 Investigation of AKT kinase as a key downstream effector of c-Kit 
signalling in the in vivo growth of post-migratory gonadal PGCs  
As mentioned previously, AKT has been shown to be a downstream effector of c-Kit 
signalling in mouse PGCs (De Miguel et al., 2002). AKT signalling is able to support 
survival and proliferation of chicken PGCs in culture after removal of insulin (Whyte 
et al., 2015). Furthermore, c-Kit signalling has been reported to phosphorylate AKT in 
cultured chicken PGCs (Dr Joni Macdonald, PhD Thesis 2011). To test if exogenous 
expression of AKT in c-Kit-/- PGCs could increase the growth of gonadal PGCs 
between day 7 and day 14, c-Kit-/- PGCs conditionally expressing AKT were 
generated and investigated.  
 
5.3.7.1 Generation of c-Kit-deficient PGCs conditionally expressing AKT 
To achieve conditional expression of AKT, male AK4M-c-Kit-/- PGCs and female 
AK2F-c-Kit-/- PGCs were co-transfected with piggyBac transposase and a piggyBac 
vector carrying a tetracycline-inducible cassette containing a hybrid CAGG promoter 
for AKT expression (PB-Tet-On-AKT; Fig 5.11A) (Glover et al., 2013). Stably 
transfected PGCs were selected with 0.4 µg/ml puromycin for two weeks and 
subsequently expanded. To demonstrate that the transposon is functional, 200, 000 
transfected PGCs (AK4M-c-Kit-AKT and AK2F-c-Kit-AKT cell lines) were treated 
with 1 µg/ml doxycycline hyclate in a starvation medium (basic medium containing 
no growth factors) for 24 hrs (CHAPTER TWO, Section 2.1.5.5). To serve as 
treatment control, wild type PGCs and a separate group of transfected PGCs (AK4M-
c-Kit-AKT and AK2F-c-Kit-AKT cell lines) were grown alongside without treating 
with doxycycline. Western blot of the total protein extracted from treated and untreated 
PGCs were probed for phosphorylated AKT. Phosphorylated AKT was detected in 
transfected PGCs treated with doxycycline but was absent in untreated and wild type 
PGCs (Fig 5.11B). To confirm that similar levels of protein were loaded for western 
blot analysis, the expression of γ-tubulin was probed, and approximately equal levels 







5.3.7.2 Analysis of the ability of heterologous AKT expression to increase the 
growth of post-migratory c-Kit-deficient PGCs between stage 30-40 HH 
500 Transposon-modified male AK4M-c-Kit-/- PGCs (from AK4M-c-Kit-AKT cell 
line) were co-injected with 500 RFP-PGCs into several stage 16 HH chick embryos 
(on incubation day 2.5) and incubated till day 7. Beginning on incubation day 7, 100 
µl of 1 mg/ml doxycycline was injected into the amnion of each embryo and the egg 
resealed. This was repeated on incubation days 9, 11 and 13 after which the embryo 
was sacrificed on incubation day 14. Several manipulated embryos injected with 
doxycycline in five independent experiments. In both control and doxycycline-treated 
embryos, GFP-PGCs were not observed in the gonadal sections whereas wild type 
RFP-PGCs were present in all gonadal sections (Fig. 5.12). This result indicates that 
A 
B 
Figure 5.11 Generation of c-Kit deficient PGCs conditionally expressing AKT. 
A) Schematic of the piggybac vector containing a CAG enhancer/promoter which 
drives the expression of a third generation reverse tetracycline transactivator protein 
(rtTA3) followed by an internal ribosome entry site (IRES) and the puromycin 
resistance gene (puro) which allows for selection and expansion of transfected cells. 
If doxycycline is present, rtTA3 binds to the tetracycline response element (TRE) to 
drive expression of constitutively active form of human AKT. (Vector schematic from 

















Figure 5.12 Representative sections of stage 37-40 HH chick embryo gonads. In 
ovo induction of AKT in AK4M-c-Kit-/- PGCs failed to rescue survival or 
proliferation. Upper images are male gonads while lower images are female gonads. 
Red signals are RFP-PGCs. Blue signals are Hoechst 3324 nuclear stains. Scale bar 






As discussed in CHAPTER ONE, the gene regulatory factors that control the 
development of the avian germ cell lineage are largely unknown. CXCR4 has 
previously been suspected to play a major role in promoting the migration of chicken 
PGCs to the genital ridges whereas no role has been described for c-Kit in promoting 
avian PGC migration (Stebler et al., 2004). In this chapter, essential roles for the 
CXCR4 and c-Kit genes in chicken germ cell development have been demonstrated 
through genome editing of PGCs.  
5.4.1 Loss of expression of c-Kit and CXCR4 has no effect on chicken PGC 
growth in vitro 
The loss of function of the CXCR4 and c-Kit receptors had no effect on chicken PGC 
proliferation in vitro. Also, the germ cell identity characterised by the expression of 
Cvh was unaffected. In contrast, c-Kit signalling activates MEK and AKT and is 
required for in vitro survival and proliferation of mouse PGCs (De Miguel et al., 2002; 
Dolci et al., 1991; Matsui et al., 1991).  c-Kit signalling has also been shown to activate 
AKT and MEK in cultured chicken PGCs if the SCF ligand is supplied in the culture 
medium (Macdonald, 2011). Furthermore, the rate of chicken PGC proliferation has 
been shown to increase when FGF2 and SCF are supplied in culture compared to the 
addition of FGF2 only (Macdonald, 2011; Miyahara et al., 2016), However, SCF alone 
was not sufficient to support chicken PGC proliferation. The finding that the loss of c-
Kit or CXCR4 is dispensable for chicken PGC culture comes as no surprise since the 
FOAT culture medium used to propagate chicken PGCs in this study does not contain 
SCF or SDF-1 (Whyte et al., 2015). 
5.4.2 CXCR4 signalling is essential for the final stage of chicken PGC migration 
to the forming gonad 
CXCR4/SDF-1 signalling is essential for the migration of PGCs in many vertebrates 
including zebrafish, mouse and Xenopus (Ara et al., 2003; Doitsidou et al., 2002; 
Knaut et al., 2003; Molyneaux et al., 2003; Takeuchi et al., 2010). Similar to reports 
in other vertebrates, the results in this study show that loss-of-function of CXCR4 
drastically reduces the number of both male and female chicken PGCs that colonise 





plate mesoderm as efficiently as wild type PGCs (Fig. 5.7). This indicates that CXCR4 
signalling is dispensable during circulatory migration and is only important in late 
migration after the germ cells have exited the vascular system. However, a quantitative 
analysis to accurately determine the proportion of CXCR4-deficient PGCs, in 
comparison to wild type PGCs, colonising the lateral plate mesoderm from the 
vascular system was not performed due to a shortage of time and should be done in 
future studies. It was previously suggested that circulatory PGCs may be attracted to 
colonise the lateral plate mesoderm due to the expression of SDF-1. Using in situ 
hybridization, SDF-1 expression was shown to occur caudally in the ectoderm 
overlaying the genital area (lateral plate mesoderm, paraxial mesoderm and 
intermediate mesoderm) between stages 12-15 (Rehimi et al., 2008; Stebler et al., 
2004). At stage 18, SDF-1 expression is confined to the lateral plate mesoderm and 
overlaps with the position of the PGCs (Rehimi et al., 2008; Stebler et al., 2004). This 
therefore suggests the presence of other migration signals that home chicken PGCs in 
the vascular system and concentrate them in the lateral plate mesoderm. A similar 
pattern is observed in mouse embryos in which CXCR4/SDF1 signalling is 
dispensable for early PGC migration from the allantois at ED 7.5 to the dorsal hindgut 
endoderm at ED 9.5 but is only essential once mouse PGCs exit the hindgut (Ara et 
al., 2003; Molyneaux et al., 2003). CXCR4/SDF-1 signalling may therefore be 
required for survival and/or proliferation of chicken PGCs during this post-circulatory 
stage of migration. With this possibility, the population of PGCs reduces progressively 
in the absence of CXCR4/SDF-1 signalling as they die out leading to a failure to 
colonise the genital ridges. This possibility is supported by the observation in this study 
wherein a few CXCR4-deficient PGCs were observed in the gonads. A similar survival 
role for CXCR4 has also been suggested for mouse PGCs (Ara et al., 2003; Molyneaux 
et al., 2003). In contrast, CXCR4 signal is not essential for survival of zebrafish PGCs 
as mutant or CXCR4-depleted zebrafish germ cells are randomly dispersed around the 
embryo (Doitsidou et al., 2002; Knaut et al., 2003). In this study, ectopic CXCR4-
deficient chicken PGCs in other parts of the chick embryo were not observed therefore 
indicating that there is no loss of directionality or that ectopic PGCs are eliminated as 





the mouse and Xenopus (Ara et al., 2003; Molyneaux et al., 2003; Takeuchi et al., 
2010).  
CXCR4 signalling has been shown to promote calcium mobilization and actin 
reorganisation in migrating zebrafish PGCs and other migrating cell types which is 
required for cell polarisation during active migration (Blaser et al., 2006; Xu et al., 
2012). It is therefore possible that CXCR4 signal is required for efficient motility of 
migrating chicken PGCs. This would indicate that CXCR4-deficient chicken PGCs are 
less motile and are eventually out of the range of other survival factors leading to their 
death. However, the embryonic stages from when PGCs colonise the lateral plate until 
the colonisation of the genital ridges need to be examined sequentially to observe the 
fate of chicken CXCR4-deficient germ cells in order to make more robust conclusion 
about a survival or motility role for CXCR4/SDF-1 interaction during this final 
migration step.  
Furthermore, mouse and chicken PGCs have been reported to be attracted to ectopic 
sources of SDF-1 in vivo (Molyneaux et al., 2003; Stebler et al., 2004). This may 
suggest a directional role for CXCR4 signalling only after exit of chicken PGCs from 
the vascular system. Therefore, chicken PGCs may concentrate in the lateral plate 
mesoderm under the guidance of a different signal but are subsequently directed by 
CXCR4/SDF-1 signalling to the genital ridges. CXCR4-deficient PGCs that fail to 
sense the SDF-1 signal do not reach the genital ridges and are stranded faraway from 
survival factors leading to their death. This may be tested by inducing a conditional 
loss-of-CXCR4 in PGCs at stage 18 HH when PGCs are expected to have colonised 
the lateral plate. A few female CXCR4-deficient PGCs were observed in this study to 
reach the genital ridges, suggesting CXCR4/SDF1 may be acting cooperatively in an 
additive manner with other migration signals to provide directionality to migrating 
PGCs.  
In conclusion, the results of this chapter show that CXCR4 is a key receptor for 
promoting the migration of chicken primordial germ cells, and is in agreement with 






5.4.3 c-Kit signalling is dispensable but required for efficient final-stage 
migration of chicken PGC migration  
The interaction of c-Kit with its ligand SCF is essential for PGC colonisation of the 
gonads in mice (Buehr et al., 1993; Gu et al., 2009; Runyan et al., 2006). In contrast 
to mammalian PGCs, the c-Kit signalling pathway plays no role in zebrafish PGC 
migration (Mellgren & Johnson, 2005; Parichy et al., 2000). Circulating male c-Kit-
deficient chicken PGCs can colonise the gonads but the number of PGCs that reach 
the genital ridges is significantly reduced to approximately 40% of control numbers 
(Fig. 5.8). Contrastingly, a more severe phenotype is seen in mice embryos harbouring 
homozygous loss-of-function mutation in SCF or c-Kit as they are almost completely 
devoid of PGCs in the genital ridges (Buehr et al., 1993; Mahakali Zama et al., 2005). 
c-Kit/SCF interaction is essential for the survival of mouse PGCs in all phases of 
migration and loss of c-Kit signal results in reduced PGC numbers which is partially 
rescued by inhibiting BAX-mediated apoptosis (Gu et al., 2009). It is therefore 
possible that the reduction in the number of c-Kit-deficient chicken PGCs colonising 
the gonads is due to reduced survival, but this will need to be proven by identifying 
key downstream signalling pathways. The growth factors that ensure the survival of 
pre-circulatory and circulatory chicken PGCs are unknown. It is possible that c-
Kit/SCF interaction plays a key role in ensuring survival during these stages but needs 
to be investigated in future studies. 
Furthermore, it is also possible that c-Kit signal is required for efficient motility of 
chicken PGCs from the lateral plate mesoderm to the genital ridges. Under this 
assumption, the observed reduction in the number of chicken c-Kit-deficient PGCs in 
the gonads may be due to reduced PGC motility that results in delayed migration. In 
SCF and c-Kit-mutant mice embryos, PGC migration is severely retarded due to poor 
motility and clumping of cells along the migration path (Buehr et al., 1993; Gu et al., 
2009). c-Kit/SCF signalling was shown to induce actin reorganisation in the 
cytoskeleton of mouse PGCs to promote motility (Farini et al., 2007). Interestingly, 
chicken PGCs have also been shown to polarize, form persistent membrane protrusions 
and exhibit significant directional migration towards gradients of SCF in vitro 





growth factors especially CXCR4/SDF-1, to promote efficient motility in this final 
phase of migration through the mesoderm.  
Since c-Kit-deficient chicken PGCs reach the gonads, other migration signals such as 
SDF1 must direct the migration of chicken PGCs in the last migration phase. c-Kit 
signal may act cooperatively with other signals, specifically CXCR4 signal, to provide 
directional cues during migration from the lateral plate mesoderm to the genital ridges. 
This kind of cooperation is observed in the attraction of hematopoietic CD34+ 
progenitor cells wherein c-Kit and CXCR4 signalling act synergistically (Dutt et al., 
1998).  
Female c-Kit-/- PGCs were generated in this study but their migratory behaviour was 
not analysed due to a shortage of time and should be analysed in future studies. The 
migratory behaviour of female c-Kit-deficient PGCs is expected to be similar to that 
of male c-Kit-deficient PGCs. Currently, there is no evidence in any organism for sex-
specific differences between the migration of male and female PGCs prior to arrival 
and differentiation in the gonads (Nikolic et al., 2016). 
 
5.4.4 c-Kit signalling may be required for proliferation of chicken PGCs in vivo 
Using in situ hybridization, SCF has been shown to be expressed in the lateral plate 
mesoderm and the stalk of the intermediate mesoderm from stages 8 to 22 HH (Reedy 
et al., 2003). In particular, a high SCF mRNA gradient was noted in the splanchnic 
mesoderm of the genital ridges between stages 17 and 22 HH (Reedy et al., 2003). 
This pattern of SCF expression is similar to what is observed in mouse embryos which 
supports PGC migration as they exit the hindgut (Gu et al., 2009, 2011; Matsui et al., 
1990). However, it is not known if SCF expression is maintained beyond stage 22 HH 
in chick embryos. Chicken PGCs also express c-Kit from at least stage 17 HH, 
increasing in intensity by stage 19 HH and persists until at least stage 22 HH (Reedy 
et al., 2003). This may suggest a role for c-Kit/SCF signalling in promoting migration 
and survival of chicken PGCs.  c-Kit is expressed by mouse PGCs from ED7.5 when 
they are exiting the allantois, during migration and early residence in the gonads and 





meiosis (Manova & Bachvarova, 1991). Mouse PGC proliferate and increase in 
number during migration and also during early residence in the gonads (Buehr et al., 
1993). Like mouse PGCs, chicken PGCs have been observed to proliferate in the 
gonads after arrival at day 6 and up to day 10 (Swift, 1914). In this study, it was 
observed that the number of c-Kit-deficient PGCs in the chick embryonic gonads at 
day 7 was significantly reduced and subsequently, it was observed that the number of 
c-Kit-deficient PGCs only increased by 3-fold (compared to 25-fold for wild type 
PGCs) between incubation day 7 and 14 (Fig. 5.11). This result suggests that chicken 
gonadal PGC proliferation or survival is supported by the c-Kit signal as observed in 
mice. However, it would be useful to check for the expression of proliferation markers 
such as Ki67 in gonadal c-Kit-deficient PGC to confirm a role for proliferation (Sun 
& Kaufman, 2018). Also, it is possible that the reduced number or complete absence 
of gonadal c-Kit-deficient PGCs is due to poor survival. This can be investigated by 
checking for the expression of apoptotic markers such as Caspase3 or inhibiting BAX 
to prevent apoptosis and rescue PGC numbers (Wolf et al., 1999).   
5.4.5 AKT expression alone may not be sufficient to rescue gonadal PGC 
survival or proliferation in vivo 
 AKT is a downstream target of c-Kit/SCF signalling that has been shown to promote 
cell survival (Blume-Jensen et al., 1998). c-Kit/SCF signalling has been shown in vitro 
to phosphorylate AKT in mouse PGCs (Farini et al., 2007) and chicken PGCs 
(Macdonald et al., 2012). However, it is not known if exogenous AKT expression 
alone can rescue PGC proliferation and survival in c-Kit- or SCF-mutant mice 
embryos. The attempt to rescue proliferation of male c-Kit-deficient chicken PGCs in 
this study through exogenous AKT expression was unsuccessful (Fig 5.12).  A 
previous study using the PB-Tet-On-AKT vector used in this report showed that the 
CAG-driven AKT expression inhibited chicken PGC migration suggesting that a 
correct level of AKT expression is required for PGC migration (Glover et al., 2013). 
Therefore, it may be useful to use a promoter that drives the correct level of AKT 
expression in order to support PGC proliferation or survival in the gonads. However, 
c-Kit signalling activates multiple pathways which may act cooperatively to support 
survival or proliferation (Rönnstrand, 2004). The MEK/MAPK pathway has been 





inhibition of  MEK/MAPK significantly reduced proliferation (De Miguel et al., 2002). 
Also, the SCF-induced migration and proliferation of human cardiac progenitor cells 
cultured ex vivo was shown to be significantly retarded when either MEK-MAPK 
and/or PI3/AKT was inhibited (Vajravelu et al., 2015). c-Kit signalling also activates 
the JAK/STAT pathway, and JAK2 was shown to be constitutively phosphorylated 
upon c-Kit activation (Rönnstrand, 2004). Inhibition of JAK2 using antisense 
oligonucleotides significantly decreased SCF-induced proliferation in human and 
murine cells and progenitor cells (Weiler et al., 1996). Furthermore, SCF-induced 
proliferation of foetal liver hematopoietic progenitor cells decreased by up to 70% 
following targeted deletion of JAK2 (Radosevic et al., 2004). Therefore, it will be 
useful to investigate each of the multiple pathways activated by c-Kit signal in chicken 














CHAPTER 6  
6 GENERAL DISCUSSION 
The central aim of this thesis was to determine if genome editing of the avian germ 
cell lineage using the CRISPR/Cas9 system can be developed as an efficient and 
simple approach to precisely introduce or remove alleles and also study gene function 
in birds. 
6.1. Making single nucleotide changes in chicken PGCs using CRISPR/Cas9 
In CHAPTER THREE, the introduction of single nucleotide changes, and the use of 
ssODN donors was successfully demonstrated in chicken PGCs for the first time. For 
avian biology, the use of this technique could help to address some of the challenges 
in predicting complex traits using genome-wide association studies (GWAS) data by 
validating SNPs, other single nucleotide mutations and small genetic changes in 
functional genetic regions identified through forward genetic screens (Goddard & 
Hayes, 2009). For example, the 535A>T nonsense mutation in chicken FGF20 which 
was introduced into PGCs by genome editing in CHAPTER THREE results in a 
truncated protein that has been associated with featherless phenotype, but this 
hypothesis has yet to be experimentally validated (Wells et al., 2012). These FGF20-
edited PGCs can now be used to generate the edited chickens to validate the 535A>T 
mutation as the cause of the scaleless phenotype in future studies. There is also the 
potential to use the technique demonstrated in CHAPTER THREE for rapid 
introduction of alleles into commercial pedigree lines while maximally conserving the 
genetics of the recipient population. 
The high fidelity SpCas9-HF1 permitted efficient monoallelic and biallelic 
incorporation of single nucleotide changes in chicken PGCs. Using SpCas9-HF1 may 
be useful for reducing CRISPR/Cas9 off-target mutations compared to the use of wild-
type SpCas9 in some loci (Kleinstiver et al., 2016). However, the amino acid 
substitutions that confer this enhanced specificity in SpCas9-HF1 also reduces its on-
target cleavage activity to 70% of the wild-type SpCas9 across many loci in human 
cells (Chen et al., 2017b; Kleinstiver et al., 2016). This reduced on-target activity may 
limit the application of SpCas9-HF1 with a cognate gRNA at some targets, similar to 





E; Figure S1). Furthermore, SpCas9-HF1 is restricted by an NGG PAM like its wild-
type counterpart.  Previous reports show that NGA can also serve as a secondary PAM 
for wild-type SpCas9 (Hu et al., 2018; Zhang et al., 2014)  Indeed, my results in 
CHAPTER THREE may suggest that SpCas9-HF1 is more sensitive to the NGG PAM 
requirement compared to wild-type Cas9. Introduction of the scaleless mutation into 
FGF20 was inefficient with wild-type Cas9 (CHAPTER THREE: Figure 5B). It is 
possible that following the AGG to AGA PAM editing, the AGA sequences was still 
able to permit activation of wild-type Cas9 but not SpCas9-HF1. If this is the case, 
then the strict PAM specificity of SpCas9-HF1 was advantageous in increasing HDR 
efficiency in my experiment but may become a hindrance in genomic sites in which 
there are no NGG sequences. This may be overcome by using modified Cas9 variants 
with broader PAM compatibility (Hu et al., 2018)  or using other artificial site-specific 
nucleases. TALENs are effective for editing chicken PGCs and may be tested with 
ssODN donors in future studies for sites where CRISPR/Cas9 PAMs are absent (Park 
et al., 2014; Taylor et al., 2017). 
ssODN donors proved to be very useful donors for introducing single nucleotide 
changes. In CHAPTER THREE, nucleotide substitutions as far as 19 bp away from 
the cleavage site were introduced using SpCas9-HF1 into many loci without mutating 
the PAM with an efficiency of up to 40% (CHAPTER THREE; Figure 2). It would be 
useful in future studies to determine the efficiency of nucleotide substitutions as 
mutation-to-cleavage site distance increases when ssODN donors are used as has been 
demonstrated for human cells (Paquet et al., 2016). This information would be useful 
for designing repair templates for biallelic and monoallelic editing in chicken PGCs.   
CRISPR/Cas9 mediates efficient HDR genome editing in chicken PGCs as 
demonstrated in this thesis, however, the introduction of double-stranded breaks 
(DSBs) has the potential to introduce chromosomal abnormalities (Spits et al., 2008; 
Van Gent et al., 2001). Previous reports have shown through the sequencing of larger 
kilobase regions around the gRNA target in mouse zygotes and targeted clonal human 
and mouse cells that CRISPR/Cas9-induced DSBs caused large deletions, 
duplications, inversions, chromosomal crossover events and other complex genomic 





2017). Some of the larger genomic alterations were missed when only small regions 
limited to the vicinity of the gRNA target were sequenced. Therefore, large genomic 
alterations induced by CRISPR/Cas9 in chicken PGCs may have been missed since 
only the immediate vicinity of the induced DSBs was analysed through the analysis of 
small PCR products (of approximately 600-bp).  In future studies, screening of larger 
genomic regions of at least 5- to 10-kb may be performed. Large chromosomal 
abnormalities, if present, may also be identified through the examination of metaphase 
chromosomes through karyotype analytical methods such as chromosome analysis by 
g-bands using trypsin and Giemsa (GTG-banding) and fluorescence in situ 
hybridization (FISH) (Schoumans & Ruivenkamp, 2010). However, avian cell 
karyotyping is difficult and complex due to the presence of multiple 
microchromosomes in avian species that are difficult identify and distinguish due to 
their small size and lower degree of chromatin compaction (Fechheimer & Jaffe, 1966; 
Fillon, 1998). The analysis for Cas9-induced genomic alterations should be coupled 
with the analysis for off-target mutagenesis and random integrations of CRISPR/Cas9 
DNA constructs or donor template DNA sequences. It is important to ensure 
unintended genomic alterations induced by genome editing are absent in PGC lines 
selected for downstream experimentation. These unintended genomic alterations may 
lead to transcriptional consequences that may affect PGC development or negatively 
impact on embryonic and post-hatch development as well as the fitness of the adult 
bird, which is especially an important consideration for poultry breeding.  
6.2. FAOT PGC medium permits clonal expansion of genome-edited PGCs 
Similar to gene targeting of mouse ES cells, the clonal permissiveness of FAOT 
medium allowed for the isolation of genome-edited clonal PGC populations with a 
defined genotype in this thesis (Capecchi, 1989a). Without clonal PGC enrichment for 
a specific genotype, many G1 birds would need to be generated in order to screen and 
identify the few individuals with the desired genotype for downstream experiments. 
The ability to perform clonal PGC enrichment will permit the generation of chickens 
with defined genotypes. This will reduce the number of birds that would need to be 
generated for experimental breeding which addresses the 3Rs (replacement, reduction 
and refinement) for humane use of animals in research (Russell & Burch, 1959; 





Single-cell clonal culture can cause genomic abnormalities in cells. Genetic 
heterogeneity and chromosomal abnormalities have been observed after clonal culture 
of human pluripotent stem cells (Bai et al., 2015; Mayshar et al., 2010; Yu et al., 2009). 
With regards to the edited PGCs generated in this thesis, it is unknown if the process 
of genome editing and subsequent single cell culturing resulted in significant 
accumulation of subtle single nucleotide mutations or chromosomal aberrations in the 
edited clonal populations or selection for loss-of-function in cell cycle regulating  and 
DNA damage response genes such as p53, ATM, PARP1 and BRCA1 (Broustas & 
Lieberman, 2014; Mandal et al., 2011; Roos et al., 2016). Also, recent reports show 
that increased CRISPR/Cas9-mediated HDR efficiency is associated with a selection 
for reduced p53 function in edited immortalized human retinal pigment epithelial and 
human induced pluripotent stem cells (Haapaniemi et al., 2018; Ihry et al., 2018). It 
will be useful to analyse edited clonal PGCs for markers of genetic instability in 
comparison to the parental unedited cell population. Karyotype analysis methods 
described in Section 6.1 may also be used to analyse chromosomal integrity of clonal 
PGCs in future studies. The ability to genetically modify, clone and propagate edited 
chicken PGCs indefinitely in FAOT medium may be an indication that PGCs are 
highly genetically stable. 
Finally, healthy genome-edited chickens harbouring small defined sequence changes 
have been generated from PGCs targeted with CRISPR/Cas9 and ssODN donors by 
Dr Michael McGrew’s group (Dr Michael J. McGrew; unpublished data). This 
indicates that PGCs edited using this method are competent in forming a productive 
germline.   
6.3. Investigating gene function in cell lines derived from genome-edited chicken 
PGCs 
There are few immortalised avian cell lines suitable for the study of host range, 
molecular genetics and molecular pathobiology of avian influenza virus in comparison 
to numerous available mammalian cell lines (Lee et al., 2008). The human 293T cells, 
in particular, has been widely used in reverse genetics experiments in avian influenza 
studies in which avian genes are heterologously expressed to study their function 





available avian cells, RNA interference gene silencing (RNA knockdown) in pooled 
cells has been utilized for the investigation of host genes suspected to play defining 
roles in avian influenza host-pathogen interaction (Haq et al., 2013; Kim & Zhou, 
2015; Kuo et al., 2017; Long et al., 2016; Tanikawa et al., 2017). However, RNA 
knockdown is transient and reduces gene function but does not completely eliminate 
it since the transcriptional product of interest is not completely degraded, and some 
mRNA can still be detected using Northern blot or real-time PCR (Mocellin & 
Provenzano, 2004).  
In contrast, genome editing permanently changes the genetic code and completely 
eliminates gene function, and CRISPR/Cas9 is reported to be far less to susceptible to 
systemic off-targets compared to RNA interference (Doudna et al., 2014; Smith et al., 
2017). Therefore, the ability to perform precise genome editing and generate clonal 
lines of genetically modified PGCs makes PGCs a useful model for studying host-
pathogen interaction as I demonstrated in the investigation of ANP32A in CHAPTER 
FOUR. Fibroblast-like cells derived from chicken PGCs successfully supported IAV 
vPol activity and have also been successfully infected (Dr Nikki Smith, Dr Jason Long; 
unpublished data). Whether, this PGC-derived cell line will support the replication of 
a wide range of avian influenza viral strains as demonstrated for chicken DF-1 cells 
and Quail QT-6 cells should be tested in future studies (Lee et al., 2008). The capacity 
to support the growth of several strains of avian influenza virus is important if PGC-
derived cell lines are to be widely adopted for influenza virological study and this 
should be determined in future experiments.  
It was assumed in this thesis that the karyotype of the PGC-derived fibroblasts was 
preserved since PGC-derived cells from mouse and human PGCs were shown to be 
stable and normal but this needs to be determined for differentiated chicken PGCs in 
future experiments (Matsui et al., 1992; Shamblott et al., 1998). I did not perform 
karyotype analysis for the reasons mentioned in SECTION 6.1. Finally, it will also be 
useful to perform a transcriptome analysis of the PGC-derived fibroblasts such as 
through total RNA sequencing to characterise these cells and determine if they are 






6.4. Dissecting the chicken genome to identify avian influenza resistance genes 
Lyall and colleagues first demonstrated the potential to use genetic engineering to 
suppress avian influenza in chickens (Lyall et al., 2011). In their study, they produced 
genetically modified chickens harbouring a transgene that encodes a decoy RNA 
hairpin molecule containing the conserved 3’ and 5‘ terminal sequences of the IAV 
genome which are the cRNA binding sites for the vPol (Fodor et al., 1994; Lyall et al., 
2011; Tiley et al., 1994). The RNA decoy binds to the vPol and inhibits its function. 
Chickens expressing this RNA decoy were susceptible to AI but did not transmit the 
virus to neighbouring uninfected birds. The development of these transgenic chickens 
that suppress the transmission of avian influenza was an important demonstration of 
the potential of using genetic engineering technology to produce superior disease-
resistant birds (Lyall et al., 2011). With the advent of genome editing technology, birds 
that are resistant to avian influenza can be developed through the direct modification 
of host genes that increase susceptibility without a need to introduce foreign genes. 
This would require the investigation of host genes that are required to support 
successful infection, replication and transmission of IAVs in avian cells.    
Using genome-edited PGC-derived chicken cells, my results in CHAPTER FOUR 
demonstrate a direct role for chicken ANP32A in promoting the vPol function of IAVs 
in chicken cells. Long et al. reported that the activity of avian vPol (PB2/627E) was 
decreased in DF-1 cells after RNAi knockdown of ANP32A (Long et al., 2016). Their 
report agrees with my observation that complete loss of ANP32A expression achieved 
through genome editing abrogated avian (PB2/627E) and human-adapted (PB2/627K) 
vPol function in PGC-derived chicken cells. Recent reports have identified critical 
domains of ANP32A that are required to support polymerase function (Baker et al., 
2018; Domingues & Hale, 2017). These reports are extended in this thesis by the 
observation that mutation of the N129 residue in the fifth LRR of chicken ANP32A is 
critical for IAV vPol function and may form the basis for generating an AI-resistant 
chicken. Exogenous expression of mutant N129I-ANP32A in ANP32A-deficient PGC 
fibroblasts was unable to rescue the activity of avian or human-adapted vPol beyond 
background levels suggesting the existence of an interaction between the N129 residue 
in ANP32A and the avian influenza vPol. This finding provides a premise to use 





chicken PGC line encoding N129I-ANP32A. Precise genome editing can be 
performed using a suitable repair template as demonstrated in CHAPTER THREE to 
perform single nucleotide replacement to change the N codon into the I codon. This 
novel PGC line can then be used to pursue an extended virological study using several 
IAV subtypes, and also investigate if the natural cellular functions of ANP32A are 
conserved in the mutant N129I-ANP32A. Importantly, this approach of investigating 
avian influenza activity in PGC-derived fibroblast-like cells can be adopted to 
investigate other host genes that have been identified through bioinformatic studies 
and are suspected to confer disease resistance to avian influenza in the chicken (Smith 
et al., 2015; Wang et al., 2014). Since defined sequence changes can now be introduced 
into any specific locus in chicken PGCs (CHAPTER THREE), it will now be possible 
to create novel chicken models to study the pathobiology of many infectious diseases, 
as has been done with numerous mouse models for the study of immune responses and 
infectious diseases (Bouabe & Okkenhaug, 2013).   
6.5. Unravelling genes that control the development of the avian germ cell lineage 
In contrast to mammals, the ease of culturing, genetically modifying and re-injecting 
avian PGCs into the avian embryo presents a useful cellular system to create unique 
germ cell mutations in PGCs to study germline genes that guide the development of 
germ cells within the developing somatic embryonic environment.  
In CHAPTER FIVE, I demonstrated, through targeted loss-of-function mutations 
created using the CRISPR/Cas9 system, that CXCR4 and c-Kit genes play essential 
roles in promoting chicken PGC migration. For CXCR4, a loss-of-function phenotype  
in the chick embryo characterised by a significantly reduced number of PGCs in the 
genital ridges is also observed in mouse, Xenopus and zebrafish (Ara et al., 2003; 
Doitsidou et al., 2002; Molyneaux et al., 2003; Takeuchi et al., 2010). From this 
observation, CXCR4 signalling may be required for directionality and/or survival as 
discussed in CHAPTER FIVE. Interestingly, the CXCR4 ligand, SDF1, is also a ligand 
for the CXCR7 receptor which has up to ten times greater affinity than for CXCR4. 
CXCR7 is essential for proper gonadal colonisation in zebrafish and depletion of 
CXCR7 through RNA knockdown in zebrafish embryos significantly reduced the 





CXCR7-deficient mice are fertile and produce offspring (Gerrits et al., 2008; Sierro et 
al., 2007). This may suggest that loss of CXCR7 function has no effect on germ cell 
development in mice. As for the chicken, in vitro cultured chicken PGCs express 
CXCR7 but it is not known whether it is essential for survival and migration of PGCs 
or fertility in adults (Jean et al., 2015; Macdonald, 2011). Since CXCR4-deficient 
chicken PGCs are significantly reduced or absent in the genital ridges, it is unlikely 
that CXCR4 and CXCR7 signalling redundantly mediate identical functions in 
providing directionality or promoting survival. In future studies, it would be useful to 
unravel any specific role for CXCR7 in avian PGC survival and/or migration. This can 
be investigated by generating clonal populations of PGCs bearing targeted loss of 
function mutations in CXCR7 using CRISPR/Cas9 and then assessing their in vitro 
and in vivo migration phenotype in a similar manner as demonstrated for CXCR4 in 
CHAPTER FIVE.  
Furthermore, I demonstrated that the type III receptor tyrosine kinase, c-Kit, is 
essential for efficient migration of PGCs from the circulatory system to the genital 
ridges. While the number of c-Kit deficient chicken PGCs present in the gonads was 
significantly reduced, this observed phenotype in the chick embryo is not as severe as 
reported in c-Kit deficient mice whose genital ridges are almost devoid of PGCs 
(Buehr et al., 1993) . However, I also observed that c-Kit deficient chicken PGCs were 
absent or failed to significantly increase in number in the gonads of older chick 
embryos (stage 40 HH). This reduced number of gonadal c-Kit deficient chicken PGCs 
indicates that the role of c-Kit/SCF signalling in survival or proliferation may be 
conserved in chicken and mouse. However, in vitro survival and proliferation of 
chicken PGCs can efficiently occur in the absence of c-Kit/SCF signalling and instead, 
relies on other pathways, namely FGF, Activin and Insulin (Miyahara et al., 2016; 
Whyte et al., 2015). This is in contrast for the requirement of c-Kit/SCF signalling for 
in vitro survival and proliferation of mouse PGC (Matsui et al., 1991).  
Additionally, c-Kit/SCF signalling and CXCR4/SDF1 signalling have been suggested 
to function redundantly with the Ror2/Wnt5a signalling pathway to regulate 
proliferation of migrating mouse PGCs (Cantú et al., 2016). Ror2 is a transmembrane 





migration to the genital ridges (Cantú et al., 2016; Laird et al., 2011). The Ror2 ligand, 
Wnt5a is expressed by somatic cells along the migratory path of PGCs from the 
hindgut to the genital ridges and overlaps Ror2 receptor expression by migrating 
mouse PGCs (Laird et al., 2011; Oishi et al., 2003). As for chicken embryos, it is yet 
to be determined if chicken PGCs express Ror2 during migration and if the Wnt5a 
ligand is expressed along the PGC migratory path and overlaps PGC location 
especially from the lateral plate to the genital ridges. Whether a similar role or other 
roles exist for Ror2/Wnt5a signalling in such a manner as to function cooperatively 
with CXCR4/SDF1 and c-Kit/SCF signalling in promoting the migration or survival 
of chicken PGC in the chick embryo is yet to be determined. The role of Ror2 
signalling can be investigated in migratory chicken PGCs through targeted deletion of 
Ror2 using CRISPR/Cas9 and analysing the in vivo migratory behaviour of the edited 
cells in a manner as demonstrated in CHAPTER FIVE.  
Furthermore, I was unable to determine the key signalling pathway activated by c-Kit 
signal which is critical for survival and proliferation of PGCs in the gonads. As 
observed in CHAPTER FIVE, deficiency of c-Kit was directly associated with a 
significant reduction of the number of PGCs in the gonads at older stages. AKT, MEK-
MAPK and JAK/STAT pathways are induced by c-Kit/SCF signalling in mouse PGCs 
and other cell types in which they drive proliferation and/or survival (Discussed in 
CHAPTER FIVE, Section 5.4.5). The relevance and function of each of the 
downstream pathways of c-Kit/SCF signalling can be investigated in future studies by 
using CRISPR/Cas9 to introduce conditional loss-of-function mutations to knockout a 
specific pathway in gonadal PGCs at specific embryonic stages. Alternatively, a 
transcriptional reporter such as GFP can be introduced into a key gene in the 
downstream pathway so that the reporter is expressed if c-Kit/SCF signalling induces 
the specific pathway. 
Using the method illustrated in this thesis, the roles of germline-specific genes such as 
Dnd1 and Dazl which are expressed by chicken PGCs but whose functions are yet to 
be experimentally elucidated can be investigated in future studies (Aramaki et al., 
2007; Lee et al., 2016; Macdonald et al., 2010; Rengaraj et al., 2010). However, the 





for chicken PGC survival as shown for mouse and zebrafish PGCs (Ruggiu et al., 1997; 
Sakurai et al., 1994; Weidinger et al., 2003; Youngren et al., 2005). Therefore, a 
strategy of using precise monoallelic editing using CRISPR/Cas9 as demonstrated in 
CHAPTER THREE can be performed to delete one allele while preserving the 
function of the second allele.   
6.6. Multiplex genome editing in poultry 
In this thesis, I have demonstrated efficient editing of single genetic loci in each of the 
PGC lines generated. In  other livestock species, genome editing has primarily been 
used to target single genes associated with specific monogenic traits that may be 
inherited in a dominant or recessive Mendelian fashion (Carlson et al., 2016; Niu et 
al., 2018; Whitworth et al., 2015). However, most traits such as disease resistance or 
resilience, egg production and growth rate in vertebrates are complex or quantitative 
traits that result from the cumulative action of many genes and the environment 
(Goddard & Hayes, 2009). Also, some monogenic traits may depend on unique 
mutations located in different locations on the same gene. Therefore, it would be useful 
to develop a multiplex genome editing method to accurately introduce multiple defined 
small sequence changes in more than one genomic location to stack beneficial traits to 
generate superior production birds, as this has not been demonstrated in any avian 
species (Cong et al., 2013). 
In future studies, it may be possible to perform multiplex genome editing in chicken 
PGCs using an all-in-one vector to achieve heterologous expression of SpCas9 
nuclease and multiple gRNAs or through the delivery of SpCas9 and multiple synthetic 
or in vitro transcribed (IVT) sgRNAs as mRNAs (Jao et al., 2013; Sakuma et al., 2015). 
Alternatively, CRISPR base editors can be used to introduce defined single nucleotide 
changes without inducing DSBs in the genome and eliminating the need for a HDR 
repair template (Komor et al., 2016).   
6.7. The commercialization of gene-edited poultry 
The first issue to address in the application of genome editing in commercial poultry 
is the prioritization of traits and the discovery of genetic targets. This issue was 
recently highlighted in a recent newsletter to the journal Poultry Science (Fulton, 





and propagation of favourable traits especially those with a low heritability 
(Bastiaansen et al., 2018; Jenko et al., 2015). This includes traits such as disease 
resistance and broiler fertility which are highly favourable in the poultry industry but 
are propagated inefficiently through traditional crossbreeding. Another major factor 
that must be considered is consumer acceptance and government regulations. From the 
consumer perspective, it will be highly advisable to focus efforts on welfare traits such 
as improving bone strength in broilers to address leg problems and disease resistance 
to reduce animal suffering/death. A visual trait such as featherlessness which confers 
heat tolerance may be unappealing to consumers (Cahaner et al., 2008). 
Once a suitable trait and its genetic target has been identified, the next step is to use a 
precise genome editing technique that addresses concerns of off-target mutagenesis, 
random DNA integration and subtle mutations of the genome that may occur during 
cell culture. The only available approach for precision genome editing of poultry, 
specifically the chicken, is presented in this thesis. Whole genome sequencing of 
edited clonal PGCs should be performed to screen the genome for random DNA 
integrations and Cas9 off-target mutations. Additionally, it would be useful to screen 
for unwanted mutations or alteration in function in key DNA damage repair genes, 
telomere-regulating genes and cell cycle regulators that control cell proliferation, cell 
growth, differentiation, and apoptosis. Some key cell cycle regulators that have been 
characterized in mammalian and chicken cells include p53, Mdm2, c-Myc and P16Ink4 
(Haapaniemi et al., 2018; Ihry et al., 2018; Kim et al., 2002; Kubbutat et al., 1997; Luo 
et al., 2018; Somerville et al., 2018). Defects in these genes could affect animal fitness. 
Once the genome-edited chickens are produced, it may be necessary to perform whole 
genome sequencing and transcriptome analysis to evaluate the introduced genetic 
change and characterize key cell cycle regulators or key functional genes from 
representative tissues in several individuals and compare with unedited individuals. 
Also, the animal phenotype expected after genome editing should be evaluated along 
with analysis of several traits and behaviours in different environments to analyse the 
fitness of the genome-edited chickens in comparison with wild type individuals. In 
particular, structural traits such as leg, hip, skin and foot pads should be evaluated. 





Reproduction/production traits such as egg production, semen quality and body weight 
should also be evaluated. However, no unexpected changes in fitness are expected to 
occur through the process of genome editing as all genome-edited chickens reported 
to date have been healthy with no obvious abnormality (Oishi et al., 2016; Oishi et al., 
2018; Park et al., 2014; Taylor et al., 2017). 
6.8. Summary of some major limitations of this thesis 
Many limitations in this thesis have been already been highlighted in previous sections. 
However, a few major limitations are highlighted in this section. 
 In CHAPTER THREE, large deletions induced by CRISPR/Cas9 in chicken PGCs 
may have been missed since only the immediate vicinity of the induced DSBs was 
analysed through the analysis of small PCR products (of approximately 600-bp). 
Furthermore, the GFP-to-BFP conversion assay was used to quantify INDEL/HDR 
outcomes after targeting of the eGFP transgene in chicken PGCs. It is not known if 
this observation is reflective of genome editing outcomes at endogenous sites in the 
chicken PGC genome. This can be investigated in future studies by using a recently 
reported approach developed to use droplet digital polymerase chain reaction to 
efficiently detect and quantify HDR and NHEJ events at endogenous gene loci (Kato-
Inui et al., 2018).  
In CHAPTER FOUR, only the reconstituted vPol of HPAI H5 N1 
A/turkey/England/50-92/91 virus was tested. It is therefore not known from this study 
if the vPol activity of other HPAI and LPAI virus serotypes are restricted by the 
ANP32A mutations demonstrated in this thesis. In future studies, reconstituted vPol 
of other IAV serotypes should be tested.  Importantly, the restriction of reconstituted 
vPol activity in ANP32A-mutant cells observed in this thesis may not be representative 
of actual viral infections. Therefore, actual viral infections of the edited cells must be 
performed in future studies and followed by subsequent validation of results by 
experimentally infecting animals.  
In CHAPTER FIVE, only a single clonal line of male and female c-Kit deficient PGCs 
were used for all experiments. Whether the same results will be obtained from using 





Also, the c-Kit female PGCs were not analysed due to shortage of time and it is 
unknown if the observations reported for male c-Kit-deficient PGCs also hold for 
female c-Kit-deficient PGCs. Furthermore, this study did not provide evidence to show 
that AKT is induced in gonadal c-Kit-deficient PGCs following doxycycline injection 
of the embryo. Therefore, the observation that exogenous AKT expression failed to 
rescue proliferation or survival of c-Kit-deficient PGCs must be taken with caution. In 
future studies, a reporter system can be used to track exogenous AKT induction in 
gonadal c-Kit-deficient PGCs.  
6.9. Conclusion 
The results I have reported in this thesis provides evidence for possible rapid 
introgression of specific haplotypes into chicken PGCs using CRISPR/Cas9 genome 
editing. Genome editing of PGCs unravelled important functions of ANP32A, CXCR4 
and c-Kit in chicken biology. This capability is yet to be demonstrated for other avian 
species which can be attributed to the unavailability of a defined culture medium for 
efficient derivation and long-term propagation of PGCs from these species. Therefore, 
it would be useful to define the growth factors and physiochemical properties that 
permit PGCs from other avian species in other to efficiently apply genome editing as 
demonstrated for chicken in this thesis. The development of a method for precision 
genome editing in avian species through editing of PGCs would be useful for studying 
gene function and dissecting genetic interactions that underlie various phenotypes in 
avian biology, including complex or quantitative traits in poultry genetics and 
breeding.  
Finally, there is the potential to apply genome editing to improve poultry health and 
welfare of pedigree lines for poultry production (Fulton, 2018). Transgenic methods 
such as the use of viral vectors to develop chickens expressing an RNA decoy to 
suppress avian influenza transmission have public concerns and may face restrictive 
regulations in comparison to genome editing (Lyall et al., 2011). Genome editing of 
poultry may gain more favourable public approval if it is used for the introduction and 
propagation of naturally-occurring defined genetic changes to improve health and 
welfare. However, the level of regulation adopted by different countries for livestock 





editing technologies in poultry. Already, the Court of Justice of the European Union 
has passed a ruling to regulate genome-edited crops and animals similar to genetically 
modified organisms containing a transgene (Court of Justice of the European Union, 
2018). This EU ruling is now predicted to slow down the development of GE 
technology in Europe resulting in calls for a new EU legislation (Bioeconomy Council 
of the Federal German Government, 2018b, 2018a). In contrast to this ruling, the 
United States has chosen not to regulate genome-edited plants that do not contain 
transgenes and this has already seen the development novel food products (U.S. 
Department of Agriculture, 2018). Unfortunately, this current USDA regulation does 
not currently apply to genome-edited animals and may negatively affect the adoption 
of animal genome editing around the world. In developing countries, genome editing 
of tropical poultry holds great promise to develop highly productive and adapted 
breeds to increase food security and boost local economies. The approval of climate-
adapted poultry through genome editing will depend on both international regulations 
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APPENDIX D: CRISPR/Cas9 transfection optimization 
 
Figure A1.  DDX4 targeting vector and gRNA targeting exon 2 of DDX4   
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APPENDIX D: CRISPR/Cas9 transfection optimization 
 
 
Transfection reagent % GFP+ cells 
No Reagent Control 0.0 
DMRIE-C (Invitrogen) 2.7 
Lipofectamine 2000 (Invitrogen) 8.8 
TransIT-X2 (Mirusbio) 1.8 
 
 
Figure A2.  Comparison of transfection reagents for transfection of cultured 
PGCs. 2 µg of DDX4 targeting vector was transfected into 150,000 non-transgenic 
PGCs (line 12F) using A) no transfection reagent B) 3 µl of DMRIE-C reagent C) 2 
µl of Lipofectamine 2000 D) 3 µl of TransIT-X2 as described in Section 2.4.5. The 
transfected PGCs were analysed for transient GFP expression by flow cytometry 48 














A. No gRNA 0% 0% 
B. 2 µg gRNA 0% 33% 
C. 1 µg gRNA 10% 22% 
 
Figure A3. Comparison of Lipofectamine 2000 and DMRIE-C. PGCs were 
transfected with CRISPR plasmid with or without DDX4 S1 gRNA and DDX targeting 
vector as described in Section 2.4.6 and then treated with puromycin 24 hours after 
transfection for 48 hours. The puromycin-resistant PGCs were expanded over a period 
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Figure A5. Comparison of HDR templates. PGCs were transfected with 1.5 µg of 
CRISPR plasmid with FGF20-gRNA1 and 0.4 µg (10 µM) of ssODN donors or 1.5 
µg of plasmid donor as described in Section 2.4.6 and then treated with puromycin 24 
hours after transfection for 48 hours. The puromycin-resistant PGCs were expanded 
over a period of three weeks and then analysed for HDR editing through EcoRI 







SUPPLEMENTARY INFORMATION  
High fidelity CRISPR/Cas9 increases precise monoallelic and biallelic editing events 
in primordial germ cells 
 
























Figure S1. Analysis of gRNA activity in FGF20 using T7 endonuclease I mismatch 
assay. gRNA sequences are highlighted in blue. PAMs are highlighted in purple. Blue 
arrowheads indicate Cas9 cleavage site.  Red arrows point to cleaved PCR substrates 




















Figure S2. Second independent experiments showing efficient oligonucleotide-
template HDR editing across multiple loci using SpCas9-HF1. gRNA sequences are 
highlighted in blue. PAMs are highlighted in purple. Blue arrowheads indicate Cas9 
cleavage site.  Black arrowheads indicate undigested PCR substrate. Red arrowheads 
indicate digested PCR products. (-) untreated substrate.  (+) treated substrate. (See 









Figure S3. Quantification of INDEL events in isolated BFP-PGC populations (Fig. 3C) 







Figure S4. Alignment of sequences from single-cell clones targeted with SpCas9-WT and 










Figure S5. Alignment of sequences from single-cell clones targeted with SpCas9-HF1 
and Sca-ssODN. Sca/INDEL clones*-refers to clones with monoallelic HDR. 
Sca/Sca*WT†-refers to clones with biallelic PAM mutation and monoallelic scaleless 
535A > T substitution. Sca/Sca clones with biallelic PAM mutation and biallelic 









Figure S6. Alignment of sequences from single-cell clones targeted with SpCas9-HF1 
and mixture of Sca-ssODN and Silent-ssODN. *-refers to Sca/INDEL clones with 
monoallelic HDR using Sca-ssODN.  †-refers to Sca/Sca*WT clones with biallelic PAM 
mutation and monoallelic scaleless 535A > T substitution. s-refers to Silent/INDEL 
clones with monoallelic HDR using Silent-ssODN. Sca/Silent clones with biallelic PAM 
mutation and monoallelic scaleless 535A > T substitution are highlighted in red. H-









Figure S7. Alignment of sequences from single-cell clones targeted with SpCas9-HF1 
and mixture of Sca-ssODN and Silent2-ssODN. *-refers to Sca/INDEL clones with 
monoallelic HDR using Sca-ssODN.  †-refers to Sca/Sca*WT clones with biallelic PAM 
mutation and monoallelic scaleless 535A > T substitution. **-refers to Silent2/INDEL 
clones with monoallelic HDR using Silent2-ssODN. ††-refers to Silent2/Silent2 clones 
with biallelic PAM mutation and monoallelic scaleless 535A > C substitution. 
Sca/Silent2 clones with biallelic PAM mutation and monoallelic scaleless 535A > C/T 







Figure S8. Uncropped gel images for Figure S1. 
 
 





















Table S1. List of gRNAs 









Table S2. List of ssODN donor sequences 
















































Table S3. List of PCR primers 
Name 5’                3’ 
CXCR4 Forward: 5’- TGTAGCACGCATCCCATTAGA -3’ 
Reverse: 5’- AGGTGATGACAAAGAGGAGGT -3’ 
Ovomucoid Forward- 5’ – GCTGGTTTATCACATGGGGAC -3’ 
Reverse- 5’ – CACCTCTCCATCCTTTTGCTC -3’ 
Ovalbumin Forward- 5’ – ACCCAAAAGACAACTGAATGCA -3’ 
Reverse- 5’ – GAGCTATGCAGTTTCCAAGGG -3’ 
FGF20 Forward- 5’- TGTCAGGTCTACACACTCCTC-3’ 
Reverse- 5’- CAAGTTTGAAGGAGGCTGGTC-3’ 
GFP Forward- 5’- TAAACGGCCACAAGTTCAGC-3’ 
Reverse- 5’- GATGTTGTGGCGGATCTTGAA-3’ 
 
 
 
 
 
